No. | Description |
---|---|
1 | 1p/19q deletion analysis (FISH) |
2 | Adenomatous polyposis coli (APC gene) |
3 | Breast-ovarian cancer, familial, 1 (BRCA1 gene) (MLPA) |
4 | ALK-Related Neuroblastoma Susceptibility (ALK Gene) (Exons 21-29) |
5 | cKIT (Exon9,11,13,17) |
6 | EGFR (FISH) |
7 | Ewing sarcoma t(11:22) (FLI1/EWSR1) (FISH) |
8 | HER2 Amplification (ERBB2 or NEU gene) (FISH) |
9 | Hereditary Nonpolyposis Colorectal Cancer (MLH1 gene) |
10 | IDH1 and IDH2 (IDH1 gene, codon 132 and IDH2 codon 172 mutations) |
11 | Polyposis, juvenile intestinal (SMAD4 gene) |
12 | Bladder cancer- UroVysion assay (FISH) |
13 | Multiple endocrine neoplasia 1 (MEN1 gene) |
14 | Neuroblastoma N-MYC (MYCN) (FISH) |
15 | P53 Gene (TP53) (17p13.1) (FISH) |
16 | Hypereosinophilic syndrome, (PDGFRA gene) (Exon12,18) |
17 | RET protooncogene (Exon 10-11-13-14-15 and 16) |
18 | Retinoblastoma (13q14) (FISH) |
19 | ROS1 (FISH) |
20 | TPMT polymorphisms (238 G>C, 460 G>A, 719 A>G) (Thioguanine Drug Metabolism) |
21 | Von Hippel-Lindau syndrome (VHL gene) |
22 | Acute myeloid leukemia, somatic, DNMT3A related |
23 | DNMT3A |
24 | Basal cell nevus syndrome |
25 | PTCH1 |
26 | Basal cell nevus syndrome |
27 | SUFU |
28 | Basal cell nevus syndrome due to germline PTCH2 mutation |
29 | PTCH2 |
30 | Beckwith-Wiedemann syndrome |
31 | CDKN1C |
32 | Beckwith-Wiedemann syndrome |
33 | chr. 11p15 |
34 | Beckwith-Wiedemann syndrome |
35 | H19 |
36 | Beckwith-Wiedemann syndrome |
37 | KCNQ1OT1 |
38 | BRAF somatic Hotspot: c.1799T>A p.V600E |
39 | BRAF, not available in the US |
40 | BRAF, selective sequencing of exon 15 |
41 | BRAF |
42 | Breast cancer, male, susceptibility to |
43 | BRCA2 |
44 | Breast cancer, RINT1 related |
45 | RINT1 |
46 | Breast cancer, susceptibility to |
47 | BARD1 |
48 | Breast cancer, susceptibility to |
49 | PALB2 |
50 | Breast cancer, susceptibility to |
51 | RECQL |
52 | Breast cancer, susceptibility to |
53 | XRCC3 |
54 | Breast-ovarian cancer |
55 | BRCA1 |
56 | Breast-ovarian cancer |
57 | RAD51C |
58 | Breast-ovarian cancer, familial, susceptibility to, type 4 |
59 | RAD51D |
60 | Breast-ovarian cancer, familial, type 2 |
61 | BRCA2 |
62 | CALR, selective sequencing of exon 9 |
63 | CALR |
64 | Carcinoid tumors, intestinal |
65 | SDHD |
66 | Carney complex type 1 |
67 | PRKAR1A |
68 | Cell cycle disorder, CDC20 related |
69 | CDC20 |
70 | Colorectal cancer, hereditary |
71 | NRAS |
72 | Colorectal cancer, hereditary nonpolyposis type 1 |
73 | MSH2 |
74 | Colorectal cancer, hereditary nonpolyposis type 2 |
75 | MLH1 |
76 | Colorectal cancer, hereditary nonpolyposis type 4 |
77 | PMS2 |
78 | Colorectal cancer, hereditary nonpolyposis type 5 |
79 | MSH6 |
80 | Colorectal cancer, hereditary nonpolyposis type 6 |
81 | TGFBR2 |
82 | Colorectal cancer, hereditary nonpolyposis type 7 |
83 | MLH3 |
84 | Colorectal cancer, hereditary nonpolyposis type 8 |
85 | EPCAM |
86 | Colorectal cancer, hereditary, susceptibility to |
87 | CCND1 |
88 | Cowden syndrome type 1 |
89 | PTEN |
90 | Cowden syndrome type 3 |
91 | SDHD |
92 | Cowden syndrome type 5 |
93 | PIK3CA |
94 | Cowden syndrome type 6 |
95 | AKT1 |
96 | Cutaneous telangiectasia and cancer syndrome, familial |
97 | ATR |
98 | Cylindromatosis, familial |
99 | CYLD |
100 | Desmoid disease, hereditary |
101 | APC |
102 | EGFR somatic Hotspot: c.2573T>G, p.L858R |
103 | EGFR, not available in the US |
104 | EGFR, selective sequencing of exons 18-21 |
105 | EGFR |
106 | Endometrial cancer, familial, MSH6 related |
107 | MSH6 |
108 | Familial adenomatous polyposis coli |
109 | APC |
110 | Familial adenomatous polyposis type 2 |
111 | MUTYH |
112 | Familial adenomatous polyposis type 3 |
113 | NTHL1 |
114 | Familial adenomatous polyposis type 4 |
115 | MSH3 |
116 | Gastric cancer, hereditary diffuse |
117 | CDH1 |
118 | Gastrointestinal stromal tumor, familial |
119 | KIT |
120 | Glioblastoma type 3, susceptibility to, due to BRCA2 germline mutation |
121 | BRCA2 |
122 | Granulomatous disease, chronic, autosomal recessive, cytochrome b- positive, type 1 |
123 | NCF1 |
124 | Hemangioma capillary infantile |
125 | ANTXR1 |
126 | Hemangioma, capillary infantile, familial, susceptibility to |
127 | KDR |
128 | Hereditary breast and ovarian cancer syndrome, RAD50 related |
129 | RAD50 |
130 | Hereditary Retinoblastoma |
131 | RB1 |
132 | Hurthle cell thyroid carcinoma, due to germline NDUFA13 mutation |
133 | NDUFA13 |
134 | IDH1, selective sequencing of exon 4 |
135 | IDH1 |
136 | IDH2, selective sequencing of exon 4 |
137 | IDH2 |
138 | JAK2, selective sequencing of exons 12, 14 and 16 |
139 | JAK2 |
140 | Juvenile myelomonocytic leukemia, due to CBL germline mutation |
141 | CBL |
142 | Juvenile polyposis syndrome |
143 | BMPR1A |
144 | Juvenile polyposis syndrome |
145 | SMAD4 |
146 | Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome |
147 | SMAD4 |
148 | KIT, selective sequencing of exons 8, 9, 11, 13 and 17 |
149 | KIT |
150 | KRAS somatic Hotspot: c.35G>A, p.G12D |
151 | KRAS, not available in the US |
152 | KRAS somatic Hotspot: c.35G>T p.G12V |
153 | KRAS, not available in the US |
154 | KRAS somatic Hotspot: c.38G>A, p.G13D |
155 | KRAS, not available in the US |
156 | KRAS, selective sequencing of exon 2 and 3 |
157 | KRAS |
158 | Leukemia, acute lymphoblastic, susceptibility to, due to PAX5 germline mutation |
159 | PAX5 |
160 | Leukemia, acute myelogenous |
161 | JAK2 |
162 | Leukemia, acute myelogenous |
163 | KRAS |
164 | Leukemia, acute myeloid |
165 | KIT |
166 | Leukemia, acute myeloid |
167 | RUNX1 |
168 | Leukemia, acute myeloid, somatic |
169 | CEBPA |
170 | Leukemia, acute promyelocytic, PL2F/RARA type |
171 | ZBTB16 |
172 | Leukemia, juvenile myelomonocytic |
173 | PTPN11 |
174 | Leukemia, lymphoblastic and myeloid, EZH2 related |
175 | EZH2 |
176 | Leukemia, myeloid acute form, due to CEBPA germline mutation |
177 | CEBPA |
178 | Li-Fraumeni syndrome type 1 |
179 | TP53 |
180 | Li-Fraumeni syndrome type 2 |
181 | CHEK2 |
182 | Medulloblastoma, desmoplastic, familial |
183 | SUFU |
184 | Medulloblastoma, due to BRCA2 germline mutation |
185 | BRCA2 |
186 | Melanoma and neural system tumor syndrome, familial |
187 | CDKN2A |
188 | Melanoma, cutaneous malignant |
189 | MC1R |
190 | Melanoma, cutaneous malignant |
191 | MITF |
192 | Melanoma, cutaneous malignant, familial |
193 | CDKN2A |
194 | Melanoma, cutaneous malignant, familial type 10, susceptibility to |
195 | POT1 |
196 | Melanoma, cutaneous malignant, familial type 6, susceptibility to |
197 | XRCC3 |
198 | Melanoma, cutaneous malignant, familial, CDK4 related |
199 | CDK4 |
200 | Meningioma, familial, PDGFB related |
201 | PDGFB |
202 | Meningioma, familial, susceptibility to |
203 | SMARCE1 |
204 | Meningioma, familial, susceptibility to |
205 | SUFU |
206 | Meningioma, MN1 deficiency related |
207 | MN1 |
208 | Mismatch repair cancer syndrome |
209 | MLH1 |
210 | Mismatch repair cancer syndrome |
211 | MSH2 |
212 | Mismatch repair cancer syndrome |
213 | MSH6 |
214 | Mismatch repair cancer syndrome |
215 | PMS2 |
216 | MMR genes methylation analysis |
217 | MMR genes |
218 | MPL, selective sequencing of exon 10 |
219 | MPL |
220 | Muir-Torre syndrome |
221 | MLH1 |
222 | Muir-Torre syndrome |
223 | MSH2 |
224 | Multiple endocrine neoplasia type 1, CDKN2B related |
225 | CDKN2B |
226 | Multiple endocrine neoplasia type 2A |
227 | RET |
228 | Multiple endocrine neoplasia type 2B |
229 | RET |
230 | Multiple endocrine neoplasia type 4 |
231 | CDKN1B |
232 | Myelodysplastic syndrome, somatic |
233 | TET2 |
234 | Myelofibrosis, somatic |
235 | JAK2 |
236 | Myxoma, intracardiac |
237 | PRKAR1A |
238 | Neurofibromatosis type 1 |
239 | NF1 |
240 | Neurofibromatosis type 1 -like syndrome |
241 | SPRED1 |
242 | Neurofibromatosis type 2 |
243 | NF2 |
244 | Nonpolyposis hereditary colon cancer, PMS1 related |
245 | PMS1 |
246 | Nonsmall cell lung cancer, familial, susceptibility to |
247 | EGFR |
248 | NPM1, selective sequencing of exon 11 |
249 | NPM1 |
250 | NRAS somatic Hotspot: c.181C>A p.Q61K |
251 | NRAS, not available in the US |
252 | NRAS somatic Hotspot: c.182A>G, p.Q61R |
253 | NRAS, not available in the US |
254 | NRAS somatic Hotspot: c.34G>T, p.G12C |
255 | NRAS, not available in the US |
256 | NRAS somatic Hotspot: c.35G>A, p.G12D |
257 | NRAS, not available in the US |
258 | NRAS, selective sequencing of exons 2 and 3 |
259 | NRAS |
260 | Pancreatic cancer type 2, susceptibility to |
261 | BRCA2 |
262 | Pancreatic cancer type 3, susceptibility to |
263 | PALB2 |
264 | Pancreatic cancer, susceptibility to, type 4 |
265 | BRCA1 |
266 | Pancreatic cancer/melanoma syndrome, familial |
267 | CDKN2A |
268 | Paraganglioma and gastric stromal sarcoma |
269 | SDHD |
270 | Paragangliomas type 1, with or without deafness |
271 | SDHD |
272 | Paragangliomas type 4 |
273 | SDHB |
274 | Paragangliomas type 5 |
275 | SDHA |
276 | PDGFRA, selective sequencing of exons 12, 14 and 18 |
277 | PDGFRA |
278 | Peutz-Jeghers syndrome |
279 | STK11 |
280 | Pheochromocytoma type 1 |
281 | SDHD |
282 | Pheochromocytoma type 2 |
283 | SDHB |
284 | Pheochromocytoma type 3 |
285 | SDHC |
286 | Pheochromocytoma type 5 |
287 | SDHAF2 |
288 | Pheochromocytoma type 8 |
289 | TMEM127 |
290 | Pheochromocytoma type 9 |
291 | MAX |
292 | Pituitary adenoma, ACTH-secreting, due to AIP germline mutation |
293 | AIP |
294 | Pituitary adenoma, growth hormone-secreting, due to AIP germline mutation |
295 | AIP |
296 | Pituitary adenoma, prolactin-secreting, due to AIP germline mutation |
297 | AIP |
298 | Pleuropulmonary blastoma |
299 | DICER1 |
300 | Polycythemia vera, somatic |
301 | JAK2 |
302 | Polyposis syndrome, hereditary mixed |
303 | GREM1 |
304 | Polyposis syndrome, hereditary mixed type 2 |
305 | BMPR1A |
306 | Prostate cancer |
307 | BRCA2 |
308 | Prostate cancer |
309 | STAG1 |
310 | Prostate cancer |
311 | ZNF783 |
312 | Prostate cancer, familial, association with |
313 | HOXB13 |
314 | Prostate cancer, hereditary type 1 |
315 | RNASEL |
316 | Prostate cancer, hereditary type 2, susceptibility to |
317 | ELAC2 |
318 | Renal cell carcinoma, due to HNF1A germline mutation |
319 | HNF1A |
320 | Renal cell carcinoma, papillary type 1, familial |
321 | MET |
322 | RET, selective sequencing of exons 5, 8, 10, 11 and 13-16 |
323 | RET |
324 | Spiegler-Brooke syndrome |
325 | CYLD |
326 | Thrombocythemia type 3, somatic |
327 | JAK2 |
328 | Thyroid cancer type 2, nonmedullary, susceptibility to |
329 | SRGAP1 |
330 | Trichoepithelioma, multiple familial, type 1 |
331 | CYLD |
332 | Tumor predisposition syndrome |
333 | BAP1 |
334 | Tumor predisposition syndrome, ARL11 related |
335 | ARL11 |
336 | Tylosis with esophageal cancer |
337 | RHBDF2 |
338 | von Hippel-Lindau syndrome |
339 | VHL |
340 | Wilms tumor, familial, due to BRCA2 mutation |
341 | BRCA2 |
No. | Description |
---|---|
1 | 46,XX sex reversal type 1 |
2 | SRY |
3 | 46,XY sex reversal type 8, modifier of |
4 | AKR1C4 |
5 | Aromatase deficiency |
6 | CYP19A1 |
7 | Azoospermia induced by Y chromosome microdeletions |
8 | AZF region |
9 | Congenital bilateral absence of vas deferens |
10 | CFTR |
11 | Cryptorchidism |
12 | RXFP2 |
13 | Deafness and male infertility |
14 | STRC |
15 | Deafness and male infertility, CATSPER2 related |
16 | CATSPER2 |
17 | Disorders of sex development with cleft palate |
18 | FOXF2 |
19 | Follicle-stimulating hormone deficiency, isolated |
20 | FSHB |
21 | Guttmacher syndrome |
22 | HOXA13 |
23 | Hand-foot-uterus syndrome |
24 | HOXA13 |
25 | Hydatidiform mole |
26 | NLRP7 |
27 | Hydatidiform mole, recurrent, type 2 |
28 | KHDC3L |
29 | Hypogonadotropic hypogonadism |
30 | KISS1 |
31 | Hypogonadotropic hypogonadism |
32 | NSMF |
33 | Hypogonadotropic hypogonadism type 6 with or without anosmia |
34 | FGF8 |
35 | Hypogonadtropic hypogonadism type 14 |
36 | WDR11 |
37 | Hypospadias type 1, X-linked |
38 | AR |
39 | Hypospadias type 2, X-linked |
40 | MAMLD1 |
41 | Leydig cell hypoplasia type 1 |
42 | LHCGR |
43 | Oligo-astheno-teratozoospermia |
44 | NANOS1 |
45 | Oocyte maturation defect |
46 | ZP1 |
47 | Oogenesis dysfunction |
48 | SOHLH1 |
49 | Ovarian dysgenesis type 1 |
50 | FSHR |
51 | Ovarian dysgenesis type 2 |
52 | BMP15 |
53 | Persistent Mullerian duct syndrome type 1 |
54 | AMH |
55 | Persistent Mullerian duct syndrome type 2 |
56 | AMHR2 |
57 | Preeclampsia/eclampsia type 5 |
58 | CORIN |
59 | Pregnancy loss, recurrent, C4BPA related |
60 | C4BPA |
61 | Pseudohermaphroditism with gynecomastia |
62 | HSD17B3 |
63 | SPGF4 |
64 | SYCP3 |
65 | SPGF5 |
66 | AURKC |
67 | SPGF6 |
68 | SPATA16 |
69 | SPGF7 |
70 | CATSPER1 |
71 | SPGF8 |
72 | NR5A1 |
73 | SPGF9 |
74 | DPY19L2 |
75 | Testicular anomalies with or without congenital heart disease |
76 | GATA4 |
No. | Description |
---|---|
1 | matopsia type 2 |
2 | CNGA3 |
3 | Achromatopsia type 3 |
4 | CNGB3 |
5 | Achromatopsia type 4 |
6 | GNAT2 |
7 | Achromatopsia type 6 |
8 | PDE6H |
9 | Aland Island eye disease |
10 | CACNA1F |
11 | Albinism, ocular type I, Nettleship-Falls type |
12 | GPR143 |
13 | Albinism, oculocutaneous nonsyndromic |
14 | SLC24A5 |
15 | Albinism, oculocutaneous type 1A |
16 | TYR |
17 | Albinism, oculocutaneous type 1B |
18 | TYR |
19 | Albinism, oculocutaneous type 2 |
20 | OCA2 |
21 | Albinism, oculocutaneous type 3 |
22 | TYRP1 |
23 | Albinism, oculocutaneous type 4 |
24 | SLC45A2 |
25 | Albinism, oculocutaneous type 5 |
26 | LRMDA |
27 | Aniridia |
28 | PAX6 |
29 | Anterior segment mesenchymal dysgenesis |
30 | PITX3 |
31 | Bardet-Biedl syndrome type 14 |
32 | CEP290 |
33 | Bestrophinopathy |
34 | BEST1 |
35 | Bietti crystalline corneoretinal dystrophy |
36 | CYP4V2 |
37 | Blepharophimosis, epicanthus inversus, and ptosis |
38 | FOXL2 |
39 | Blepharophimosis-ptosis-intellectual disability syndrome |
40 | UBE3B |
41 | Bothnia retinal dystrophy |
42 | RLBP1 |
43 | Bradyopsia |
44 | RGS9 |
45 | Bradyopsia |
46 | RGS9BP |
47 | Branchiootorenal syndrome type 1 |
48 | EYA1 |
49 | Branchiootorenal syndrome type 2 |
50 | SIX5 |
51 | Brittle cornea syndrome |
52 | ZNF469 |
53 | Cataract 11, multiple types |
54 | PITX3 |
55 | Cataract type 17, multiple types |
56 | CRYBB1 |
57 | Cataract type 23 |
58 | CRYBA4 |
59 | Cataract type 41 |
60 | WFS1 |
61 | Cataract type 43 |
62 | UNC45B |
63 | Cataract, autosomal dominant |
64 | GCNT2 |
65 | Cataract, autosomal recessive congenital nuclear type 2 |
66 | CRYBB3 |
67 | Cataract, autosomal recessive congenital type 1 |
68 | CRYAA |
69 | Cataract, autosomal recessive congenital type 2 |
70 | FYCO1 |
71 | Cataract, autosomal recessive congenital type 4 |
72 | TDRD7 |
73 | Cataract, autosomal recessive type 38 |
74 | AGK |
75 | Cataract, congenital |
76 | SORD |
77 | Cataract, congenital, associated with Marinesco-Sjogren Syndrome |
78 | SIL1 |
79 | Cataract, cortical pulverulent, late-onset |
80 | LIM2 |
81 | Cataract, lamellar |
82 | HSF4 |
83 | Cataract, posterior polar type 2 |
84 | CRYAB |
85 | Cataract, pulverulent or cerulean, with or without microcornea |
86 | MAF |
87 | Cataract, X-linked |
88 | NHS |
89 | Cataract-microcornea syndrome |
90 | GJA8 |
91 | Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia |
92 | IARS2 |
93 | Cerebellar-retinal degeneration, infantile |
94 | ACO2 |
95 | Choroidal dystrophy, central areolar type 2 |
96 | PRPH2 |
97 | Coat plus syndrome |
98 | CTC1 |
99 | Coloboma of optic nerve |
100 | PAX6 |
101 | Coloboma, ocular, autosomal dominant |
102 | PAX6 |
103 | Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation |
104 | YAP1 |
105 | Colobomatous microphthalmia |
106 | TENM1 |
107 | Cone-rod dystrophy |
108 | AIPL1 |
109 | Cone-rod dystrophy |
110 | UNC119 |
111 | Cone-rod dystrophy type 11 |
112 | RAX2 |
113 | Cone-rod dystrophy type 12 |
114 | PROM1 |
115 | Cone-rod dystrophy type 13 |
116 | RPGRIP1 |
117 | Cone-rod dystrophy type 14 |
118 | GUCA1A |
119 | Cone-rod dystrophy type 15 |
120 | CDHR1 |
121 | Cone-rod dystrophy type 17 |
122 | CD3G |
123 | Cone-rod dystrophy type 2 |
124 | CRX |
125 | Cone-rod dystrophy type 20 |
126 | POC1B |
127 | Cone-rod dystrophy type 3 |
128 | ABCA4 |
129 | Cone-rod dystrophy type 4 |
130 | PDE6C |
131 | Cone-rod dystrophy type 5 |
132 | PITPNM3 |
133 | Cone-rod dystrophy type 7 |
134 | RIMS1 |
135 | Cone-rod dystrophy type 9 |
136 | ADAM9 |
137 | Cone-rod dystrophy, C21orf2 related |
138 | C21orf2 |
139 | Cone-rod dystrophy, X-linked type 3 |
140 | CACNA1F |
141 | Corneal dystrophy, epithelial basement membrane |
142 | TGFBI |
143 | Corneal dystrophy, posterior polymorphous, type 1 |
144 | VSX1 |
145 | Corneal endothelial dystrophy type 2 |
146 | SLC4A11 |
147 | Corneal intraepithelial dyskeratosis and ectodermal dysplasia |
148 | NLRP1 |
149 | Corneal opacification and other ocular anomalies |
150 | PXDN |
151 | Doyne honeycob retinal dystrophy |
152 | EFEMP1 |
153 | Duane Retraction syndrome |
154 | CHN1 |
155 | Duane Retraction syndrome |
156 | SALL4 |
157 | Dyschromatosis symmetrica hereditaria |
158 | ADAR |
159 | Early onset glaucoma, phenotype modifier of, COL15A1 related |
160 | COL15A1 |
161 | Ectopia lentis et pupillae |
162 | ADAMTSL4 |
163 | Ectopia lentis, familial |
164 | FBN1 |
165 | Ectopia lentis, isolated, autosomal recessive |
166 | ADAMTSL4 |
167 | Exfoliation syndrome, susceptibility to |
168 | LOXL1 |
169 | Exudative vitreoretinopathy |
170 | FZD4 |
171 | Exudative vitreoretinopathy type 2 |
172 | NDP |
173 | Exudative vitreoretinopathy type 5 |
174 | TSPAN12 |
175 | Fibrosis of extraocular muscles, congenital type 1 |
176 | KIF21A |
177 | Fibrosis of extraocular muscles, congenital type 3a |
178 | TUBB3 |
179 | Fleck retina, familial benign |
180 | PLA2G5 |
181 | Foveal hypoplasia type 1 |
182 | PAX6 |
183 | Fundus albipunctatus |
184 | PRPH2 |
185 | Fundus albipunctatus |
186 | RDH5 |
187 | Gaze palsy, horizontal, with progressive scoliosis |
188 | ROBO3 |
189 | Gillespie syndrome |
190 | ITPR1 |
191 | Glaucoma, open angle type 1A |
192 | MYOC |
193 | Glaucoma, open angle type 1E |
194 | OPTN |
195 | Glaucoma, open angle type 1F |
196 | ASB10 |
197 | Glaucoma, open angle type 1F |
198 | NTF4 |
199 | Glaucoma, open angle type 1G |
200 | WDR36 |
201 | Glaucoma, primary type 3A |
202 | CYP1B1 |
203 | Glaucoma, primary type 3D |
204 | LTBP2 |
205 | Gyrate atrophy of choroid and retina with or without ornithinemia |
206 | OAT |
207 | Hereditary Retinoblastoma |
208 | RB1 |
209 | Hermansky Pudlak syndrome type 4 |
210 | HPS4 |
211 | Hermansky-Pudlak syndrome type 1 |
212 | HPS1 |
213 | Hermansky-Pudlak syndrome type 2 |
214 | AP3B1 |
215 | Hermansky-Pudlak syndrome type 3 |
216 | HPS3 |
217 | Hermansky-Pudlak syndrome type 5 |
218 | HPS5 |
219 | Hermansky-Pudlak syndrome type 6 |
220 | HPS6 |
221 | Hermansky-Pudlak syndrome type 7 |
222 | DTNBP1 |
223 | Hermansky-Pudlak syndrome type 8 |
224 | BLOC1S3 |
225 | Hyperferritinemia-cataract syndrome |
226 | FTL |
227 | Iridogoniodysgenesis type 1 |
228 | FOXC1 |
229 | Jalili syndrome |
230 | CNNM4 |
231 | Keratoconus type 1 |
232 | VSX1 |
233 | Leber congenital amaurosis type 1 |
234 | GUCY2D |
235 | Leber congenital amaurosis type 10 |
236 | CEP290 |
237 | Leber congenital amaurosis type 11 |
238 | IMPDH1 |
239 | Leber congenital amaurosis type 12 |
240 | RD3 |
241 | Leber congenital amaurosis type 16 |
242 | KCNJ13 |
243 | Leber congenital amaurosis type 17 |
244 | GDF6 |
245 | Leber congenital amaurosis type 3 |
246 | SPATA7 |
247 | Leber congenital amaurosis type 5 |
248 | LCA5 |
249 | Leber congenital amaurosis type 6 |
250 | RPGRIP1 |
251 | Leber congenital amaurosis type 7 |
252 | CRX |
253 | Leber congenital amaurosis type 8 |
254 | CRB1 |
255 | Leber congenital amaurosis type 9 |
256 | NMNAT1 |
257 | Leber congenital amaurosis with myopathy |
258 | DTHD1 |
259 | Leber optic atrophy |
260 | MT-ATP6 |
261 | Leber optic atrophy |
262 | MT-CO1 |
263 | Leber optic atrophy |
264 | MT-CO3 |
265 | Leber optic atrophy |
266 | MT-CYB |
267 | Leber optic atrophy |
268 | MT-ND1 |
269 | Leber optic atrophy |
270 | MT-ND2 |
271 | Leber optic atrophy |
272 | MT-ND4 |
273 | Leber optic atrophy |
274 | MT-ND4L |
275 | Leber optic atrophy |
276 | MT-ND5 |
277 | Leber optic atrophy |
278 | MT-ND6 |
279 | Macular degeneration, age-related type 11 |
280 | CST3 |
281 | Macular degeneration, age-related type 3 |
282 | FBLN5 |
283 | Macular degeneration, age-related type 6 |
284 | RAX2 |
285 | Macular degeneration, age-related type 8, association with |
286 | ARMS2 |
287 | Macular degeneration, early-onset |
288 | FBN2 |
289 | Macular dystrophy retinal type 2 |
290 | PROM1 |
291 | Macular dystrophy with central cone involvement |
292 | MFSD8 |
293 | Macular dystrophy, BEST2-related |
294 | BEST2 |
295 | Macular dystrophy, BEST3-related |
296 | BEST3 |
297 | Macular dystrophy, BEST4-related |
298 | BEST4 |
299 | Macular dystrophy, vitelliform |
300 | BEST1 |
301 | Macular dystrophy, vitelliform |
302 | PRPH2 |
303 | Mainzer Saldino syndrome |
304 | IFT140 |
305 | Marshall syndrome |
306 | COL11A1 |
307 | Megalocornea, X-linked |
308 | CHRDL1 |
309 | MELAS syndrome, MT-TL1 related |
310 | MT-TL1 |
311 | Microphthalmia syndromic type 2 |
312 | BCOR |
313 | Microphthalmia syndromic type 3 |
314 | SOX2 |
315 | Microphthalmia syndromic type 5 |
316 | OTX2 |
317 | Microphthalmia syndromic type 6 |
318 | BMP4 |
319 | Microphthalmia syndromic type 6 |
320 | SIX6 |
321 | Microphthalmia syndromic type 7 |
322 | HCCS |
323 | Microphthalmia syndromic type 8 |
324 | ALDH1A3 |
325 | Microphthalmia syndromic type 9 |
326 | STRA6 |
327 | Microphthalmia, isolated type 2 |
328 | VSX2 |
329 | Microphthalmia, isolated type 3 |
330 | RAX |
331 | Microphthalmia, isolated type 4 |
332 | GDF6 |
333 | Microphthalmia, isolated type 5 |
334 | MFRP |
335 | Microphthalmia, isolated type 6 |
336 | PRSS56 |
337 | Microphthalmia, isolated type 9 |
338 | GDF3 |
339 | Microphthalmia, isolated with coloboma type 3 |
340 | VSX2 |
341 | Microphthalmia, isolated with coloboma type 6, digenic |
342 | GDF3 |
343 | Microphthalmia, isolated with coloboma type 6, digenic |
344 | GDF6 |
345 | Microphthalmia, isolated with coloboma type 9 |
346 | TENM3 |
347 | Microphthalmia, syndromic type 1 |
348 | NAA10 |
349 | Microphthalmia, syndromic type 11 |
350 | VAX1 |
351 | Microphthalmia, VAX2 related |
352 | VAX2 |
353 | Microspherophakia and/or megalocornea |
354 | LTBP2 |
355 | Nance-Horan syndrome |
356 | NHS |
357 | Nanophthalmia type 2 |
358 | MFRP |
359 | Night blindness type 1, congenital stationary, autosomal dominant |
360 | RHO |
361 | Night blindness, congenital stationar type 1B |
362 | GRM6 |
363 | Night blindness, congenital stationar type 1C |
364 | TRPM1 |
365 | Night blindness, congenital stationary type 1A |
366 | NYX |
367 | Night blindness, congenital stationary type 2A |
368 | CACNA1F |
369 | Night blindness, congenital stationary type 2B |
370 | CABP4 |
371 | Night blindness, congenital stationary type 3 |
372 | GNAT1 |
373 | Night blindness, congenital stationary, autosomal dominant type 2 |
374 | PDE6B |
375 | Night blindness, congenital stationary, type 1E |
376 | GPR179 |
377 | Nonarteritic anterior ischemic optic neuropathy |
378 | GP1BA |
379 | Nystagmus type 1 |
380 | FRMD7 |
381 | Nystagmus type 6 |
382 | GPR143 |
383 | Occult macular dystrophy |
384 | RP1L1 |
385 | Oguchi disease |
386 | GRK1 |
387 | Oguchi disease |
388 | SAG |
389 | Ophthalmoplegia, isolated, MT-TN related |
390 | MT-TN |
391 | Optic atrophy type 1 |
392 | OPA1 |
393 | Optic atrophy type 3 |
394 | OPA3 |
395 | Optic atrophy type 7 |
396 | TMEM126A |
397 | Optic atrophy type 9 |
398 | ACO2 |
399 | Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy |
400 | OPA1 |
401 | Patterned dystrophy of retinal pigment epithelium |
402 | PRPH2 |
403 | Peters Anomaly |
404 | CYP1B1 |
405 | Peters anomaly |
406 | PAX6 |
407 | Peters Anomaly |
408 | PITX2 |
409 | Peters-Plus syndrome |
410 | B3GLCT |
411 | Pigmented paravenous chorioretinal atrophy |
412 | CRB1 |
413 | Plasminogen deficiency type 1 |
414 | PLG |
415 | Progressive external ophthalmoplegia with mitochondrial deletions type 1, autosomal dominant |
416 | POLG |
417 | Progressive external ophthalmoplegia with mitochondrial deletions type 1, autosomal recessive |
418 | POLG |
419 | Progressive external ophthalmoplegia with mitochondrial deletions type 2, autosomal recessive |
420 | RNASEH1 |
421 | Progressive external ophthalmoplegia with mitochondrial deletions type 3, autosomal dominant |
422 | TWNK |
423 | Progressive external ophthalmoplegia with mitochondrial deletions type 4, autosomal dominant |
424 | POLG2 |
425 | Progressive external ophthalmoplegia with mitochondrial deletions type 6, autosomal dominant |
426 | DNA2 |
427 | Retinal cone dystrophy type 3B |
428 | KCNV2 |
429 | Retinal cone dystrophy type 4 |
430 | CACNA2D4 |
431 | Retinal degeneration, late-onset, autosomal dominant |
432 | C1QTNF5 |
433 | Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities |
434 | ITM2B |
435 | Retinal dystrophy, juvenile cataracts, and short stature syndrome |
436 | RDH11 |
437 | Retinal nonattachment nonsyndromic congenital |
438 | ATOH7 |
439 | Retinitis pigmentosa juvenile |
440 | LRAT |
441 | Retinitis pigmentosa SEMA4C related |
442 | SEMA4C |
443 | Retinitis pigmentosa type 1, autosomal dominant |
444 | RP1 |
445 | Retinitis pigmentosa type 10, autosomal dominant |
446 | IMPDH1 |
447 | Retinitis pigmentosa type 11, autosomal dominant |
448 | PRPF31 |
449 | Retinitis pigmentosa type 12, autosomal recessive |
450 | CRB1 |
451 | Retinitis pigmentosa type 13, autosomal dominant |
452 | PRPF8 |
453 | Retinitis pigmentosa type 14, autosomal recessive |
454 | TULP1 |
455 | Retinitis pigmentosa type 17, autosomal dominant |
456 | CA4 |
457 | Retinitis pigmentosa type 18, autosomal dominant |
458 | PRPF3 |
459 | Retinitis pigmentosa type 19, autosomal recessive |
460 | ABCA4 |
461 | Retinitis pigmentosa type 2 X-linked |
462 | RP2 |
463 | Retinitis pigmentosa type 20, autosomal recessive |
464 | RPE65 |
465 | Retinitis pigmentosa type 23 X-linked |
466 | OFD1 |
467 | Retinitis pigmentosa type 25 |
468 | EYS |
469 | Retinitis pigmentosa type 26, autosomal recessive |
470 | CERKL |
471 | Retinitis pigmentosa type 27, autosomal dominant |
472 | NRL |
473 | Retinitis pigmentosa type 28, autosomal recessive |
474 | FAM161A |
475 | Retinitis pigmentosa type 3 X-linked |
476 | RPGR |
477 | Retinitis pigmentosa type 30, autosomal dominant |
478 | FSCN2 |
479 | Retinitis pigmentosa type 31, autosomal dominant |
480 | TOPORS |
481 | Retinitis pigmentosa type 33, autosomal dominant |
482 | SNRNP200 |
483 | Retinitis pigmentosa type 35, autosomal dominant/recessive |
484 | SEMA4A |
485 | Retinitis pigmentosa type 36, autosomal recessive |
486 | PRCD |
487 | Retinitis pigmentosa type 38, autosomal recessive |
488 | MERTK |
489 | Retinitis pigmentosa type 39 |
490 | USH2A |
491 | Retinitis pigmentosa type 4, autosomal dominant/recessive |
492 | RHO |
493 | Retinitis pigmentosa type 40, autosomal recessive |
494 | PDE6B |
495 | Retinitis pigmentosa type 41, autosomal recessive |
496 | PROM1 |
497 | Retinitis pigmentosa type 42, autosomal dominant |
498 | KLHL7 |
499 | Retinitis pigmentosa type 43, autosomal recessive |
500 | PDE6A |
501 | Retinitis pigmentosa type 44, autosomal dominant/recessive |
502 | RGR |
503 | Retinitis pigmentosa type 45, autosomal recessive |
504 | CNGB1 |
505 | Retinitis pigmentosa type 46, autosomal recessive |
506 | IDH3B |
507 | Retinitis pigmentosa type 47, autosomal recessive |
508 | SAG |
509 | Retinitis pigmentosa type 48, autosomal dominant |
510 | GUCA1B |
511 | Retinitis pigmentosa type 49, autosomal recessive |
512 | CNGA1 |
513 | Retinitis pigmentosa type 50, autosomal dominant |
514 | BEST1 |
515 | Retinitis pigmentosa type 51, autosomal recessive |
516 | TTC8 |
517 | Retinitis pigmentosa type 53, autosomal recessive |
518 | RDH12 |
519 | Retinitis pigmentosa type 54, autosomal recessive |
520 | PCARE |
521 | Retinitis pigmentosa type 55, autosomal recessive |
522 | ARL6 |
523 | Retinitis pigmentosa type 56, autosomal recessive |
524 | IMPG2 |
525 | Retinitis pigmentosa type 57, autosomal recessive |
526 | PDE6G |
527 | Retinitis pigmentosa type 58, autosomal recessive |
528 | ZNF513 |
529 | Retinitis pigmentosa type 59, autosomal recessive |
530 | DHDDS |
531 | Retinitis pigmentosa type 60 |
532 | PRPF6 |
533 | Retinitis pigmentosa type 61, autosomal recessive |
534 | CLRN1 |
535 | Retinitis pigmentosa type 62, autosomal recessive |
536 | MAK |
537 | Retinitis pigmentosa type 64, autosomal recessive |
538 | C8ORF37 |
539 | Retinitis pigmentosa type 66, autosomal recessive |
540 | RBP3 |
541 | Retinitis pigmentosa type 7 |
542 | ROM1 |
543 | Retinitis pigmentosa type 7, autosomal dominant |
544 | PRPH2 |
545 | Retinitis pigmentosa type 74, autosomal recessive |
546 | BBS2 |
547 | Retinitis pigmentosa type 9, autosomal dominant |
548 | RP9 |
549 | Retinitis pigmentosa, juvenile, autosomal recessive |
550 | SPATA7 |
551 | Retinitis punctata albescens |
552 | RHO |
553 | Retinoschisis |
554 | RS1 |
555 | Revesz syndrome |
556 | TINF2 |
557 | Ring dermoid of cornea |
558 | PITX2 |
559 | Senior-Loken syndrome type 5 |
560 | IQCB1 |
561 | Sorsby fundus dystrophy |
562 | TIMP3 |
563 | Stargardt Disease type 1 |
564 | ABCA4 |
565 | Stargardt Disease type 1 |
566 | CNGB3 |
567 | Stargardt Disease type 3 |
568 | ELOVL4 |
569 | Stargardt Disease type 4 |
570 | PROM1 |
571 | Stickler syndrome type 1 |
572 | COL2A1 |
573 | Stickler syndrome type 1, nonsyndromic ocular |
574 | COL2A1 |
575 | Stickler syndrome type 2 |
576 | COL11A1 |
577 | Stickler syndrome type 3 |
578 | COL11A2 |
579 | Stickler syndrome type 5 |
580 | COL9A2 |
581 | Stickler syndrome, autosomal recessive |
582 | COL9A1 |
583 | Sveinsson choreoretinal atrophy |
584 | TEAD1 |
585 | Usher syndrome type 1D |
586 | CDH23 |
587 | Usher syndrome type 1D/F |
588 | PCDH15 |
589 | Usher syndrome type 1G |
590 | USH1G |
591 | Usher syndrome type 1J |
592 | CIB2 |
593 | Usher syndrome type 2C |
594 | ADGRV1 |
595 | Usher syndrome type 2C |
596 | PDZD7 |
597 | Usher syndrome type 2D |
598 | WHRN |
599 | Usher syndrome type 3A |
600 | CLRN1 |
601 | Vitreoretinochoroidopathy |
602 | BEST1 |
603 | Waardenburg syndrome/albinism |
604 | MITF |
605 | Waardenburg syndrome/albinism |
606 | TYR |
607 | Wagner syndrome |
608 | VCAN |
609 | Warburg micro syndrome 3 |
610 | RAB18 |
611 | Warburg micro syndrome type 1 |
612 | RAB3GAP1 |
613 | Weill-Marchesani syndrome - AR |
614 | ADAMTS10 |
615 | Weill-Marchesani syndrome, dominant type 2 |
616 | FBN1 |
617 | Wolfram syndrome type 1 |
618 | WFS1 |
619 | Wolfram syndrome type 2 |
620 | CISD2 |
621 | Wolfram-like syndrome, autosomal dominant |
622 | WFS1 |
No. | Sdescription |
---|---|
1 | Amyotrophic lateral sclerosis (ALS) panel |
2 | Ataxia comprehensive panel |
3 | Ataxia panel |
4 | Ataxia repeat expansion panel |
5 | Dementia panel |
6 | Dystonia panel |
7 | Epilepsy panel |
8 | Intellectual disability panel |
9 | Neuromuscular panel |
10 | Parkinson disease panel |
11 | Spastic paraplegia panel |
No. | Description |
---|---|
1 | Alport syndrome, autosomal recessive |
2 | COL4A3 |
3 | Alport syndrome, autosomal recessive |
4 | COL4A4 |
5 | Alport syndrome, X-Linked |
6 | COL4A5 |
7 | Auditory neuropathy, autosomal dominant |
8 | DIAPH3 |
9 | Auriculocondylar syndrome type 2 |
10 | PLCB4 |
11 | Branchiootic syndrome type 1 |
12 | EYA1 |
13 | Brown-Vialetto-Van Laere syndrome 1 |
14 | SLC52A3 |
15 | Brown-Vialetto-Van Laere syndrome type 2 |
16 | SLC52A2 |
17 | Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia |
18 | IARS2 |
19 | Ciliogenesis related disorder |
20 | PTPN23 |
21 | Deafness and male infertility, CATSPER2 related |
22 | CATSPER2 |
23 | Deafness with keratopachydermia and constrictions of fingers and toes |
24 | GJB2 |
25 | Deafness, autosomal dominant type 1 |
26 | DIAPH1 |
27 | Deafness, autosomal dominant type 10 |
28 | EYA4 |
29 | Deafness, autosomal dominant type 11 |
30 | MYO7A |
31 | Deafness, autosomal dominant type 12 |
32 | TECTA |
33 | Deafness, autosomal dominant type 13 |
34 | COL11A2 |
35 | Deafness, autosomal dominant type 15 |
36 | POU4F3 |
37 | Deafness, autosomal dominant type 17 |
38 | MYH9 |
39 | Deafness, autosomal dominant type 20 |
40 | ACTG1 |
41 | Deafness, autosomal dominant type 22 |
42 | MYO6 |
43 | Deafness, autosomal dominant type 23 |
44 | SIX1 |
45 | Deafness, autosomal dominant type 25 |
46 | SLC17A8 |
47 | Deafness, autosomal dominant type 28 |
48 | GRHL2 |
49 | Deafness, autosomal dominant type 2A |
50 | KCNQ4 |
51 | Deafness, autosomal dominant type 2B |
52 | GJB3 |
53 | Deafness, autosomal dominant type 36 |
54 | TMC1 |
55 | Deafness, autosomal dominant type 39, with dentinogenesis type 1 |
56 | DSPP |
57 | Deafness, autosomal dominant type 3A |
58 | GJB2 |
59 | Deafness, autosomal dominant type 3B |
60 | GJB6 |
61 | Deafness, autosomal dominant type 4 |
62 | MYH14 |
63 | Deafness, autosomal dominant type 40 |
64 | CRYM |
65 | Deafness, autosomal dominant type 44 |
66 | CCDC50 |
67 | Deafness, autosomal dominant type 48 |
68 | MYO1A |
69 | Deafness, autosomal dominant type 4B |
70 | CEACAM16 |
71 | Deafness, autosomal dominant type 5 |
72 | GSDME |
73 | Deafness, autosomal dominant type 52 |
74 | POU4F3 |
75 | Deafness, autosomal dominant type 6 |
76 | WFS1 |
77 | Deafness, autosomal dominant type 64 |
78 | DIABLO |
79 | Deafness, autosomal dominant type 65 |
80 | TBC1D24 |
81 | Deafness, autosomal dominant type 9 |
82 | COCH |
83 | Deafness, autosomal recessive |
84 | GJB3 |
85 | Deafness, autosomal recessive |
86 | SUN1 |
87 | Deafness, autosomal recessive type 12 |
88 | CDH23 |
89 | Deafness, autosomal recessive type 15 |
90 | GIPC3 |
91 | Deafness, autosomal recessive type 16 |
92 | STRC |
93 | Deafness, autosomal recessive type 18 |
94 | USH1C |
95 | Deafness, autosomal recessive type 1A |
96 | GJB2 |
97 | Deafness, autosomal recessive type 1B |
98 | GJB6 |
99 | Deafness, autosomal recessive type 2 |
100 | MYO7A |
101 | Deafness, autosomal recessive type 22 |
102 | OTOA |
103 | Deafness, autosomal recessive type 23 |
104 | PCDH15 |
105 | Deafness, autosomal recessive type 24 |
106 | RDX |
107 | Deafness, autosomal recessive type 25 |
108 | GRXCR1 |
109 | Deafness, autosomal recessive type 28 |
110 | TRIOBP |
111 | Deafness, autosomal recessive type 29 |
112 | CLDN14 |
113 | Deafness, autosomal recessive type 3 |
114 | MYO15A |
115 | Deafness, autosomal recessive type 30 |
116 | MYO3A |
117 | Deafness, autosomal recessive type 31 |
118 | WHRN |
119 | Deafness, autosomal recessive type 35 |
120 | ESRRB |
121 | Deafness, autosomal recessive type 36 |
122 | ESPN |
123 | Deafness, autosomal recessive type 39 |
124 | HGF |
125 | Deafness, autosomal recessive type 4 |
126 | FOXI1 |
127 | Deafness, autosomal recessive type 42 |
128 | ILDR1 |
129 | Deafness, autosomal recessive type 48 |
130 | CIB2 |
131 | Deafness, autosomal recessive type 49 |
132 | MARVELD2 |
133 | Deafness, autosomal recessive type 53 |
134 | COL11A2 |
135 | Deafness, autosomal recessive type 59 |
136 | PJVK |
137 | Deafness, autosomal recessive type 6 |
138 | TMIE |
139 | Deafness, autosomal recessive type 61 |
140 | SLC26A5 |
141 | Deafness, autosomal recessive type 63 |
142 | LRTOMT |
143 | Deafness, autosomal recessive type 66 |
144 | DCDC2 |
145 | Deafness, autosomal recessive type 67 |
146 | LHFPL5 |
147 | Deafness, autosomal recessive type 7 |
148 | TMC1 |
149 | Deafness, autosomal recessive type 70 |
150 | PNPT1 |
151 | Deafness, autosomal recessive type 74 |
152 | MSRB3 |
153 | Deafness, autosomal recessive type 76 |
154 | SYNE4 |
155 | Deafness, autosomal recessive type 77 |
156 | LOXHD1 |
157 | Deafness, autosomal recessive type 79 |
158 | TPRN |
159 | Deafness, autosomal recessive type 8/10 |
160 | TMPRSS3 |
161 | Deafness, autosomal recessive type 86 |
162 | TBC1D24 |
163 | Deafness, autosomal recessive type 89 |
164 | KARS1 |
165 | Deafness, autosomal recessive type 9 |
166 | OTOF |
167 | Deafness, autosomal recessive type 91 |
168 | SERPINB6 |
169 | Deafness, autosomal recessive type 93 |
170 | CABP2 |
171 | Deafness, congenital with inner ear agenesis, microtia, and microdontia |
172 | FGF3 |
173 | Deafness, dystonia, and cerebral hypomyelination, X-linked |
174 | BCAP31 |
175 | Deafness, nonsyndromic, sensorineural, mitochondrial |
176 | MT-RNR1 |
177 | Deafness, X-linked type 1 |
178 | PRPS1 |
179 | Deafness, X-linked type 2 |
180 | POU3F4 |
181 | Deafness, X-linked type 4 |
182 | SMPX |
183 | Deafness, X-linked type 5 |
184 | AIFM1 |
185 | Deafness, X-linked type 6 |
186 | COL4A6 |
187 | Fazio-Londe disease |
188 | SLC52A3 |
189 | Hearing loss, MAP1A related |
190 | MAP1A |
191 | Hearing loss, MYH7B related |
192 | MYH7B |
193 | Heimler syndrome type 1 |
194 | PEX1 |
195 | Keratitis ichthyosis deafness syndrome autosomal dominant |
196 | GJB2 |
197 | Keratoderma, palmoplantar, with deafness |
198 | GJB2 |
199 | Knuckle pads and leukonychia sensorineural deafness |
200 | GJB2 |
201 | Marshall syndrome |
202 | COL11A1 |
203 | Mitochondrial modifier of deafness |
204 | TRMU |
205 | Opticoacoustic nerve atrophy with dementia |
206 | TIMM8A |
207 | Otopaladigital syndrome type 1 |
208 | FLNA |
209 | Otopaladigital syndrome type 2 |
210 | FLNA |
211 | Pendred syndrome |
212 | SLC26A4 |
213 | Pneumothorax, primary spontaneous |
214 | FLCN |
215 | Primary ciliary dyskinesia type 1 |
216 | DNAI1 |
217 | Primary ciliary dyskinesia type 10 |
218 | DNAAF2 |
219 | Primary ciliary dyskinesia type 11 |
220 | RSPH4A |
221 | Primary ciliary dyskinesia type 12 |
222 | RSPH9 |
223 | Primary ciliary dyskinesia type 13 |
224 | DNAAF1 |
225 | Primary ciliary dyskinesia type 14 |
226 | CCDC39 |
227 | Primary ciliary dyskinesia type 15 |
228 | CCDC40 |
229 | Primary ciliary dyskinesia type 16 |
230 | DNAL1 |
231 | Primary ciliary dyskinesia type 17 |
232 | CCDC103 |
233 | Primary ciliary dyskinesia type 18 |
234 | DNAAF5 |
235 | Primary ciliary dyskinesia type 19 |
236 | LRRC6 |
237 | Primary ciliary dyskinesia type 2 |
238 | DNAAF3 |
239 | Primary ciliary dyskinesia type 20 |
240 | CCDC114 |
241 | Primary ciliary dyskinesia type 23 |
242 | ARMC4 |
243 | Primary ciliary dyskinesia type 24 |
244 | RSPH1 |
245 | Primary ciliary dyskinesia type 25 |
246 | DYX1C1 |
247 | Primary ciliary dyskinesia type 26 |
248 | CFAP298 |
249 | Primary ciliary dyskinesia type 27 |
250 | CCDC65 |
251 | Primary ciliary dyskinesia type 28 |
252 | SPAG1 |
253 | Primary ciliary dyskinesia type 29 |
254 | CCNO |
255 | Primary ciliary dyskinesia type 3 |
256 | DNAH5 |
257 | Primary ciliary dyskinesia type 5 |
258 | HYDIN |
259 | Primary ciliary dyskinesia type 6 |
260 | NME8 |
261 | Primary ciliary dyskinesia type 7 |
262 | DNAH11 |
263 | Primary ciliary dyskinesia type 9 |
264 | DNAI2 |
265 | Primary ciliary dyskinesia, DNAH9 related |
266 | DNAH9 |
267 | Progressive hearing loss |
268 | P2RX2 |
269 | Pulmonary fibrosis, idiopathic |
270 | SFTPA2 |
271 | Sinoatrial node dysfunction and deafness |
272 | CACNA1D |
273 | Tietz albinism-deafness syndrome |
274 | MITF |
275 | Wolfram syndrome type 1 |
276 | WFS1 |
277 | Wolfram syndrome type 2 |
278 | CISD2 |
279 | Wolfram-like syndrome, autosomal dominant |
280 | WFS1 |
No. | Description |
---|---|
1 | Alveolar capillary dysplasia with misalignment of pulmonary veins |
2 | FOXF1 |
3 | Arrhythmogenic right ventricular cardiomyopathy type 1 |
4 | TGFB3 |
5 | Arrhythmogenic right ventricular cardiomyopathy type 10 |
6 | DSG2 |
7 | Arrhythmogenic right ventricular cardiomyopathy type 11 |
8 | DSC2 |
9 | Arrhythmogenic right ventricular cardiomyopathy type 12 |
10 | JUP |
11 | Arrhythmogenic right ventricular cardiomyopathy type 5 |
12 | TMEM43 |
13 | Arrhythmogenic right ventricular cardiomyopathy type 8 |
14 | DSP |
15 | Arrhythmogenic right ventricular cardiomyopathy type 9 |
16 | PKP2 |
17 | Arrhythmogenic right ventricular dysplasia type 2 |
18 | RYR2 |
19 | Atrial fibrillation type 10 |
20 | SCN5A |
21 | Atrial fibrillation type 11 |
22 | GJA5 |
23 | Atrial fibrillation type 12 |
24 | ABCC9 |
25 | Atrial fibrillation type 3 |
26 | KCNQ1 |
27 | Atrial fibrillation type 4 |
28 | KCNE2 |
29 | Atrial fibrillation type 6 |
30 | NPPA |
31 | Atrial fibrillation type 7 |
32 | KCNA5 |
33 | Atrial septal defect type 3 |
34 | MYH6 |
35 | Atrial septal defect type 4 |
36 | TBX20 |
37 | Atrial septal defect type 5 |
38 | ACTC1 |
39 | Atrial septal defect type 6 |
40 | TLL1 |
41 | Atrial septal defect type 8 |
42 | CITED2 |
43 | Atrial septal defect type 9 |
44 | GATA6 |
45 | Atrioventricular septal defect type 4 |
46 | GATA4 |
47 | Atrioventricular septal defect type 5 |
48 | GATA6 |
49 | Barth syndrome |
50 | TAZ |
51 | Bicuspid aortic valve |
52 | TIMP1 |
53 | Brugada syndrome type 1 |
54 | SCN5A |
55 | Brugada syndrome type 2 |
56 | GPD1L |
57 | Brugada syndrome type 3 |
58 | CACNA1C |
59 | Brugada syndrome type 4 |
60 | CACNB2 |
61 | Brugada syndrome type 5 |
62 | SCN1B |
63 | Brugada syndrome type 6 |
64 | KCNE3 |
65 | Brugada syndrome type 7 |
66 | SCN3B |
67 | Brugada syndrome type 8 |
68 | HCN4 |
69 | Brugada syndrome type 9 |
70 | SLMAP |
71 | Cardiac defects, CNOT3 related |
72 | CNOT3 |
73 | Cardiac defects, PPP1R8 related |
74 | PPP1R8 |
75 | Cardiac valvular dysplesia, X-linked |
76 | FLNA |
77 | Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency |
78 | SCO2 |
79 | Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency type 2 |
80 | COX15 |
81 | Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency type 3 |
82 | COA5 |
83 | Cardiofaciocutaneous syndrome |
84 | BRAF |
85 | Cardiofaciocutaneous syndrome |
86 | KRAS |
87 | Cardiofaciocutaneous syndrome type 3 |
88 | MAP2K1 |
89 | Cardiofaciocutaneous syndrome type 4 |
90 | MAP2K2 |
91 | Cardiomyopathy, apical hypertrophic, and neuropathy, MT-ATP8 related |
92 | MT-ATP8 |
93 | Cardiomyopathy, dilated |
94 | MYBPC3 |
95 | Cardiomyopathy, dilated type 1 |
96 | CRYAB |
97 | Cardiomyopathy, dilated type 1A |
98 | LMNA |
99 | Cardiomyopathy, dilated type 1AA |
100 | ACTN2 |
101 | Cardiomyopathy, dilated type 1BB |
102 | DSG2 |
103 | Cardiomyopathy, dilated type 1C |
104 | LDB3 |
105 | Cardiomyopathy, dilated type 1CC |
106 | NEXN |
107 | Cardiomyopathy, dilated type 1D |
108 | TNNT2 |
109 | Cardiomyopathy, dilated type 1DD |
110 | RBM20 |
111 | Cardiomyopathy, dilated type 1E |
112 | SCN5A |
113 | Cardiomyopathy, dilated type 1EE |
114 | MYH6 |
115 | Cardiomyopathy, dilated type 1G |
116 | TTN |
117 | Cardiomyopathy, dilated type 1GG |
118 | SDHA |
119 | Cardiomyopathy, dilated type 1HH |
120 | BAG3 |
121 | Cardiomyopathy, dilated type 1I |
122 | DES |
123 | Cardiomyopathy, dilated type 1J |
124 | EYA4 |
125 | Cardiomyopathy, dilated type 1KK |
126 | MYPN |
127 | Cardiomyopathy, dilated type 1L |
128 | SGCD |
129 | Cardiomyopathy, dilated type 1LL |
130 | PRDM16 |
131 | Cardiomyopathy, dilated type 1M |
132 | CSRP3 |
133 | Cardiomyopathy, dilated type 1N |
134 | TCAP |
135 | Cardiomyopathy, dilated type 1O |
136 | ABCC9 |
137 | Cardiomyopathy, dilated type 1P |
138 | PLN |
139 | Cardiomyopathy, dilated type 1R |
140 | ACTC1 |
141 | Cardiomyopathy, dilated type 1S |
142 | MYH7 |
143 | Cardiomyopathy, dilated type 1T |
144 | TMPO |
145 | Cardiomyopathy, dilated type 1U |
146 | PSEN1 |
147 | Cardiomyopathy, dilated type 1V |
148 | PSEN2 |
149 | Cardiomyopathy, dilated type 1W |
150 | VCL |
151 | Cardiomyopathy, dilated type 1X |
152 | FKTN |
153 | Cardiomyopathy, dilated type 1Y |
154 | TPM1 |
155 | Cardiomyopathy, dilated type 1Z |
156 | TNNC1 |
157 | Cardiomyopathy, dilated type 2A |
158 | TNNI3 |
159 | Cardiomyopathy, dilated type 2B |
160 | GATAD1 |
161 | Cardiomyopathy, dilated type 3B |
162 | DMD |
163 | Cardiomyopathy, dilated with ataxia |
164 | DNAJC19 |
165 | Cardiomyopathy, dilated with hypergonadotropic hypogonadism |
166 | LMNA |
167 | Cardiomyopathy, dilated with woolly hair and keratoderma |
168 | DSP |
169 | Cardiomyopathy, familial hypertrophic |
170 | CAV3 |
171 | Cardiomyopathy, familial hypertrophic type 1 |
172 | MYH7 |
173 | Cardiomyopathy, familial hypertrophic type 10 |
174 | MYL2 |
175 | Cardiomyopathy, familial hypertrophic type 11 |
176 | ACTC1 |
177 | Cardiomyopathy, familial hypertrophic type 12 |
178 | CSRP3 |
179 | Cardiomyopathy, familial hypertrophic type 16 |
180 | MYOZ2 |
181 | Cardiomyopathy, familial hypertrophic type 17 |
182 | JPH2 |
183 | Cardiomyopathy, familial hypertrophic type 19 |
184 | CALR3 |
185 | Cardiomyopathy, familial hypertrophic type 2 |
186 | TNNT2 |
187 | Cardiomyopathy, familial hypertrophic type 3 |
188 | TPM1 |
189 | Cardiomyopathy, familial hypertrophic type 4 |
190 | MYBPC3 |
191 | Cardiomyopathy, familial hypertrophic type 6 |
192 | PRKAG2 |
193 | Cardiomyopathy, familial hypertrophic type 7 |
194 | TNNI3 |
195 | Cardiomyopathy, familial hypertrophic type 8 |
196 | MYL3 |
197 | Cardiomyopathy, familial hypertrophic type 9 |
198 | TTN |
199 | Cardiomyopathy, familial restrictive type 1 |
200 | TNNI3 |
201 | Cardiomyopathy, fatal, MT-TI related |
202 | MT-TI |
203 | Cardiomyopathy, hypertrophic, midventricular, digenic |
204 | MYLK2 |
205 | Cardiomyopathy, hypertrophic, MT-TG related |
206 | MT-TG |
207 | Cardiomyopathy, hypertrophic, type 18 |
208 | PLN |
209 | Cardiomyopathy, idiopathic dilated, mitochondrial, MT-TH related |
210 | MT-TH |
211 | Cardiomyopathy, infantile hypertrophic, MT-ATP8 related |
212 | MT-ATP8 |
213 | Cardiomyopathy, left ventricular noncompaction, MYH7B related |
214 | MYH7B |
215 | Central hypoventilation syndrome with or without Hirschsprung disease |
216 | PHOX2B |
217 | Central hypoventilation syndrome, congenital |
218 | ASCL1 |
219 | Congenital heart defects and ectodermal dysplasia |
220 | PRKD1 |
221 | Congenital heart defects multiple types |
222 | GATA5 |
223 | Congenital heart defects multiple types |
224 | TAB2 |
225 | Coronary heart disease, susceptibility to, type 6 |
226 | MMP3 |
227 | CR1 deficiency |
228 | CR1 |
229 | Danon disease |
230 | LAMP2 |
231 | Diaphragmatic hernia type 3 |
232 | ZFPM2 |
233 | Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis |
234 | DSP |
235 | Dopamine beta-hydroxylase (DBH) deficiency |
236 | DBH |
237 | Familial atrial fibrillation type 13 |
238 | SCN1B |
239 | Heart block, progressive, familial, type 1A |
240 | SCN5A |
241 | Heart-hand syndrome, Slovenian type |
242 | LMNA |
243 | Jervell and Lange-Nielsen syndrome type 1 |
244 | KCNQ1 |
245 | Jervell and Lange-Nielsen syndrome type 2 |
246 | KCNE1 |
247 | Left ventricular noncompaction 1, with or without congenital heart defects |
248 | DTNA |
249 | Left ventricular noncompaction 7 |
250 | MIB1 |
251 | Legionnaire disease, susceptibility to |
252 | TLR5 |
253 | Long QT syndrome type 1 |
254 | KCNQ1 |
255 | Long QT syndrome type 10 |
256 | SCN4B |
257 | Long QT syndrome type 11 |
258 | AKAP9 |
259 | Long QT syndrome type 12 |
260 | SNTA1 |
261 | Long QT syndrome type 13 |
262 | KCNJ5 |
263 | Long QT syndrome type 15 |
264 | CALM2 |
265 | Long QT syndrome type 2 |
266 | KCNH2 |
267 | Long QT syndrome type 3 |
268 | SCN5A |
269 | Long QT syndrome type 4 |
270 | ANK2 |
271 | Long QT syndrome type 5 |
272 | KCNE1 |
273 | Long QT syndrome type 6 |
274 | KCNE2 |
275 | Long QT syndrome type 8 |
276 | CACNA1C |
277 | Long QT syndrome type 9 |
278 | CAV3 |
279 | Marfan syndrome |
280 | FBN1 |
281 | MASS syndrome |
282 | FBN1 |
283 | McKusick-Kaufman syndrome |
284 | MKKS |
285 | MELAS syndrome |
286 | MT-TC |
287 | MELAS syndrome |
288 | MT-TF |
289 | MELAS syndrome, MT-TL1 related |
290 | MT-TL1 |
291 | MERRF/MELAS overlap syndrome, MT-TS1 related |
292 | MT-TS1 |
293 | MERRF/MELAS overlap syndrome, MT-TS2 related |
294 | MT-TS2 |
295 | Mitochondrial myopathy and sideroblastic anemia type 1 |
296 | PUS1 |
297 | Mitochondrial myopathy, infantile, transient, MT-TE related |
298 | MT-TE |
299 | Mitochondrial myopathy, isolated |
300 | MT-TD |
301 | Mitochondrial myopathy, MT-TA related |
302 | MT-TA |
303 | Mitochondrial myopathy, MT-TM related |
304 | MT-TM |
305 | Mitochondrial phosphate carrier deficiency |
306 | SLC25A3 |
307 | Moyamoya disease type 5 |
308 | ACTA2 |
309 | Multisystemic smooth muscle dysfunction syndrome |
310 | ACTA2 |
311 | Myopathy, MT-TQ related |
312 | MT-TQ |
313 | Pancreatic agenesis and congenital heart defects |
314 | GATA6 |
315 | Progressive familial heart block |
316 | TRPM4 |
317 | Pulmonary fibrosis, idiopathic |
318 | SFTPA1 |
319 | Pulmonary newborn hypertension |
320 | CRHR1 |
321 | Pulmonary venoocclusive disease type 2 |
322 | EIF2AK4 |
323 | Sengers syndrome |
324 | AGK |
325 | Short QT syndrome type 1 |
326 | KCNH2 |
327 | Short QT syndrome type 2 |
328 | KCNQ1 |
329 | Short QT syndrome type 3 |
330 | KCNJ2 |
331 | Sick sinus syndrome type 1 |
332 | SCN5A |
333 | Sick sinus syndrome type 3 |
334 | MYH6 |
335 | Sinoatrial node dysfunction and deafness |
336 | CACNA1D |
337 | Sudden infant death syndrome, susceptibility to |
338 | SCN5A |
339 | Sudden infant death with dysgenesis of the testes syndrome |
340 | TSPYL1 |
341 | Testicular anomalies with or without congenital heart disease |
342 | GATA4 |
343 | Tetralogy of Fallot |
344 | ALDH1A2 |
345 | Tetralogy of Fallot |
346 | GATA4 |
347 | Tetralogy of Fallot |
348 | GATA6 |
349 | Tetralogy of Fallot |
350 | ZFPM2 |
351 | Thoracic aortic aneurysm dissection |
352 | SMAD2 |
353 | Transposition of the great arteries, dextro-looped 1 |
354 | MED13L |
355 | Ventricular fibrillation, paroxysmal familial type 1 |
356 | SCN5A |
357 | Ventricular septal defect type 1 |
358 | GATA4 |
359 | Ventricular septal defect type 2 |
360 | CITED2 |
361 | Ventricular tachycardia, catecholaminergic polymorphic type 1 |
362 | RYR2 |
363 | Ventricular tachycardia, catecholaminergic polymorphic type 2 |
364 | CASQ2 |
365 | Ventricular tachycardia, catecholaminergic polymorphic type 4 |
366 | CALM1 |
367 | Ventricular tachycardia, catecholaminergic polymorphic type 5 |
368 | TRDN |
369 | Wolff -Parkinson-White syndrome |
370 | PRKAG2 |
No. | Description |
---|---|
1 | genesis, partial, with minifascicular neuropathy |
2 | DHH |
3 | Achalasia addisonianism alacrimia syndrome |
4 | AAAS |
5 | Acrocallosal syndrome |
6 | KIF7 |
7 | Acyl-CoA peroxisomal oxidase deficiency |
8 | ACOX1 |
9 | Adrenoleukodystrophy, x-linked |
10 | ABCD1 |
11 | Adrenoleukodystrophy, x-linked |
12 | PLXNB3 |
13 | Adrenoleukodystrophy/Adrenomyeloneuropathy |
14 | ABCD1 |
15 | Agenesis of the corpus callosum with peripheral neuropathy |
16 | SLC12A6 |
17 | Aicardi-Goutieres syndrome type 1 |
18 | TREX1 |
19 | Aicardi-Goutieres syndrome type 2 |
20 | RNASEH2B |
21 | Aicardi-Goutieres syndrome type 3 |
22 | RNASEH2C |
23 | Aicardi-Goutieres syndrome type 4 |
24 | RNASEH2A |
25 | Aicardi-Goutieres syndrome type 5 |
26 | SAMHD1 |
27 | Aicardi-Goutieres syndrome type 6 |
28 | ADAR |
29 | Aicardi-Goutieres syndrome type 7 |
30 | IFIH1 |
31 | Al-Raqad syndrome |
32 | DCPS |
33 | Alexander disease |
34 | GFAP |
35 | Allan-Herndon-Dudley syndrome |
36 | SLC16A2 |
37 | Alpha-thalassemia/mental retardation syndrome |
38 | ATRX |
39 | Alternating hemiplegia of childhood type 1 |
40 | ATP1A2 |
41 | Alternating hemiplegia of childhood type 2 |
42 | ATP1A3 |
43 | Alzheimer disease type 1 |
44 | APP |
45 | Alzheimer disease type 1 |
46 | NOS3 |
47 | Alzheimer disease type 18, susceptibility to |
48 | ADAM10 |
49 | Alzheimer disease type 2 |
50 | APOE |
51 | Alzheimer disease type 3 |
52 | PSEN1 |
53 | Alzheimer disease type 4 |
54 | PSEN2 |
55 | Alzheimers disease, early onset, autosomal dominant |
56 | SORL1 |
57 | Alzheimers disease, RTN3 related |
58 | RTN3 |
59 | Amish infantile epilepsy syndrome |
60 | ST3GAL5 |
61 | Amyloidosis |
62 | TTR |
63 | Amyloidosis, finnish type |
64 | GSN |
65 | Amyotrophic lateral sclerosis risk factor |
66 | CHGB |
67 | Amyotrophic lateral sclerosis type 1 |
68 | SOD1 |
69 | Amyotrophic lateral sclerosis type 10 |
70 | TARDBP |
71 | Amyotrophic lateral sclerosis type 11 |
72 | FIG4 |
73 | Amyotrophic lateral sclerosis type 12 |
74 | OPTN |
75 | Amyotrophic lateral sclerosis type 14 |
76 | VCP |
77 | Amyotrophic lateral sclerosis type 16 |
78 | SIGMAR1 |
79 | Amyotrophic lateral sclerosis type 17 |
80 | CHMP2B |
81 | Amyotrophic lateral sclerosis type 18 |
82 | PFN1 |
83 | Amyotrophic lateral sclerosis type 2, juvenile |
84 | ALS2 |
85 | Amyotrophic lateral sclerosis type 21 |
86 | MATR3 |
87 | Amyotrophic lateral sclerosis type 4 |
88 | SETX |
89 | Amyotrophic lateral sclerosis type 6 |
90 | FUS |
91 | Amyotrophic lateral sclerosis type 8 |
92 | VAPB |
93 | Amyotrophic lateral sclerosis type 9 |
94 | ANG |
95 | Amyotrophic lateral sclerosis with frontotemporal dementia |
96 | C9orf72 |
97 | Amyotrophic lateral sclerosis, CREST related |
98 | SS18L1 |
99 | Amyotrophic lateral sclerosis, susceptibility to |
100 | NEFH |
101 | Amyotrophic lateral sclerosis, VPS54 related |
102 | VPS54 |
103 | Amyotrophic lateral sclerosis, x-linked juvenile and adult-onset ALS |
104 | UBQLN2 |
105 | Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to |
106 | TRPM7 |
107 | Amyotrophy hereditary neuralgic |
108 | 9-Sep |
109 | Angelman syndrome |
110 | chr. 15q11 |
111 | Angelman syndrome |
112 | UBE3A |
113 | Angelman-like syndrome |
114 | CDKL5 |
115 | Angelman-like syndrome |
116 | MECP2 |
117 | Arts syndrome |
118 | PRPS1 |
119 | Asperger syndrome susceptibility X-linked type 2 |
120 | NLGN3 |
121 | Ataxia and muscle hypotonia |
122 | COX20 |
123 | Ataxia telangiectasia like disorder |
124 | MRE11 |
125 | Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus |
126 | DNAJC3 |
127 | Ataxia, posterior column, with retinitis pigmentosa |
128 | FLVCR1 |
129 | Ataxia, progressive seizures, mental deterioration, and hearing loss, MT-TV related |
130 | MT-TV |
131 | Ataxia, sensory type 1, autosomal dominant |
132 | RNF170 |
133 | Ataxia-oculomotor apraxia type 1 |
134 | APTX |
135 | Ataxia-oculomotor apraxia type 2 |
136 | SETX |
137 | Ataxia-oculomotor apraxia type 3 |
138 | PIK3R5 |
139 | Ataxia-oculomotor apraxia type 4 |
140 | PNKP |
141 | Ataxia-telangiectasia |
142 | ATM |
143 | Attention deficit-hyperactivity disorder |
144 | DRD4 |
145 | Attention deficit-hyperactivity disorder |
146 | DRD5 |
147 | Autism spectrum disorder |
148 | AHNAK2 |
149 | Autism spectrum disorder |
150 | ANKS3 |
151 | Autism spectrum disorder |
152 | BPIFA3 |
153 | Autism spectrum disorder |
154 | EN2 |
155 | Autism spectrum disorder |
156 | RABGGTA |
157 | Autism spectrum disorder, MYO16 related |
158 | MYO16 |
159 | Autism spectrum, MXRA5 related |
160 | MXRA5 |
161 | Autism spectrum/ hyperactivity/ bipolar disorder, GRM7 related |
162 | GRM7 |
163 | Autism susceptibility, type 16 |
164 | SLC9A9 |
165 | Autism susceptibility, type 18 |
166 | CHD8 |
167 | Autism susceptibility, type 19 |
168 | EIF4E |
169 | Autism susceptibility, X-linked type 1 |
170 | NLGN3 |
171 | Autism susceptibility, X-linked type 17 |
172 | SHANK2 |
173 | Autism susceptibility, X-linked type 2 |
174 | NLGN4X |
175 | Autism susceptibility, X-linked type 3 |
176 | MECP2 |
177 | Autism susceptibility, X-linked type 4 |
178 | PTCHD1 |
179 | Autism susceptibility, X-linked type 5 |
180 | RPL10 |
181 | Autism susceptibility, X-linked type 6 |
182 | TMLHE |
183 | Autism, ATP1B4 related |
184 | ATP1B4 |
185 | Autism, AVPR1A related |
186 | AVPR1A |
187 | Autism, C7orf43 related |
188 | C7orf43 |
189 | Autism, CELF6 related |
190 | CELF6 |
191 | Autism, EFCAB13 related |
192 | EFCAB13 |
193 | Autism, FAAH2 related |
194 | FAAH2 |
195 | Autism, FCRL6 related |
196 | FCRL6 |
197 | Autism, GYG2 related |
198 | GYG2 |
199 | Autism, IQCE related |
200 | IQCE |
201 | Autism, MBD1 related |
202 | MBD1 |
203 | Autism, NTNG1 related |
204 | NTNG1 |
205 | Autism, OR13H1 related |
206 | OR13H1 |
207 | Autism, OXTR related |
208 | OXTR |
209 | Autism, PKHD1L1 related |
210 | PKHD1L1 |
211 | Autism, RNF128 related |
212 | RNF128 |
213 | Autism, RRM1 related |
214 | RRM1 |
215 | Autism, SETD2 related |
216 | SETD2 |
217 | Autism, SLC22A9 related |
218 | SLC22A9 |
219 | Autism, UNC13B related |
220 | UNC13B |
221 | Autism, ZNF778 related |
222 | ZNF778 |
223 | Autism/Mental retardation/Angelman syndrome, susceptibility to, ATP10A related |
224 | ATP10A |
225 | Bethlem myopathy |
226 | COL6A1 |
227 | Bethlem myopathy |
228 | COL6A2 |
229 | Bethlem myopathy type 1 |
230 | COL6A3 |
231 | Bethlem myopathy type 2 |
232 | COL12A1 |
233 | Borjeson-Forssman-Lehmann syndrome |
234 | PHF6 |
235 | Brody myopathy |
236 | ATP2A1 |
237 | Brunner syndrome |
238 | MAOA |
239 | Budd-Chiari syndrome |
240 | F5 |
241 | Canavan disease |
242 | ASPA |
243 | CAPOS syndrome |
244 | ATP1A3 |
245 | Cardiomyopathy, hypertrophic, type 24 |
246 | LDB3 |
247 | Cataracts with facial dysmorphism and neuropathy |
248 | CTDP1 |
249 | Central core disease |
250 | RYR1 |
251 | Central hypoventilation syndrome with or without Hirschsprung disease |
252 | PHOX2B |
253 | Central hypoventilation syndrome, congenital |
254 | ASCL1 |
255 | Centronuclear myopathy type 1 |
256 | DNM2 |
257 | Centronuclear myopathy type 1 |
258 | MTMR14 |
259 | Centronuclear myopathy type 2 |
260 | BIN1 |
261 | Centronuclear myopathy type 3 |
262 | MYF6 |
263 | Centronuclear myopathy type 4 |
264 | CCDC78 |
265 | Centronuclear myopathy type 5 |
266 | SPEG |
267 | Cerebellar ataxia |
268 | CP |
269 | Cerebellar ataxia and mental retardation with or without quadrupedal locomotion type 3 |
270 | CA8 |
271 | Cerebellar ataxia with deafness and narcolepsy, autosomal recessive |
272 | DNMT1 |
273 | Cerebellar ataxia with mental retardation and dysequilibrium syndrome type 2 |
274 | WDR81 |
275 | Cerebellar ataxia with spasticity |
276 | GBA2 |
277 | Cerebellar ataxia, mental retardation, and dysequilibrium syndrome type 4 |
278 | ATP8A2 |
279 | Cerebellar ataxia, nonprogressive, with mental retardation |
280 | CAMTA1 |
281 | Cerebellar ataxia, SNX14 related |
282 | SNX14 |
283 | Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion type 1 |
284 | VLDLR |
285 | Cerebral amyloid angiopathy |
286 | CST3 |
287 | Cerebral amyloid angiopathy, APP related |
288 | APP |
289 | Cerebral infarction, susceptibility to |
290 | PRKCH |
291 | Cerebral palsy type 1, spastic quadriplegic |
292 | GAD1 |
293 | Cerebral palsy type 2, spastic quadriplegic |
294 | KANK1 |
295 | Cerebrotendinous xanthomatosis |
296 | CYP27A1 |
297 | Cervical dystonia |
298 | CIZ1 |
299 | Charcot-Marie-Tooth disease, axonal type 20 |
300 | DYNC1H1 |
301 | CHILD syndrome |
302 | NSDHL |
303 | Chorea, hereditary benign |
304 | NKX2-1 |
305 | Choreoacanthocytosis |
306 | VPS13A |
307 | CK syndrome |
308 | NSDHL |
309 | CMT1A |
310 | PMP22 |
311 | CMT1B |
312 | MPZ |
313 | CMT1C |
314 | LITAF |
315 | CMT1D |
316 | EGR2 |
317 | CMT1E |
318 | PMP22 |
319 | CMT2A1 |
320 | KIF1B |
321 | CMT2A2 |
322 | MFN2 |
323 | CMT2B |
324 | RAB7A |
325 | CMT2B1 |
326 | LMNA |
327 | CMT2B2 |
328 | MED25 |
329 | CMT2C |
330 | TRPV4 |
331 | CMT2D |
332 | GARS1 |
333 | CMT2F |
334 | HSPB1 |
335 | CMT2I |
336 | MPZ |
337 | CMT2J |
338 | MPZ |
339 | CMT2K |
340 | GDAP1 |
341 | CMT2L |
342 | HSPB8 |
343 | CMT2N |
344 | AARS1 |
345 | CMT2P |
346 | LRSAM1 |
347 | CMT4, CTDP1 related |
348 | CTDP1 |
349 | CMT4A |
350 | GDAP1 |
351 | CMT4B1 |
352 | MTMR2 |
353 | CMT4B2 |
354 | SBF2 |
355 | CMT4C |
356 | SH3TC2 |
357 | CMT4D |
358 | NDRG1 |
359 | CMT4E |
360 | EGR2 |
361 | CMT4E |
362 | MPZ |
363 | CMT4F |
364 | PRX |
365 | CMT4H |
366 | FGD4 |
367 | CMT4J |
368 | FIG4 |
369 | CMTDIF |
370 | GNB4 |
371 | CMTRIB |
372 | KARS1 |
373 | CMTRID |
374 | COX6A1 |
375 | CMTX1 |
376 | GJB1 |
377 | CMTX4 |
378 | AIFM1 |
379 | CMTX5 |
380 | PRPS1 |
381 | COACH syndrome |
382 | CC2D2A |
383 | COACH syndrome |
384 | RPGRIP1L |
385 | COACH syndrome |
386 | TMEM67 |
387 | Coenzyme Q10 deficiency type 1 |
388 | COQ2 |
389 | Coenzyme Q10 deficiency type 2 |
390 | PDSS1 |
391 | Coenzyme Q10 deficiency type 3 |
392 | PDSS2 |
393 | Coenzyme Q10 deficiency type 5 |
394 | COQ9 |
395 | Coffin-Lowry syndrome |
396 | RPS6KA3 |
397 | Cohen syndrome |
398 | VPS13B |
399 | Compton-North congenital myopathy |
400 | CNTN1 |
401 | Congenital muscular dystrophy and hypoglycosylation of ?-dystroglycan |
402 | B3GALNT2 |
403 | Convulsions, benign familial infantile, 3 |
404 | SCN2A |
405 | Convulsions, familial infantile, with paroxysmal choreoathetosis |
406 | PRRT2 |
407 | Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia |
408 | IGBP1 |
409 | Cortical dysplasia, complex, with other brain malformations, type 1 |
410 | TUBB3 |
411 | Cortical dysplasia, complex, with other brain malformations, type 5 |
412 | TUBB2A |
413 | Cortical dysplasia-focal epilepsy syndrome |
414 | CNTNAP2 |
415 | Corticobasal Degeneration, CFL1 related |
416 | CFL1 |
417 | CR1 deficiency |
418 | CR1 |
419 | Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome |
420 | TMCO1 |
421 | Creatine deficiency syndrome X-linked |
422 | SLC6A8 |
423 | Creatine phosphokinase, elevated serum |
424 | CAV3 |
425 | Creutzfeldt-Jakob disease |
426 | PRNP |
427 | Cytochrome c oxidase 1 deficiency |
428 | MT-CO1 |
429 | Cytochrome c oxidase 2 deficiency |
430 | MT-CO2 |
431 | Cytochrome c oxidase 3 deficiency |
432 | MT-CO3 |
433 | Danon disease |
434 | LAMP2 |
435 | Dejerine-Sottas disease |
436 | EGR2 |
437 | Dejerine-Sottas disease |
438 | GJB1 |
439 | Dejerine-Sottas disease |
440 | MPZ |
441 | Dejerine-Sottas disease |
442 | PMP22 |
443 | Dejerine-Sottas disease |
444 | PRX |
445 | Dementia, familial, British type |
446 | ITM2B |
447 | Dementia, familial, Danish type |
448 | ITM2B |
449 | Dementia, frontotemporal |
450 | GRN |
451 | Dementia, frontotemporal |
452 | MAPT |
453 | Dementia, frontotemporal |
454 | PSEN1 |
455 | Dementia, frontotemporal |
456 | TARDBP |
457 | Dementia, Lewy body |
458 | SNCA |
459 | Dent disease type 2 |
460 | OCRL |
461 | Dentatorubral-pallidoluysian atrophy |
462 | ATN1 |
463 | Developmental delay and microcephaly, SLC1A4 related |
464 | SLC1A4 |
465 | Developmental delay, GNAQ related |
466 | GNAQ |
467 | Developmental delay, KMT2C related |
468 | KMT2C |
469 | DI-CMTB |
470 | DNM2 |
471 | DI-CMTC |
472 | YARS1 |
473 | DI-CMTD |
474 | MPZ |
475 | Dravet syndrome |
476 | GABRG2 |
477 | Dravet syndrome |
478 | SCN2A |
479 | Dravet syndrome, modifier of |
480 | SCN9A |
481 | Dysautonomia, FRRS1L-related |
482 | FRRS1L |
483 | Dyskinesia, familial, with facial myokymia |
484 | ADCY5 |
485 | Dyskinesia, limb and orofacial, infantile-onset |
486 | PDE10A |
487 | Dyslexia |
488 | PCDH11X |
489 | Dyssegmental dysplasia, Silverman-Handmaker type |
490 | HSPG2 |
491 | Dystonia juvenile-onset |
492 | ACTB |
493 | Dystonia, DOPA-responsive, autosomanl recessive |
494 | SPR |
495 | Dystonia-deafness syndrome |
496 | TIMM8A |
497 | DYT1 |
498 | TOR1A |
499 | DYT10 |
500 | PRRT2 |
501 | DYT11 |
502 | SGCE |
503 | DYT11, DRD2 related |
504 | DRD2 |
505 | DYT12 |
506 | ATP1A3 |
507 | DYT16 |
508 | PRKRA |
509 | DYT18 |
510 | SLC2A1 |
511 | DYT2 |
512 | HPCA |
513 | DYT23 |
514 | CACNA1B |
515 | DYT24 |
516 | ANO3 |
517 | DYT25 |
518 | GNAL |
519 | DYT26, myoclonic |
520 | KCTD17 |
521 | DYT27 |
522 | COL6A3 |
523 | DYT3 |
524 | TAF1 |
525 | DYT4 |
526 | TUBB4A |
527 | DYT5A |
528 | GCH1 |
529 | DYT6 |
530 | THAP1 |
531 | DYT8 |
532 | SLC2A1 |
533 | Early infantile epileptic encephalopathy type 1 |
534 | ARX |
535 | Early infantile epileptic encephalopathy type 10 |
536 | PNKP |
537 | Early infantile epileptic encephalopathy type 11 |
538 | SCN2A |
539 | Early infantile epileptic encephalopathy type 12 |
540 | PLCB1 |
541 | Early infantile epileptic encephalopathy type 13 |
542 | SCN8A |
543 | Early infantile epileptic encephalopathy type 14 |
544 | KCNT1 |
545 | Early infantile epileptic encephalopathy type 15 |
546 | ST3GAL3 |
547 | Early infantile epileptic encephalopathy type 16 |
548 | TBC1D24 |
549 | Early infantile epileptic encephalopathy type 17 |
550 | GNAO1 |
551 | Early infantile epileptic encephalopathy type 19 |
552 | GABRA1 |
553 | Early infantile epileptic encephalopathy type 2 |
554 | CDKL5 |
555 | Early infantile epileptic encephalopathy type 20 |
556 | PIGA |
557 | Early infantile epileptic encephalopathy type 21 |
558 | NECAP1 |
559 | Early infantile epileptic encephalopathy type 23 |
560 | DOCK7 |
561 | Early infantile epileptic encephalopathy type 24 |
562 | HCN1 |
563 | Early infantile epileptic encephalopathy type 25 |
564 | SLC13A5 |
565 | Early infantile epileptic encephalopathy type 26 |
566 | KCNB1 |
567 | Early infantile epileptic encephalopathy type 27 |
568 | GRIN2B |
569 | Early infantile epileptic encephalopathy type 28 |
570 | WWOX |
571 | Early infantile epileptic encephalopathy type 29 |
572 | AARS1 |
573 | Early infantile epileptic encephalopathy type 3 |
574 | SLC25A22 |
575 | Early infantile epileptic encephalopathy type 30 |
576 | SIK1 |
577 | Early infantile epileptic encephalopathy type 31 |
578 | DNM1 |
579 | Early infantile epileptic encephalopathy type 32 |
580 | KCNA2 |
581 | Early infantile epileptic encephalopathy type 33 |
582 | EEF1A2 |
583 | Early infantile epileptic encephalopathy type 4 |
584 | STXBP1 |
585 | Early infantile epileptic encephalopathy type 40 |
586 | GUF1 |
587 | Early infantile epileptic encephalopathy type 45 |
588 | GABRB1 |
589 | Early infantile epileptic encephalopathy type 46 |
590 | GRIN2D |
591 | Early infantile epileptic encephalopathy type 47 |
592 | FGF12 |
593 | Early infantile epileptic encephalopathy type 5 |
594 | SPTAN1 |
595 | Early infantile epileptic encephalopathy type 6 |
596 | SCN1A |
597 | Early infantile epileptic encephalopathy type 67 |
598 | CUX2 |
599 | Early infantile epileptic encephalopathy type 7 |
600 | KCNQ2 |
601 | Early infantile epileptic encephalopathy type 8 |
602 | ARHGEF9 |
603 | Early infantile epileptic encephalopathy type 9 |
604 | PCDH19 |
605 | Emery-Dreifuss muscular dystrophy type 1 |
606 | EMD |
607 | Emery-Dreifuss muscular dystrophy type 2 |
608 | LMNA |
609 | Emery-Dreifuss muscular dystrophy type 4 |
610 | SYNE1 |
611 | Emery-Dreifuss muscular dystrophy type 5 |
612 | SYNE2 |
613 | Emery-Dreifuss muscular dystrophy type 6 |
614 | FHL1 |
615 | Encephalomyopathy, mitochondrial, MT-TL2 related |
616 | MT-TL2 |
617 | Encephalomyopathy, mitochondrial, MT-TR related |
618 | MT-TR |
619 | Encephalopathy lethal, due to defective mitochondrial peroxisomal fission |
620 | DNM1L |
621 | Encephalopathy mitochondrial |
622 | VDAC1 |
623 | Encephalopathy mitochondrial with proximal renal tubulopathy due to cytochrome c oxidase deficiency |
624 | COX10 |
625 | Encephalopathy mitochondrial, MT-TW related |
626 | MT-TW |
627 | Encephalopathy neonatal severe |
628 | MECP2 |
629 | Encephalopathy thiamine-responsive |
630 | SLC19A3 |
631 | Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, type 5 |
632 | TRAF3 |
633 | Encephalopathy, acute, necrotizing, type 1 |
634 | RANBP2 |
635 | Encephalopathy, familial, with neuroserpin inclusion bodies |
636 | SERPINI1 |
637 | Encephalopathy, progressive, with or without lipodystrophy |
638 | BSCL2 |
639 | Endplate acetylcholinesterase deficiency |
640 | COLQ |
641 | Epidermolysis bullosa simplex with muscular dystrophy |
642 | PLEC |
643 | Epidermolysis bullosa simplex, autosomal recessive type 2 |
644 | DST |
645 | Epilepsy with neurodevelopmental defects |
646 | GRIN2A |
647 | Epilepsy, childhood absence type 2 |
648 | GABRG2 |
649 | Epilepsy, childhood absence type 4, susceptibility to |
650 | GABRA1 |
651 | Epilepsy, childhood absence type 5 |
652 | GABRB3 |
653 | Epilepsy, childhood absence type 6, susceptibility to |
654 | CACNA1H |
655 | Epilepsy, familial focal with variable foci |
656 | DEPDC5 |
657 | Epilepsy, familial temporal lobe type 1 |
658 | LGI1 |
659 | Epilepsy, familial temporal lobe type 5 |
660 | CPA6 |
661 | Epilepsy, familial temporal lobe type 7 |
662 | RELN |
663 | Epilepsy, focal, SCN3A related |
664 | SCN3A |
665 | Epilepsy, HCN2 related |
666 | HCN2 |
667 | Epilepsy, hearing loss, and mental retardation syndrome |
668 | SPATA5 |
669 | Epilepsy, idiopathic generalized type 10 |
670 | GABRD |
671 | Epilepsy, idiopathic generalized type 11 |
672 | CLCN2 |
673 | Epilepsy, idiopathic generalized type 12 |
674 | SLC2A1 |
675 | Epilepsy, juvenile absence type 1 |
676 | EFHC1 |
677 | Epilepsy, nocturnal frontal lobe |
678 | KCNT1 |
679 | Epilepsy, nocturnal frontal lobe type 1 |
680 | CHRNA4 |
681 | Epilepsy, nocturnal frontal lobe type 3 |
682 | CHRNB2 |
683 | Epilepsy, nocturnal frontal lobe type 4 |
684 | CHRNA2 |
685 | Epilepsy, progressive myoclonic type 4, with or without renal failure |
686 | SCARB2 |
687 | Epilepsy, progressive myoclonic type 5 |
688 | PRICKLE2 |
689 | Epilepsy, progressive myoclonic type 7 |
690 | KCNC1 |
691 | Epilepsy, X-linked, with learning disabilities and behavior disorders |
692 | SYN1 |
693 | Epileptic encephalopathy, childhood-onset |
694 | CHD2 |
695 | Epileptic encephalopathy, Lennox-Gastaut type |
696 | MAPK10 |
697 | Episodic ataxia type 1 |
698 | KCNA1 |
699 | Episodic ataxia type 2 |
700 | CACNA1A |
No. | Description |
701 | Episodic ataxia type 5 |
702 | CACNB4 |
703 | Episodic ataxia type 6 |
704 | SLC1A3 |
705 | Episodic pain syndrome type 2, familial |
706 | SCN10A |
707 | Episodic pain syndrome type 3, familial |
708 | SCN11A |
709 | Erythermalgia, primary |
710 | SCN9A |
711 | Ethylmalonic encephalopathy |
712 | ETHE1 |
713 | Facial paresis type 3 |
714 | HOXB1 |
715 | Facioscapulohumeral dystrophy-like phenotype, FAT1 related |
716 | FAT1 |
717 | Familial hemiplegic migraine type 1 |
718 | CACNA1A |
719 | Familial hemiplegic migraine type 2 |
720 | ATP1A2 |
721 | Familial hemiplegic migraine type 3 |
722 | SCN1A |
723 | Familial infantile myoclonic epilepsy |
724 | TBC1D24 |
725 | Fatal familial imsomnia |
726 | PRNP |
727 | Febrile seizures, familial, type 4 |
728 | ADGRV1 |
729 | FG syndrome type 1 |
730 | MED12 |
731 | FG syndrome type 2 |
732 | FLNA |
733 | FG syndrome type 4 |
734 | CASK |
735 | Filaminopathy |
736 | FLNC |
737 | Fragile X syndrome |
738 | FMR1 |
739 | Fragile X tremor/ataxia syndrome |
740 | FMR1 |
741 | Friedreich ataxia |
742 | FXN |
743 | Frontometaphyseal dysplasia |
744 | FLNA |
745 | Fucosidosis |
746 | FUCA1 |
747 | Fukuyama congenital muscular dystrophy |
748 | FKTN |
749 | Gaze palsy, horizontal, with progressive scoliosis |
750 | ROBO3 |
751 | Generalized epilepsy and paroxysmal dyskinesia |
752 | KCNMA1 |
753 | Generalized epilepsy with febrile seizures plus type 1 |
754 | SCN1B |
755 | Generalized epilepsy with febrile seizures plus type 2 |
756 | SCN1A |
757 | Generalized epilepsy with febrile seizures plus type 3 |
758 | GABRG2 |
759 | Generalized epilepsy with febrile seizures plus type 7 |
760 | SCN9A |
761 | Generalized epilepsy with febrile seizures plus type 9 |
762 | STX1B |
763 | Gerstmann-Straussler disease |
764 | PRNP |
765 | Giant axonal neuropathy type 1 |
766 | GAN |
767 | Gillespie syndrome |
768 | ITPR1 |
769 | GLUT1 deficiency syndrome type 1 |
770 | SLC2A1 |
771 | Glycine encephalopathy |
772 | AMT |
773 | Glycine encephalopathy |
774 | GCSH |
775 | Glycosylation disorde type 2A |
776 | MGAT2 |
777 | Glycosylation disorde type 2C |
778 | SLC35C1 |
779 | Glycosylation disorder type 1C |
780 | ALG6 |
781 | Glycosylation disorder type 1E |
782 | DPM1 |
783 | Glycosylation disorder type 1J |
784 | DPAGT1 |
785 | Glycosylation disorder type 1M |
786 | DOLK |
787 | Glycosylation disorder type 2D |
788 | B4GALT1 |
789 | Glycosylation disorder type 2E |
790 | COG7 |
791 | Glycosylation disorder type 2F |
792 | SLC35A1 |
793 | Glycosylation disorder type 2G |
794 | COG1 |
795 | Glycosylation disorder type 2H |
796 | COG8 |
797 | GM1-gangliosidosis |
798 | GLB1 |
799 | Gordon Holmes Syndrome |
800 | RNF216 |
801 | Griscelli syndrome type 2 |
802 | RAB27A |
803 | Hereditary motor and sensory neuropathy, Okinawa type |
804 | TFG |
805 | Hereditary myopathy with early respiratory failure |
806 | TTN |
807 | Heterotopia, periventricular, ED variant |
808 | FLNA |
809 | Heterotopia, periventricular, X-linked dominant |
810 | FLNA |
811 | Hippocampal longterm potentiation, RFN39 related |
812 | RNF39 |
813 | Hoyeraal-Hreidarsson syndrome |
814 | DKC1 |
815 | HSAN1 |
816 | SPTLC1 |
817 | HSAN2A |
818 | WNK1 |
819 | HSAN2B |
820 | RETREG1 |
821 | HSAN3 |
822 | ELP1 |
823 | HSAN4 |
824 | NTRK1 |
825 | HSAN5 |
826 | NGF |
827 | HSAN8 |
828 | PRDM12 |
829 | HSN2C |
830 | KIF1A |
831 | Huntington disease |
832 | HTT |
833 | Huntington disease, ZDHHC17 related |
834 | ZDHHC17 |
835 | Huntington disease-like type 1 |
836 | PRNP |
837 | Huntington disease-like type 2 |
838 | JPH3 |
839 | Hydranencephaly with abnormal genitalia/Lissencephaly X-linked 2 |
840 | ARX |
841 | Hydrocephalus with aqueductal stenosis and congenital intestinal pseudoobstraction |
842 | L1CAM |
843 | Hydrocephalus, nonsyndromic, autosomal recessive type 1 |
844 | CCDC88C |
845 | Hydrocephalus, nonsyndromic, autosomal recessive type 2 |
846 | MPDZ |
847 | Hyperekplexia |
848 | GLRA1 |
849 | Hyperekplexia |
850 | GLRB |
851 | Hyperekplexia |
852 | SLC6A5 |
853 | Hyperekplexia, EIEE8 related |
854 | ARHGEF9 |
855 | Hyperkalemic periodic paralysis |
856 | SCN4A |
857 | Hyperphenylalaninemia, BH4-deficient, B |
858 | GCH1 |
859 | Hypokalemic periodic paralysis type 1 |
860 | CACNA1S |
861 | Hypomyelination with brainstem and spinal cord involvement and leg spasticity |
862 | DARS |
863 | Inclusion body myopathy |
864 | GNE |
865 | Inclusion body myopathy |
866 | MYH2 |
867 | Infantile neuroaxonal dystrophy type 1 |
868 | PLA2G6 |
869 | Insensitivity to pain, channelopathy-associated |
870 | SCN9A |
871 | Intellectual disability nonsyndromic, CIC related |
872 | CIC |
873 | Intellectual disability nonsyndromic, CNKSR2 related |
874 | CNKSR2 |
875 | Intellectual disability, TBR1 related |
876 | TBR1 |
877 | Intestinal pseudoobstraction, neuronal |
878 | FLNA |
879 | Jensen syndrome |
880 | TIMM8A |
881 | Joubert syndrome type 1 |
882 | INPP5E |
883 | Joubert syndrome type 10 |
884 | OFD1 |
885 | Joubert syndrome type 13 |
886 | TCTN1 |
887 | Joubert syndrome type 14 |
888 | TMEM237 |
889 | Joubert syndrome type 15 |
890 | CEP41 |
891 | Joubert syndrome type 16 |
892 | TMEM138 |
893 | Joubert syndrome type 17 |
894 | CPLANE1 |
895 | Joubert syndrome type 18 |
896 | TCTN3 |
897 | Joubert syndrome type 2 |
898 | TMEM216 |
899 | Joubert syndrome type 20 |
900 | TMEM231 |
901 | Joubert syndrome type 21 |
902 | CSPP1 |
903 | Joubert syndrome type 22 |
904 | PDE6D |
905 | Joubert syndrome type 23 |
906 | KIAA0586 |
907 | Joubert syndrome type 24 |
908 | TCTN2 |
909 | Joubert syndrome type 3 |
910 | AHI1 |
911 | Joubert syndrome type 4 |
912 | NPHP1 |
913 | Joubert syndrome type 5 |
914 | CEP290 |
915 | Joubert syndrome type 6 |
916 | TMEM67 |
917 | Joubert syndrome type 7 |
918 | RPGRIP1L |
919 | Joubert syndrome type 8 |
920 | ARL13B |
921 | Joubert syndrome type 9 |
922 | CC2D2A |
923 | Joubert syndrome, EXOC8 related |
924 | EXOC8 |
925 | Joubert syndrome, EXOSC8 related |
926 | EXOSC8 |
927 | Kabuki syndrome type 2 |
928 | KDM6A |
929 | Kenny-Caffey syndrome type 2 |
930 | FAM111A |
931 | King-Denborough syndrome |
932 | RYR1 |
933 | Kohlschutter Tonz syndrome |
934 | ROGDI |
935 | Krabbe disease |
936 | GALC |
937 | Leigh syndrome |
938 | BCS1L |
939 | Leigh syndrome |
940 | COX15 |
941 | Leigh syndrome |
942 | FOXRED1 |
943 | Leigh syndrome |
944 | NDUFA10 |
945 | Leigh syndrome |
946 | NDUFA2 |
947 | Leigh syndrome |
948 | NDUFA9 |
949 | Leigh syndrome |
950 | NDUFAF1 |
951 | Leigh syndrome |
952 | NDUFAF2 |
953 | Leigh syndrome |
954 | NDUFAF3 |
955 | Leigh syndrome |
956 | NDUFAF6 |
957 | Leigh syndrome |
958 | NDUFS3 |
959 | Leigh syndrome |
960 | NDUFS4 |
961 | Leigh syndrome |
962 | NDUFS7 |
963 | Leigh syndrome |
964 | NDUFS8 |
965 | Leigh syndrome |
966 | NUBPL |
967 | Leigh syndrome |
968 | SDHA |
969 | Leigh syndrome and mitochondrial encephalopathy |
970 | ACAD9 |
971 | Leigh syndrome due to COX deficiency |
972 | SURF1 |
973 | Leigh syndrome due to mitochondrial complex I deficiency |
974 | MT-ND3 |
975 | Leigh syndrome due to mitochondrial complex I deficiency |
976 | MT-ND5 |
977 | Leigh syndrome due to mitochondrial complex I deficiency |
978 | MT-ND6 |
979 | Leigh syndrome due to mitochondrial complex I deficiency |
980 | NDUFA12 |
981 | Leigh syndrome due to pyruvate and alpha-ketoglutarate dehydrogenase deficiencies, LIPT1 related |
982 | LIPT1 |
983 | Leigh syndrome due to pyruvate carboxylase deficiency |
984 | PC |
985 | Leigh syndrome due to the mitochondrial complex IV deficiency |
986 | TACO1 |
987 | Leigh syndrome, French-Canadian type |
988 | LRPPRC |
989 | Leigh syndrome, X-linked |
990 | PDHA1 |
991 | Lesch-Nyham syndrome |
992 | HPRT1 |
993 | Leukodystrophy demyelinating adult-onset, autosomal dominant |
994 | LMNB1 |
995 | Leukodystrophy hypomyelinating |
996 | GJC2 |
997 | Leukodystrophy hypomyelinating type 3 |
998 | AIMP1 |
999 | Leukodystrophy hypomyelinating type 4 |
1000 | HSPD1 |
1001 | Leukodystrophy hypomyelinating type 5 |
1002 | FAM126A |
1003 | Leukodystrophy hypomyelinating type 6 |
1004 | TUBB4A |
1005 | Leukodystrophy hypomyelinating type 7 |
1006 | POLR3A |
1007 | Leukodystrophy hypomyelinating type 8 |
1008 | POLR3B |
1009 | Leukodystrophy hypomyelinating type 9 |
1010 | RARS |
1011 | Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation |
1012 | DARS2 |
1013 | Leukoencephalopathy with dystonia and motor neuropathy |
1014 | SCP2 |
1015 | Leukoencephalopathy with vanishing white matter |
1016 | EIF2B1 |
1017 | Leukoencephalopathy with vanishing white matter |
1018 | EIF2B2 |
1019 | Leukoencephalopathy with vanishing white matter |
1020 | EIF2B3 |
1021 | Leukoencephalopathy with vanishing white matter |
1022 | EIF2B4 |
1023 | Leukoencephalopathy with vanishing white matter |
1024 | EIF2B5 |
1025 | Leukoencephalopathy, cystic without megalencephaly |
1026 | RNASET2 |
1027 | Leukoencephalopathy, diffuse hereditary, with spheroids |
1028 | CSF1R |
1029 | Leukoencephalopathy, progressive, with ovarian failure |
1030 | AARS2 |
1031 | Lewy body dementia, susceptibility to |
1032 | GBA |
1033 | Limb-girdle muscular dystrophy, autosomal dominant type 1A |
1034 | MYOT |
1035 | Limb-girdle muscular dystrophy, autosomal dominant type 1B |
1036 | LMNA |
1037 | Limb-girdle muscular dystrophy, autosomal dominant type 1C |
1038 | CAV3 |
1039 | Limb-girdle muscular dystrophy, autosomal dominant type 1E |
1040 | DNAJB6 |
1041 | Limb-girdle muscular dystrophy, autosomal recessice type 2F |
1042 | SGCD |
1043 | Limb-girdle muscular dystrophy, autosomal recessive type 12C |
1044 | POMK |
1045 | Limb-girdle muscular dystrophy, autosomal recessive type 2A |
1046 | CAPN3 |
1047 | Limb-girdle muscular dystrophy, autosomal recessive type 2B |
1048 | DYSF |
1049 | Limb-girdle muscular dystrophy, autosomal recessive type 2C |
1050 | SGCG |
1051 | Limb-girdle muscular dystrophy, autosomal recessive type 2D |
1052 | SGCA |
1053 | Limb-girdle muscular dystrophy, autosomal recessive type 2E |
1054 | SGCB |
1055 | Limb-Girdle Muscular Dystrophy, autosomal recessive type 2G |
1056 | TCAP |
1057 | Limb-girdle muscular dystrophy, autosomal recessive type 2H |
1058 | TRIM32 |
1059 | Limb-girdle muscular dystrophy, autosomal recessive type 2I |
1060 | FKRP |
1061 | Limb-girdle muscular dystrophy, autosomal recessive type 2J |
1062 | TTN |
1063 | Limb-girdle muscular dystrophy, autosomal recessive type 2K |
1064 | POMT1 |
1065 | Limb-girdle muscular dystrophy, autosomal recessive type 2L |
1066 | ANO5 |
1067 | Limb-girdle muscular dystrophy, autosomal recessive type 2M |
1068 | FKTN |
1069 | Limb-girdle muscular dystrophy, autosomal recessive type 2N |
1070 | POMT1 |
1071 | Limb-girdle muscular dystrophy, autosomal recessive type 2S |
1072 | TRAPPC11 |
1073 | Lissencephaly type 4 with microcephaly |
1074 | NDE1 |
1075 | Lissencephaly/Subcortical laminal heteropia, X-linked |
1076 | DCX |
1077 | Lowe oculocerebrorenal syndrome |
1078 | OCRL |
1079 | Major affective disorder 7 |
1080 | XBP1 |
1081 | Malignant hyperthermia type 5 |
1082 | CACNA1S |
1083 | Mandibulofacial dysostosis with microcephaly |
1084 | EFTUD2 |
1085 | Marden-Walker syndrome |
1086 | PIEZO2 |
1087 | MASA syndrome |
1088 | L1CAM |
1089 | McLeod syndrome with or without chronic granulomatous disease |
1090 | XK |
1091 | Megalencephalic leukoencephalopathy with subcortical cysts |
1092 | MLC1 |
1093 | Megalencephalic leukoencephalopathy with subcortical cysts 2A |
1094 | HEPACAM |
1095 | MELAS syndrome, MT-TL1 related |
1096 | MT-TL1 |
1097 | Melnick-Needles syndrome |
1098 | FLNA |
1099 | Mental retardation and microcephaly with pontine and cerebellar hypoplasia |
1100 | CASK |
1101 | Mental retardation non-syndromic |
1102 | ELK1 |
1103 | Mental retardation non-syndromic |
1104 | KLF8 |
1105 | Mental retardation non-syndromic |
1106 | NXF5 |
1107 | Mental retardation non-syndromic |
1108 | ZCCHC12 |
1109 | Mental retardation with Cerebellar ataxia and dysequilibrium syndrome type 2 |
1110 | WDR81 |
1111 | Mental retardation with hypotonic facies syndrome, X-linked |
1112 | ATRX |
1113 | Mental retardation with language impairment and autistic features |
1114 | FOXP1 |
1115 | Mental retardation X-linked, SMARCA1 related |
1116 | SMARCA1 |
1117 | Mental retardation X-linked, syndromic, Claes-Jensen type |
1118 | KDM5C |
1119 | Mental retardation X-linked, syndromic, Lubs type |
1120 | MECP2 |
1121 | Mental retardation, anterior maxillary protrusion, and strabismus |
1122 | SOBP |
1123 | Mental retardation, autosomal dominant type 1 |
1124 | MBD5 |
1125 | Mental retardation, autosomal dominant type 11 |
1126 | EPB41L1 |
1127 | Mental retardation, autosomal dominant type 12 |
1128 | ARID1B |
1129 | Mental retardation, autosomal dominant type 13 |
1130 | DYNC1H1 |
1131 | Mental retardation, autosomal dominant type 13 |
1132 | TRAPPC9 |
1133 | Mental retardation, autosomal dominant type 14 |
1134 | ARID1A |
1135 | Mental retardation, autosomal dominant type 15 |
1136 | SMARCB1 |
1137 | Mental retardation, autosomal dominant type 16 |
1138 | SMARCA4 |
1139 | Mental retardation, autosomal dominant type 17 |
1140 | PACS1 |
1141 | Mental retardation, autosomal dominant type 18 |
1142 | GATAD2B |
1143 | Mental retardation, autosomal dominant type 19 |
1144 | CTNNB1 |
1145 | Mental retardation, autosomal dominant type 2 |
1146 | DOCK8 |
1147 | Mental retardation, autosomal dominant type 20 |
1148 | MEF2C |
1149 | Mental retardation, autosomal dominant type 23 |
1150 | SETD5 |
1151 | Mental retardation, autosomal dominant type 24 |
1152 | DEAF1 |
1153 | Mental retardation, autosomal dominant type 25 |
1154 | AHDC1 |
1155 | Mental retardation, autosomal dominant type 27 |
1156 | SOX11 |
1157 | Mental retardation, autosomal dominant type 28 |
1158 | ADNP |
1159 | Mental retardation, autosomal dominant type 3 |
1160 | CDH15 |
1161 | Mental retardation, autosomal dominant type 31 |
1162 | PURA |
1163 | Mental retardation, autosomal dominant type 32 |
1164 | KAT6A |
1165 | Mental retardation, autosomal dominant type 37 |
1166 | POGZ |
1167 | Mental retardation, autosomal dominant type 38 |
1168 | EEF1A2 |
1169 | Mental retardation, autosomal dominant type 5 |
1170 | SYNGAP1 |
1171 | Mental retardation, autosomal dominant type 6 |
1172 | GRIN2B |
1173 | Mental retardation, autosomal dominant type 7 |
1174 | DYRK1A |
1175 | Mental retardation, autosomal dominant type 8 |
1176 | GRIN1 |
1177 | Mental retardation, autosomal dominant type 9 |
1178 | KIF1A |
1179 | Mental retardation, autosomal recessive type 1 |
1180 | PRSS12 |
1181 | Mental retardation, autosomal recessive type 12 |
1182 | ST3GAL3 |
1183 | Mental retardation, autosomal recessive type 14 |
1184 | TECR |
1185 | Mental retardation, autosomal recessive type 15 |
1186 | MAN1B1 |
1187 | Mental retardation, autosomal recessive type 18 |
1188 | MED23 |
1189 | Mental retardation, autosomal recessive type 2 |
1190 | CRBN |
1191 | Mental retardation, autosomal recessive type 27 |
1192 | LINS1 |
1193 | Mental retardation, autosomal recessive type 3 |
1194 | CC2D1A |
1195 | Mental retardation, autosomal recessive type 36 |
1196 | ADAT3 |
1197 | Mental retardation, autosomal recessive type 37 |
1198 | ANK3 |
1199 | Mental retardation, autosomal recessive type 38 |
1200 | HERC2 |
1201 | Mental retardation, autosomal recessive type 39 |
1202 | TTI2 |
1203 | Mental retardation, autosomal recessive type 40 |
1204 | TAF2 |
1205 | Mental retardation, autosomal recessive type 41 |
1206 | KPTN |
1207 | Mental retardation, autosomal recessive type 42 |
1208 | PGAP1 |
1209 | Mental retardation, autosomal recessive type 46 |
1210 | NDST1 |
1211 | Mental retardation, autosomal recessive type 49 |
1212 | GPT2 |
1213 | Mental retardation, autosomal recessive type 5 |
1214 | NSUN2 |
1215 | Mental retardation, autosomal recessive type 55 |
1216 | PUS3 |
1217 | Mental retardation, autosomal recessive type 7 |
1218 | TUSC3 |
1219 | Mental retardation, X-linked |
1220 | RAB40AL |
1221 | Mental retardation, X-linked syndromic, Christianson type |
1222 | SLC9A6 |
1223 | Mental retardation, X-linked syndromic, Nascimento-type |
1224 | UBE2A |
1225 | Mental retardation, X-linked syndromic, Raymond type |
1226 | ZDHHC9 |
1227 | Mental retardation, X-linked syndromic, Turner type |
1228 | HUWE1 |
1229 | Mental retardation, X-linked type 1 |
1230 | IQSEC2 |
1231 | Mental retardation, X-linked type 101 |
1232 | MID2 |
1233 | Mental retardation, X-linked type 102 |
1234 | DDX3X |
1235 | Mental retardation, X-Linked type 13 |
1236 | MECP2 |
1237 | Mental retardation, X-linked type 14 |
1238 | UPF3B |
1239 | Mental retardation, X-linked type 15 |
1240 | CUL4B |
1241 | Mental retardation, X-linked type 16 |
1242 | FGD1 |
1243 | Mental retardation, X-linked type 17 |
1244 | HSD17B10 |
1245 | Mental retardation, X-linked type 19 |
1246 | RPS6KA3 |
1247 | Mental retardation, X-linked type 21 |
1248 | IL1RAPL1 |
1249 | Mental retardation, X-linked type 29 |
1250 | ARX |
1251 | Mental retardation, X-linked type 3 |
1252 | HCFC1 |
1253 | Mental retardation, X-linked type 30 |
1254 | PAK3 |
1255 | Mental retardation, X-linked type 32 |
1256 | CLIC2 |
1257 | Mental retardation, X-linked type 41 |
1258 | GDI1 |
1259 | Mental retardation, X-linked type 44 |
1260 | FTSJ1 |
1261 | Mental retardation, X-linked type 45 |
1262 | ZNF81 |
1263 | Mental retardation, X-linked type 46 |
1264 | ARHGEF6 |
1265 | Mental retardation, X-linked type 58 |
1266 | TSPAN7 |
1267 | Mental retardation, X-linked type 59 |
1268 | AP1S2 |
1269 | Mental retardation, X-linked type 63 |
1270 | ACSL4 |
1271 | Mental retardation, X-linked type 72 |
1272 | RAB39B |
1273 | Mental retardation, X-linked type 88, AGTR2 related |
1274 | AGTR2 |
1275 | Mental retardation, X-linked type 89 |
1276 | ZNF41 |
1277 | Mental retardation, X-linked type 90 |
1278 | DLG3 |
1279 | Mental retardation, X-linked type 91 |
1280 | ZDHHC15 |
1281 | Mental retardation, X-linked type 92 |
1282 | ZNF674 |
1283 | Mental retardation, X-linked type 93 |
1284 | BRWD3 |
1285 | Mental retardation, X-linked type 94 |
1286 | GRIA3 |
1287 | Mental retardation, X-linked type 95 |
1288 | MAGT1 |
1289 | Mental retardation, X-linked type 96 |
1290 | SYP |
1291 | Mental retardation, X-linked type 97 |
1292 | ZNF711 |
1293 | Mental retardation, X-linked type 99 |
1294 | USP9X |
1295 | Mental retardation, X-linked with epilepsy |
1296 | ATP6AP2 |
1297 | Mental retardation, X-linked, associated with fragile site FRAXE |
1298 | AFF2 |
1299 | Mental retardation, x-linked, EFHC2 related |
1300 | EFHC2 |
No. | Description |
1301 | Mental retardation, X-linked, nonsyndromic |
1302 | NEXMIF |
1303 | Mental retardation, X-linked, Siderius type |
1304 | PHF8 |
1305 | Mental retardation, X-linked, Snyder-Robinson type |
1306 | SMS |
1307 | Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance |
1308 | OPHN1 |
1309 | Mental retardation, X-linked, with isolated growth hormone deficiency |
1310 | SOX3 |
1311 | MERRF syndrome, MT-TK related |
1312 | MT-TK |
1313 | MERRF syndrome, MT-TP related |
1314 | MT-TP |
1315 | MERRF/MELAS overlap syndrome, MT-TS1 related |
1316 | MT-TS1 |
1317 | MERRF/MELAS overlap syndrome, MT-TS2 related |
1318 | MT-TS2 |
1319 | Metachromatic leukodystrophy due to Saposin B deficiency |
1320 | PSAP |
1321 | Methionine adenosyltransferase deficiency, autosomal recessive |
1322 | MAT1A |
1323 | Microcephaly-capillary malformation syndrome |
1324 | STAMBP |
1325 | Minicore myopathy with external ophthalmoplegia |
1326 | RYR1 |
1327 | Mirror movements type 1 |
1328 | DCC |
1329 | Mirror movements type 2 |
1330 | RAD51 |
1331 | Mirror movements type 3 |
1332 | DNAL4 |
1333 | Mitochondrial complex I deficiency |
1334 | FOXRED1 |
1335 | Mitochondrial complex I deficiency |
1336 | MT-ND1 |
1337 | Mitochondrial complex I deficiency |
1338 | MT-ND2 |
1339 | Mitochondrial complex I deficiency |
1340 | MT-ND3 |
1341 | Mitochondrial complex I deficiency |
1342 | MT-ND4 |
1343 | Mitochondrial complex I deficiency |
1344 | MT-ND4L |
1345 | Mitochondrial complex I deficiency |
1346 | MT-ND5 |
1347 | Mitochondrial complex I deficiency |
1348 | MT-ND6 |
1349 | Mitochondrial complex I deficiency |
1350 | NDUFA1 |
1351 | Mitochondrial complex I deficiency |
1352 | NDUFA11 |
1353 | Mitochondrial complex I deficiency |
1354 | NDUFAF1 |
1355 | Mitochondrial complex I deficiency |
1356 | NDUFAF3 |
1357 | Mitochondrial complex I deficiency |
1358 | NDUFAF4 |
1359 | Mitochondrial complex I deficiency |
1360 | NDUFAF5 |
1361 | Mitochondrial complex I deficiency |
1362 | NDUFB3 |
1363 | Mitochondrial complex I deficiency |
1364 | NDUFS1 |
1365 | Mitochondrial complex I deficiency |
1366 | NDUFS2 |
1367 | Mitochondrial complex I deficiency |
1368 | NDUFS4 |
1369 | Mitochondrial complex I deficiency |
1370 | NDUFS6 |
1371 | Mitochondrial complex I deficiency |
1372 | NDUFV1 |
1373 | Mitochondrial complex I deficiency |
1374 | NDUFV2 |
1375 | Mitochondrial complex I deficiency, MT-TN related |
1376 | MT-TN |
1377 | Mitochondrial complex II deficiency |
1378 | SDHAF1 |
1379 | Mitochondrial complex II deficiency |
1380 | SDHD |
1381 | Mitochondrial complex III deficiency |
1382 | BCS1L |
1383 | Mitochondrial complex III deficiency |
1384 | UQCRB |
1385 | Mitochondrial complex III deficiency |
1386 | UQCRC2 |
1387 | Mitochondrial complex III deficiency |
1388 | UQCRQ |
1389 | Mitochondrial complex III deficiency, nuclear type 2 |
1390 | TTC19 |
1391 | Mitochondrial complex III deficiency, nuclear type 7 |
1392 | UQCC2 |
1393 | Mitochondrial complex IV deficiency |
1394 | COA8 |
1395 | Mitochondrial complex IV deficiency |
1396 | COX6B1 |
1397 | Mitochondrial complex IV deficiency |
1398 | FASTKD2 |
1399 | Mitochondrial complex IV deficiency |
1400 | MT-CO3 |
1401 | Mitochondrial complex IV deficiency |
1402 | PET100 |
1403 | Mitochondrial complex V (ATP synthase) deficiency |
1404 | MT-ATP6 |
1405 | Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1 |
1406 | ATPAF2 |
1407 | Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2 |
1408 | TMEM70 |
1409 | Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3 |
1410 | ATP5F1E |
1411 | Mitochondrial complex V deficiency, nuclear type 4 |
1412 | ATP5F1A |
1413 | Mitochondrial Disorders, AKAP1 related |
1414 | AKAP1 |
1415 | Mitochondrial DNA depletion syndrome |
1416 | DGUOK |
1417 | Mitochondrial DNA depletion syndrome |
1418 | SUCLA2 |
1419 | Mitochondrial DNA depletion syndrome |
1420 | TK2 |
1421 | Mitochondrial DNA depletion syndrome 8B, MNGIE type |
1422 | RRM2B |
1423 | Mitochondrial DNA depletion syndrome type 11 |
1424 | MGME1 |
1425 | Mitochondrial DNA depletion syndrome type 13 |
1426 | FBXL4 |
1427 | Mitochondrial DNA depletion syndrome type 4A |
1428 | POLG |
1429 | Mitochondrial DNA depletion syndrome type 4B |
1430 | POLG |
1431 | Mitochondrial DNA depletion syndrome type 6 |
1432 | MPV17 |
1433 | Mitochondrial DNA depletion syndrome type 7 |
1434 | TWNK |
1435 | Mitochondrial DNA depletion syndrome, encephalomyopathic type with methylmalonic aciduria |
1436 | SUCLG1 |
1437 | Mitochondrial encephalomyopathy |
1438 | MFF |
1439 | Mitochondrial encephalomyopathy |
1440 | MT-CYB |
1441 | Mitochondrial myopathy and sideroblastic anemia type 1 |
1442 | PUS1 |
1443 | Mitochondrial neurogastrointestinal encephalopathy syndrome without leukoencephalopathy |
1444 | POLG |
1445 | Mitochondrial neurogastrointestinal encephalopathy syndrome without leukoencephalopathy |
1446 | TYMP |
1447 | Mitochondrial respiratory chain complex II deficiency |
1448 | SDHA |
1449 | Mitochondrial respiratory chain disease, TIMM21 related |
1450 | TIMM21 |
1451 | Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency |
1452 | ECHS1 |
1453 | Miyoshi muscular dystrophy type 3 |
1454 | ANO5 |
1455 | Miyoshi myopathy |
1456 | DYSF |
1457 | Multiple congenital anomalies-hypotonia-seizures syndrome type 3 |
1458 | PIGT |
1459 | Multiple mitochondrial dysfunctions syndrome type 1 |
1460 | NFU1 |
1461 | Multiple mitochondrial dysfunctions syndrome type 2 |
1462 | BOLA3 |
1463 | Multiple mitochondrial dysfunctions syndrome type 3 |
1464 | IBA57 |
1465 | Multiple mitochondrial dysfunctions syndrome type 4 |
1466 | ISCA2 |
1467 | Multisystemic smooth muscle dysfunction syndrome |
1468 | ACTA2 |
1469 | Muscle hypertrophy |
1470 | MSTN |
1471 | Muscle-eye-brain disease, POMK related |
1472 | POMK |
1473 | Muscular dystrophy type 1A |
1474 | LAMA2 |
1475 | Muscular dystrophy type 1C |
1476 | FKRP |
1477 | Muscular dystrophy type 1D |
1478 | LARGE1 |
1479 | Muscular dystrophy, Becker type |
1480 | DMD |
1481 | Muscular dystrophy, congenital, LMNA related |
1482 | LMNA |
1483 | Muscular dystrophy, congenital, megaconial type |
1484 | CHKB |
1485 | Muscular dystrophy, Duchenne type |
1486 | DMD |
1487 | Muscular dystrophy, limb-girdle type 2A |
1488 | CAPN3 |
1489 | Muscular dystrophy, limb-girdle, type 2Q |
1490 | PLEC |
1491 | Muscular dystrophy, oculopharyngeal |
1492 | PABPN1 |
1493 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A10 |
1494 | RXYLT1 |
1495 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A13 |
1496 | B4GAT1 |
1497 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
1498 | POMT2 |
1499 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 |
1500 | POMGNT1 |
1501 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A8 |
1502 | POMGNT2 |
1503 | Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B1 |
1504 | POMT1 |
1505 | Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B2 |
1506 | POMT2 |
1507 | Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B3 |
1508 | POMGNT1 |
1509 | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C2 |
1510 | POMT2 |
1511 | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C3 |
1512 | POMGNT1 |
1513 | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C9 |
1514 | DAG1 |
1515 | Muscular-skeletal disorder, CAPN1 related |
1516 | CAPN1 |
1517 | Myasthenia congenital with tubular aggregates 1 |
1518 | GFPT1 |
1519 | Myasthenic syndrome associated with acetylcholine receptor deficiency |
1520 | MUSK |
1521 | Myasthenic syndrome due to mutation in SCN4A |
1522 | SCN4A |
1523 | Myasthenic syndrome, congenital |
1524 | AGRN |
1525 | Myasthenic syndrome, congenital |
1526 | CHAT |
1527 | Myasthenic syndrome, congenital |
1528 | CHRNB1 |
1529 | Myasthenic syndrome, congenital |
1530 | CHRNE |
1531 | Myasthenic syndrome, congenital, fast channel |
1532 | CHRNA1 |
1533 | Myasthenic syndrome, congenital, slow-channel |
1534 | CHRNA1 |
1535 | Myasthenic syndrome, congenital, type 10 |
1536 | DOK7 |
1537 | Myasthenic syndrome, congenital, type 11, associated with acetylcholine receptor deficiency |
1538 | RAPSN |
1539 | Myasthenic syndrome, congenital, type 20, presynaptic |
1540 | SLC5A7 |
1541 | Myasthenic syndrome, congenital, type 3A, slow channel |
1542 | CHRND |
1543 | Myasthenic syndrome, congenital, type 3B, fast-channel |
1544 | CHRND |
1545 | Myasthenic syndrome, congenital, type 3C, associated with acetylcholine receptor deficiency |
1546 | CHRND |
1547 | Myoclonic dystonia, DRD2 related |
1548 | DRD2 |
1549 | Myoclonic epilepsy of Lafora |
1550 | EPM2A |
1551 | Myoclonic epilepsy of Lafora |
1552 | NHLRC1 |
1553 | Myoclonus, familial cortical |
1554 | NOL3 |
1555 | Myoglobinuria acute recurrent |
1556 | LPIN1 |
1557 | Myopathy due to Integrin 7A deficiency |
1558 | ITGA7 |
1559 | Myopathy due to myoadenylate deaminase deficiency |
1560 | AMPD1 |
1561 | Myopathy with extrapyramidal signs |
1562 | MICU1 |
1563 | Myopathy with fiber-type disproportion |
1564 | ACTA1 |
1565 | Myopathy with fiber-type disproportion |
1566 | SELENON |
1567 | Myopathy, areflexia, respiratory distress, and dysphagia, early-onset |
1568 | MEGF10 |
1569 | Myopathy, COL6A6 related |
1570 | COL6A6 |
1571 | Myopathy, desmin related, associated with mutation in the CRYAB gene |
1572 | CRYAB |
1573 | Myopathy, distal type 1 |
1574 | MYH7 |
1575 | Myopathy, distal type 4 |
1576 | FLNC |
1577 | Myopathy, distal with anterior tibial onset |
1578 | DYSF |
1579 | Myopathy, distal, Tateyama type |
1580 | CAV3 |
1581 | Myopathy, early-onset with fatal cardiomyopathy |
1582 | TTN |
1583 | Myopathy, lactic acidosis, and sideroblastic anemia type 2 |
1584 | YARS2 |
1585 | Myopathy, limb girdle with bone fragility |
1586 | MTAP |
1587 | Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay |
1588 | GFER |
1589 | Myopathy, MT-TQ related |
1590 | MT-TQ |
1591 | Myopathy, myofibrillar type 6 |
1592 | BAG3 |
1593 | Myopathy, myofibrillar, Desmin related |
1594 | DES |
1595 | Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related |
1596 | CRYAB |
1597 | Myopathy, myofibrillar, ZASP related |
1598 | LDB3 |
1599 | Myopathy, scapulohumeroperoneal |
1600 | ACTA1 |
1601 | Myopathy, tubular aggregate, type 1 |
1602 | STIM1 |
1603 | Myosclerosis, autosomal recessive |
1604 | COL6A2 |
1605 | Myosin storage myopathy |
1606 | MYH7 |
1607 | Myotilinopathy |
1608 | MYOT |
1609 | Myotonia congenita |
1610 | CLCN1 |
1611 | Myotonic dystrophy type 1 |
1612 | DMPK |
1613 | Myotonic dystrophy type 2 |
1614 | CNBP |
1615 | Myotubular myopathy X-linked |
1616 | MTM1 |
1617 | Narcolepsy |
1618 | HCRT |
1619 | Nemaline myopathy type 1 |
1620 | TPM3 |
1621 | Nemaline myopathy type 2, autosomal recessive |
1622 | NEB |
1623 | Nemaline myopathy type 3 |
1624 | ACTA1 |
1625 | Nemaline myopathy type 4 |
1626 | TPM2 |
1627 | Nemaline myopathy type 5 |
1628 | TNNT1 |
1629 | Nemaline myopathy type 6 |
1630 | KBTBD13 |
1631 | Nemaline myopathy type 7 |
1632 | CFL2 |
1633 | Neonatal death due Leigh syndrome, MT-TV related |
1634 | MT-TV |
1635 | Neurodegeneration due to cerebral folate transport deficiency |
1636 | FOLR1 |
1637 | Neurodegeneration with brain iron accululation type 5 |
1638 | WDR45 |
1639 | Neurodegeneration with brain iron accumulation type 4 |
1640 | C19orf12 |
1641 | Neurodegeneration with brain iron accumulation type 6 |
1642 | COASY |
1643 | Neurodegeneration with brain iron accumulation, GTPBP2 related |
1644 | GTPBP2 |
1645 | Neurodevelopmental disorder with cerebellar atrophy and with or without seizures |
1646 | BRAT1 |
1647 | Neurodevelopmental disorder, ADAM22 related |
1648 | ADAM22 |
1649 | Neurodevelopmental disorder, APC2-related |
1650 | APC2 |
1651 | Neurodevelopmental disorder, CNTNAP4 related |
1652 | CNTNAP4 |
1653 | Neurodevelopmental disorder, CROCC related |
1654 | CROCC |
1655 | Neurodevelopmental disorder, FRMPD4 related |
1656 | FRMPD4 |
1657 | Neurodevelopmental disorder, KCTD3 related |
1658 | KCTD3 |
1659 | Neurodevelopmental disorder, MACF1 related |
1660 | MACF1 |
1661 | Neurodevelopmental disorder, MTOR related |
1662 | MTOR |
1663 | Neurodevelopmental disorder, NGEF related |
1664 | NGEF |
1665 | Neurodevelopmental disorder, PIGQ related |
1666 | PIGQ |
1667 | Neurodevelopmental disorder, TUBB related |
1668 | TUBB |
1669 | Neurodevelopmental disorder, ZNF311 related |
1670 | ZNF311 |
1671 | Neurodevelopmental malformation and microcephaly |
1672 | KIF2A |
1673 | Neurodevelopmental malformation and microcephaly |
1674 | KIF5C |
1675 | Neurodevelopmental malformation and microcephaly |
1676 | TUBG1 |
1677 | Neurogenic scapuloperoneal syndrome, Kaeser type |
1678 | DES |
1679 | Neuromyotonia and axonal neuropathy, autosomal recessive |
1680 | HINT1 |
1681 | Neuronal migration disorder |
1682 | CTNNA2 |
1683 | Neuronal migration disorder |
1684 | EOMES |
1685 | Neuronal migration disorder |
1686 | SPTBN5 |
1687 | Neuronal migration disorder |
1688 | SRGAP2 |
1689 | Neuronopathy distal hereditary motor type 2A |
1690 | HSPB8 |
1691 | Neuronopathy distal hereditary motor type 2B |
1692 | HSPB1 |
1693 | Neuronopathy distal hereditary motor type 5 |
1694 | GARS1 |
1695 | Neuronopathy distal hereditary motor type 6 |
1696 | IGHMBP2 |
1697 | Neuronopathy distal hereditary motor type 7B |
1698 | DCTN1 |
1699 | Neuropathy sensor type 1E |
1700 | DNMT1 |
1701 | Neuropathy with liability to pressure palsies [HNPP] |
1702 | PMP22 |
1703 | Neuropathy with sensory ataxic, dysarthria, and ophthalmoparesis |
1704 | POLG |
1705 | Neuropathy, distal hereditary motor, type 5A |
1706 | BSCL2 |
1707 | Neuropathy, hereditary sensory and autonomic type 1C |
1708 | SPTLC2 |
1709 | Neuropathy, hereditary sensory and autonomic type 2 |
1710 | SCN9A |
1711 | Neuropathy, hereditary sensory and autonomic type 6 |
1712 | DST |
1713 | Neuropathy, hereditary sensory, type 1D |
1714 | ATL1 |
1715 | Neuropathy, hereditary sensory, type 1F |
1716 | ATL3 |
1717 | Neuropathy, hereditary sensory, with spastic paraplegia |
1718 | CCT5 |
1719 | Neutral lipid storage disease with myopathy |
1720 | PNPLA2 |
1721 | Niemann-Pick disease type C1 |
1722 | NPC1 |
1723 | Nonaka myopathy |
1724 | GNE |
1725 | Norrie disease |
1726 | NDP |
1727 | Occipital horn syndrome |
1728 | ATP7A |
1729 | Opitz G syndrome |
1730 | MID1 |
1731 | Oral-facial-digital syndrome type 1 |
1732 | OFD1 |
1733 | Pantothenate kinase-associated neurodegeneration |
1734 | PANK2 |
1735 | Paramyotonia congenita of von Eulenburg |
1736 | SCN4A |
1737 | Parietal foramina type 2 |
1738 | ALX4 |
1739 | PARK1 Parkinson |
1740 | SNCA |
1741 | PARK13 Parkinson |
1742 | HTRA2 |
1743 | PARK14 Parkinson |
1744 | PLA2G6 |
1745 | PARK15 Parkinson |
1746 | FBXO7 |
1747 | PARK17 Parkinson |
1748 | VPS35 |
1749 | PARK19 Parkinson, juvenile-onset |
1750 | DNAJC6 |
1751 | PARK2 Parkinson |
1752 | PRKN |
1753 | PARK20 Parkinson |
1754 | SYNJ1 |
1755 | PARK21 Parkinson |
1756 | DNAJC13 |
1757 | PARK4 Parkinson |
1758 | SNCA |
1759 | PARK5 Parkinson |
1760 | UCHL1 |
1761 | PARK6 Parkinson |
1762 | PINK1 |
1763 | PARK7 Parkinson |
1764 | PARK7 |
1765 | PARK8 Parkinson |
1766 | LRRK2 |
1767 | PARK9 Parkinson |
1768 | ATP13A2 |
1769 | Parkinson disease, late-onset, susceptibility to |
1770 | GBA |
1771 | Parkinson disease, susceptibility to, MT-TT related |
1772 | MT-TT |
1773 | Parkinsonism with spasticity, X-linked |
1774 | ATP6AP2 |
1775 | Parkinsonism-Dystonia, infantile |
1776 | SLC6A3 |
1777 | Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia |
1778 | SLC2A1 |
1779 | Paroxysmal nonkinesigenic dyskinesia |
1780 | PNKD |
1781 | Partington syndrome |
1782 | ARX |
1783 | Pelizaeus-Merzbacher disease |
1784 | PLP1 |
1785 | Pelizaeus-Merzbacher disease |
1786 | SLC16A2 |
1787 | Peripheral demyelinating neuropathy Waardenburg syndrome and Hirschsprung disease |
1788 | SOX10 |
1789 | Periventricular heterotopia with microcephaly |
1790 | ARFGEF2 |
1791 | Peroxisome biogenesis disorder 14B |
1792 | PEX11B |
1793 | Peroxisome biogenesis disorder type 10A |
1794 | PEX3 |
1795 | Peroxisome biogenesis disorder type 1B |
1796 | PEX1 |
1797 | Peroxisome biogenesis disorder type 2A |
1798 | PEX5 |
1799 | Peroxisome biogenesis disorder type 2B |
1800 | PEX5 |
1801 | Perrault syndrome |
1802 | HSD17B4 |
1803 | Perrault syndrome type 2 |
1804 | HARS2 |
1805 | Perrault syndrome type 4 |
1806 | LARS2 |
1807 | Perrault syndrome type 5 |
1808 | TWNK |
1809 | Phosphoglycerate kinase 1 deficiency |
1810 | PGK1 |
1811 | Pick disease |
1812 | PSEN1 |
1813 | Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy |
1814 | TREM2 |
1815 | Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy |
1816 | TYROBP |
1817 | Polyglucosan body myopathy type 1 with or without immunodeficiency |
1818 | RBCK1 |
1819 | Polymicrogyria bilateral occipital |
1820 | NR2E1 |
1821 | Pompe disease |
1822 | GAA |
1823 | Pontocerebellar hypoplasia type 1A |
1824 | VRK1 |
1825 | Pontocerebellar hypoplasia type 1B |
1826 | EXOSC3 |
1827 | Pontocerebellar hypoplasia type 2A |
1828 | TSEN54 |
1829 | Pontocerebellar hypoplasia type 2B |
1830 | TSEN2 |
1831 | Pontocerebellar hypoplasia type 2C |
1832 | TSEN34 |
1833 | Pontocerebellar hypoplasia type 2D |
1834 | SEPSECS |
1835 | Pontocerebellar hypoplasia type 2E |
1836 | VPS53 |
1837 | Pontocerebellar hypoplasia type 4 |
1838 | TSEN54 |
1839 | Pontocerebellar hypoplasia type 5 |
1840 | TSEN54 |
1841 | Pontocerebellar hypoplasia type 6 |
1842 | RARS2 |
1843 | Pontocerebellar hypoplasia type 8 |
1844 | CHMP1A |
1845 | Pontocerebellar hypoplasia, type 10 |
1846 | CLP1 |
1847 | Pontocerebellar hypoplasia, type 9 |
1848 | AMPD2 |
1849 | Porencephaly type 2 |
1850 | COL4A2 |
1851 | Potassium-aggravated myotonia |
1852 | SCN4A |
1853 | Prader-Willi syndrome |
1854 | chr. 15q11 |
1855 | Prader-Willi syndrome |
1856 | NDN |
1857 | Prader-Willi syndrome |
1858 | SNRPN |
1859 | Primary lateral sclerosis, juvenile |
1860 | ALS2 |
1861 | Progressive external ophthalmoplegia with mitochondrial deletions type 1, autosomal dominant |
1862 | POLG |
1863 | Progressive external ophthalmoplegia with mitochondrial deletions type 2, autosomal dominant |
1864 | SLC25A4 |
1865 | Progressive external ophthalmoplegia with mitochondrial deletions type 2, autosomal recessive |
1866 | RNASEH1 |
1867 | Progressive external ophthalmoplegia with mitochondrial deletions type 3, autosomal dominant |
1868 | TWNK |
1869 | Progressive external ophthalmoplegia with mitochondrial deletions type 4, autosomal dominant |
1870 | POLG2 |
1871 | Progressive external ophthalmoplegia with mitochondrial deletions type 5, autosomal dominant |
1872 | RRM2B |
1873 | Progressive myoclonus epilepsy type 1A |
1874 | PRICKLE1 |
1875 | Progressive myoclonus epilepsy type 3 |
1876 | KCTD7 |
1877 | Progressive myoclonus epilepsy type 6 |
1878 | GOSR2 |
1879 | Progressive myoclonus epilepsy type 8 |
1880 | CERS1 |
1881 | Psychomotor retardation |
1882 | TANC1 |
1883 | Ptosis, congenital |
1884 | ZFHX4 |
1885 | Pyridoxine-dependent epilepsy |
1886 | ALDH7A1 |
1887 | Pyruvate carboxylase deficiency |
1888 | PC |
1889 | Raynaud-Claes syndrome |
1890 | CLCN4 |
1891 | Renpenning syndrome |
1892 | PQBP1 |
1893 | Rett syndrome preserved speech variant |
1894 | MECP2 |
1895 | Rigid spine muscular dystrophy |
1896 | SELENON |
1897 | Rippling muscle disease |
1898 | CAV3 |
1899 | Rolandic epilepsy, mental retardation, and speech dyspraxia |
1900 | SRPX2 |
1901 | Roussy-Levy syndrome |
1902 | PMP22 |
1903 | Salih ataxia |
1904 | RUBCN |
1905 | Scapuloperoneal myopathy, MYH7 related |
1906 | MYH7 |
1907 | Schizophrenia, CALR related |
1908 | CALR |
1909 | Schizophrenia, CELSR2 related |
1910 | CELSR2 |
1911 | Schizophrenia, GRID2 related |
1912 | GRID2 |
1913 | Schizophrenia, NOTCH4 related |
1914 | NOTCH4 |
1915 | Schwartz-Jampel syndrome type 1 |
1916 | HSPG2 |
1917 | Segawa syndrome, autosomal recessive |
1918 | TH |
1919 | Seizures, benign familial infantile, type 2 |
1920 | PRRT2 |
1921 | Seizures, benign neonatal, type 1 |
1922 | KCNQ2 |
1923 | Seizures, benign neonatal, type 2 |
1924 | KCNQ3 |
1925 | SESAME syndrome |
1926 | KCNJ10 |
1927 | Sialuria, finish type |
1928 | SLC17A5 |
1929 | Simpson-Golabi-Behmel syndrome type 1 |
1930 | GPC3 |
1931 | Sjogren-Larsson syndrome |
1932 | ALDH3A2 |
1933 | Slowed nerve conduction velocity, autosomanal dominant |
1934 | ARHGEF10 |
1935 | Smith-Magenis syndrome |
1936 | RAI1 |
1937 | Smith-Magenis syndrome, ULK2 related |
1938 | ULK2 |
1939 | Spastic ataxia Charlevoix-Saguenay type |
1940 | SACS |
1941 | Spastic ataxia type 1, autosomal dominant |
1942 | VAMP1 |
1943 | Spastic ataxia type 2, autosomal recessive |
1944 | KIF1C |
1945 | Spastic ataxia type 3, autosomal recessive |
1946 | MARS2 |
1947 | Spastic ataxia type 4, autosomal recessive |
1948 | MTPAP |
1949 | Spastic ataxia type 5, autosomal recessive |
1950 | AFG3L2 |
1951 | Spastic paralysis, infantile onset ascending |
1952 | ALS2 |
1953 | Spastic paraplegia type 74, autosomal recessive |
1954 | IBA57 |
1955 | SPG1 |
1956 | L1CAM |
1957 | SPG10 |
1958 | KIF5A |
1959 | SPG11 |
1960 | SPG11 |
1961 | SPG12 |
1962 | RTN2 |
1963 | SPG13 |
1964 | HSPD1 |
1965 | SPG15 |
1966 | ZFYVE26 |
1967 | SPG17 |
1968 | BSCL2 |
1969 | SPG18 |
No. | Description |
1301 | Mental retardation, X-linked, nonsyndromic |
1302 | NEXMIF |
1303 | Mental retardation, X-linked, Siderius type |
1304 | PHF8 |
1305 | Mental retardation, X-linked, Snyder-Robinson type |
1306 | SMS |
1307 | Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance |
1308 | OPHN1 |
1309 | Mental retardation, X-linked, with isolated growth hormone deficiency |
1310 | SOX3 |
1311 | MERRF syndrome, MT-TK related |
1312 | MT-TK |
1313 | MERRF syndrome, MT-TP related |
1314 | MT-TP |
1315 | MERRF/MELAS overlap syndrome, MT-TS1 related |
1316 | MT-TS1 |
1317 | MERRF/MELAS overlap syndrome, MT-TS2 related |
1318 | MT-TS2 |
1319 | Metachromatic leukodystrophy due to Saposin B deficiency |
1320 | PSAP |
1321 | Methionine adenosyltransferase deficiency, autosomal recessive |
1322 | MAT1A |
1323 | Microcephaly-capillary malformation syndrome |
1324 | STAMBP |
1325 | Minicore myopathy with external ophthalmoplegia |
1326 | RYR1 |
1327 | Mirror movements type 1 |
1328 | DCC |
1329 | Mirror movements type 2 |
1330 | RAD51 |
1331 | Mirror movements type 3 |
1332 | DNAL4 |
1333 | Mitochondrial complex I deficiency |
1334 | FOXRED1 |
1335 | Mitochondrial complex I deficiency |
1336 | MT-ND1 |
1337 | Mitochondrial complex I deficiency |
1338 | MT-ND2 |
1339 | Mitochondrial complex I deficiency |
1340 | MT-ND3 |
1341 | Mitochondrial complex I deficiency |
1342 | MT-ND4 |
1343 | Mitochondrial complex I deficiency |
1344 | MT-ND4L |
1345 | Mitochondrial complex I deficiency |
1346 | MT-ND5 |
1347 | Mitochondrial complex I deficiency |
1348 | MT-ND6 |
1349 | Mitochondrial complex I deficiency |
1350 | NDUFA1 |
1351 | Mitochondrial complex I deficiency |
1352 | NDUFA11 |
1353 | Mitochondrial complex I deficiency |
1354 | NDUFAF1 |
1355 | Mitochondrial complex I deficiency |
1356 | NDUFAF3 |
1357 | Mitochondrial complex I deficiency |
1358 | NDUFAF4 |
1359 | Mitochondrial complex I deficiency |
1360 | NDUFAF5 |
1361 | Mitochondrial complex I deficiency |
1362 | NDUFB3 |
1363 | Mitochondrial complex I deficiency |
1364 | NDUFS1 |
1365 | Mitochondrial complex I deficiency |
1366 | NDUFS2 |
1367 | Mitochondrial complex I deficiency |
1368 | NDUFS4 |
1369 | Mitochondrial complex I deficiency |
1370 | NDUFS6 |
1371 | Mitochondrial complex I deficiency |
1372 | NDUFV1 |
1373 | Mitochondrial complex I deficiency |
1374 | NDUFV2 |
1375 | Mitochondrial complex I deficiency, MT-TN related |
1376 | MT-TN |
1377 | Mitochondrial complex II deficiency |
1378 | SDHAF1 |
1379 | Mitochondrial complex II deficiency |
1380 | SDHD |
1381 | Mitochondrial complex III deficiency |
1382 | BCS1L |
1383 | Mitochondrial complex III deficiency |
1384 | UQCRB |
1385 | Mitochondrial complex III deficiency |
1386 | UQCRC2 |
1387 | Mitochondrial complex III deficiency |
1388 | UQCRQ |
1389 | Mitochondrial complex III deficiency, nuclear type 2 |
1390 | TTC19 |
1391 | Mitochondrial complex III deficiency, nuclear type 7 |
1392 | UQCC2 |
1393 | Mitochondrial complex IV deficiency |
1394 | COA8 |
1395 | Mitochondrial complex IV deficiency |
1396 | COX6B1 |
1397 | Mitochondrial complex IV deficiency |
1398 | FASTKD2 |
1399 | Mitochondrial complex IV deficiency |
1400 | MT-CO3 |
1401 | Mitochondrial complex IV deficiency |
1402 | PET100 |
1403 | Mitochondrial complex V (ATP synthase) deficiency |
1404 | MT-ATP6 |
1405 | Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1 |
1406 | ATPAF2 |
1407 | Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2 |
1408 | TMEM70 |
1409 | Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3 |
1410 | ATP5F1E |
1411 | Mitochondrial complex V deficiency, nuclear type 4 |
1412 | ATP5F1A |
1413 | Mitochondrial Disorders, AKAP1 related |
1414 | AKAP1 |
1415 | Mitochondrial DNA depletion syndrome |
1416 | DGUOK |
1417 | Mitochondrial DNA depletion syndrome |
1418 | SUCLA2 |
1419 | Mitochondrial DNA depletion syndrome |
1420 | TK2 |
1421 | Mitochondrial DNA depletion syndrome 8B, MNGIE type |
1422 | RRM2B |
1423 | Mitochondrial DNA depletion syndrome type 11 |
1424 | MGME1 |
1425 | Mitochondrial DNA depletion syndrome type 13 |
1426 | FBXL4 |
1427 | Mitochondrial DNA depletion syndrome type 4A |
1428 | POLG |
1429 | Mitochondrial DNA depletion syndrome type 4B |
1430 | POLG |
1431 | Mitochondrial DNA depletion syndrome type 6 |
1432 | MPV17 |
1433 | Mitochondrial DNA depletion syndrome type 7 |
1434 | TWNK |
1435 | Mitochondrial DNA depletion syndrome, encephalomyopathic type with methylmalonic aciduria |
1436 | SUCLG1 |
1437 | Mitochondrial encephalomyopathy |
1438 | MFF |
1439 | Mitochondrial encephalomyopathy |
1440 | MT-CYB |
1441 | Mitochondrial myopathy and sideroblastic anemia type 1 |
1442 | PUS1 |
1443 | Mitochondrial neurogastrointestinal encephalopathy syndrome without leukoencephalopathy |
1444 | POLG |
1445 | Mitochondrial neurogastrointestinal encephalopathy syndrome without leukoencephalopathy |
1446 | TYMP |
1447 | Mitochondrial respiratory chain complex II deficiency |
1448 | SDHA |
1449 | Mitochondrial respiratory chain disease, TIMM21 related |
1450 | TIMM21 |
1451 | Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency |
1452 | ECHS1 |
1453 | Miyoshi muscular dystrophy type 3 |
1454 | ANO5 |
1455 | Miyoshi myopathy |
1456 | DYSF |
1457 | Multiple congenital anomalies-hypotonia-seizures syndrome type 3 |
1458 | PIGT |
1459 | Multiple mitochondrial dysfunctions syndrome type 1 |
1460 | NFU1 |
1461 | Multiple mitochondrial dysfunctions syndrome type 2 |
1462 | BOLA3 |
1463 | Multiple mitochondrial dysfunctions syndrome type 3 |
1464 | IBA57 |
1465 | Multiple mitochondrial dysfunctions syndrome type 4 |
1466 | ISCA2 |
1467 | Multisystemic smooth muscle dysfunction syndrome |
1468 | ACTA2 |
1469 | Muscle hypertrophy |
1470 | MSTN |
1471 | Muscle-eye-brain disease, POMK related |
1472 | POMK |
1473 | Muscular dystrophy type 1A |
1474 | LAMA2 |
1475 | Muscular dystrophy type 1C |
1476 | FKRP |
1477 | Muscular dystrophy type 1D |
1478 | LARGE1 |
1479 | Muscular dystrophy, Becker type |
1480 | DMD |
1481 | Muscular dystrophy, congenital, LMNA related |
1482 | LMNA |
1483 | Muscular dystrophy, congenital, megaconial type |
1484 | CHKB |
1485 | Muscular dystrophy, Duchenne type |
1486 | DMD |
1487 | Muscular dystrophy, limb-girdle type 2A |
1488 | CAPN3 |
1489 | Muscular dystrophy, limb-girdle, type 2Q |
1490 | PLEC |
1491 | Muscular dystrophy, oculopharyngeal |
1492 | PABPN1 |
1493 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A10 |
1494 | RXYLT1 |
1495 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A13 |
1496 | B4GAT1 |
1497 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
1498 | POMT2 |
1499 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 |
1500 | POMGNT1 |
1501 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A8 |
1502 | POMGNT2 |
1503 | Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B1 |
1504 | POMT1 |
1505 | Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B2 |
1506 | POMT2 |
1507 | Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B3 |
1508 | POMGNT1 |
1509 | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C2 |
1510 | POMT2 |
1511 | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C3 |
1512 | POMGNT1 |
1513 | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C9 |
1514 | DAG1 |
1515 | Muscular-skeletal disorder, CAPN1 related |
1516 | CAPN1 |
1517 | Myasthenia congenital with tubular aggregates 1 |
1518 | GFPT1 |
1519 | Myasthenic syndrome associated with acetylcholine receptor deficiency |
1520 | MUSK |
1521 | Myasthenic syndrome due to mutation in SCN4A |
1522 | SCN4A |
1523 | Myasthenic syndrome, congenital |
1524 | AGRN |
1525 | Myasthenic syndrome, congenital |
1526 | CHAT |
1527 | Myasthenic syndrome, congenital |
1528 | CHRNB1 |
1529 | Myasthenic syndrome, congenital |
1530 | CHRNE |
1531 | Myasthenic syndrome, congenital, fast channel |
1532 | CHRNA1 |
1533 | Myasthenic syndrome, congenital, slow-channel |
1534 | CHRNA1 |
1535 | Myasthenic syndrome, congenital, type 10 |
1536 | DOK7 |
1537 | Myasthenic syndrome, congenital, type 11, associated with acetylcholine receptor deficiency |
1538 | RAPSN |
1539 | Myasthenic syndrome, congenital, type 20, presynaptic |
1540 | SLC5A7 |
1541 | Myasthenic syndrome, congenital, type 3A, slow channel |
1542 | CHRND |
1543 | Myasthenic syndrome, congenital, type 3B, fast-channel |
1544 | CHRND |
1545 | Myasthenic syndrome, congenital, type 3C, associated with acetylcholine receptor deficiency |
1546 | CHRND |
1547 | Myoclonic dystonia, DRD2 related |
1548 | DRD2 |
1549 | Myoclonic epilepsy of Lafora |
1550 | EPM2A |
1551 | Myoclonic epilepsy of Lafora |
1552 | NHLRC1 |
1553 | Myoclonus, familial cortical |
1554 | NOL3 |
1555 | Myoglobinuria acute recurrent |
1556 | LPIN1 |
1557 | Myopathy due to Integrin 7A deficiency |
1558 | ITGA7 |
1559 | Myopathy due to myoadenylate deaminase deficiency |
1560 | AMPD1 |
1561 | Myopathy with extrapyramidal signs |
1562 | MICU1 |
1563 | Myopathy with fiber-type disproportion |
1564 | ACTA1 |
1565 | Myopathy with fiber-type disproportion |
1566 | SELENON |
1567 | Myopathy, areflexia, respiratory distress, and dysphagia, early-onset |
1568 | MEGF10 |
1569 | Myopathy, COL6A6 related |
1570 | COL6A6 |
1571 | Myopathy, desmin related, associated with mutation in the CRYAB gene |
1572 | CRYAB |
1573 | Myopathy, distal type 1 |
1574 | MYH7 |
1575 | Myopathy, distal type 4 |
1576 | FLNC |
1577 | Myopathy, distal with anterior tibial onset |
1578 | DYSF |
1579 | Myopathy, distal, Tateyama type |
1580 | CAV3 |
1581 | Myopathy, early-onset with fatal cardiomyopathy |
1582 | TTN |
1583 | Myopathy, lactic acidosis, and sideroblastic anemia type 2 |
1584 | YARS2 |
1585 | Myopathy, limb girdle with bone fragility |
1586 | MTAP |
1587 | Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay |
1588 | GFER |
1589 | Myopathy, MT-TQ related |
1590 | MT-TQ |
1591 | Myopathy, myofibrillar type 6 |
1592 | BAG3 |
1593 | Myopathy, myofibrillar, Desmin related |
1594 | DES |
1595 | Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related |
1596 | CRYAB |
1597 | Myopathy, myofibrillar, ZASP related |
1598 | LDB3 |
1599 | Myopathy, scapulohumeroperoneal |
1600 | ACTA1 |
1601 | Myopathy, tubular aggregate, type 1 |
1602 | STIM1 |
1603 | Myosclerosis, autosomal recessive |
1604 | COL6A2 |
1605 | Myosin storage myopathy |
1606 | MYH7 |
1607 | Myotilinopathy |
1608 | MYOT |
1609 | Myotonia congenita |
1610 | CLCN1 |
1611 | Myotonic dystrophy type 1 |
1612 | DMPK |
1613 | Myotonic dystrophy type 2 |
1614 | CNBP |
1615 | Myotubular myopathy X-linked |
1616 | MTM1 |
1617 | Narcolepsy |
1618 | HCRT |
1619 | Nemaline myopathy type 1 |
1620 | TPM3 |
1621 | Nemaline myopathy type 2, autosomal recessive |
1622 | NEB |
1623 | Nemaline myopathy type 3 |
1624 | ACTA1 |
1625 | Nemaline myopathy type 4 |
1626 | TPM2 |
1627 | Nemaline myopathy type 5 |
1628 | TNNT1 |
1629 | Nemaline myopathy type 6 |
1630 | KBTBD13 |
1631 | Nemaline myopathy type 7 |
1632 | CFL2 |
1633 | Neonatal death due Leigh syndrome, MT-TV related |
1634 | MT-TV |
1635 | Neurodegeneration due to cerebral folate transport deficiency |
1636 | FOLR1 |
1637 | Neurodegeneration with brain iron accululation type 5 |
1638 | WDR45 |
1639 | Neurodegeneration with brain iron accumulation type 4 |
1640 | C19orf12 |
1641 | Neurodegeneration with brain iron accumulation type 6 |
1642 | COASY |
1643 | Neurodegeneration with brain iron accumulation, GTPBP2 related |
1644 | GTPBP2 |
1645 | Neurodevelopmental disorder with cerebellar atrophy and with or without seizures |
1646 | BRAT1 |
1647 | Neurodevelopmental disorder, ADAM22 related |
1648 | ADAM22 |
1649 | Neurodevelopmental disorder, APC2-related |
1650 | APC2 |
1651 | Neurodevelopmental disorder, CNTNAP4 related |
1652 | CNTNAP4 |
1653 | Neurodevelopmental disorder, CROCC related |
1654 | CROCC |
1655 | Neurodevelopmental disorder, FRMPD4 related |
1656 | FRMPD4 |
1657 | Neurodevelopmental disorder, KCTD3 related |
1658 | KCTD3 |
1659 | Neurodevelopmental disorder, MACF1 related |
1660 | MACF1 |
1661 | Neurodevelopmental disorder, MTOR related |
1662 | MTOR |
1663 | Neurodevelopmental disorder, NGEF related |
1664 | NGEF |
1665 | Neurodevelopmental disorder, PIGQ related |
1666 | PIGQ |
1667 | Neurodevelopmental disorder, TUBB related |
1668 | TUBB |
1669 | Neurodevelopmental disorder, ZNF311 related |
1670 | ZNF311 |
1671 | Neurodevelopmental malformation and microcephaly |
1672 | KIF2A |
1673 | Neurodevelopmental malformation and microcephaly |
1674 | KIF5C |
1675 | Neurodevelopmental malformation and microcephaly |
1676 | TUBG1 |
1677 | Neurogenic scapuloperoneal syndrome, Kaeser type |
1678 | DES |
1679 | Neuromyotonia and axonal neuropathy, autosomal recessive |
1680 | HINT1 |
1681 | Neuronal migration disorder |
1682 | CTNNA2 |
1683 | Neuronal migration disorder |
1684 | EOMES |
1685 | Neuronal migration disorder |
1686 | SPTBN5 |
1687 | Neuronal migration disorder |
1688 | SRGAP2 |
1689 | Neuronopathy distal hereditary motor type 2A |
1690 | HSPB8 |
1691 | Neuronopathy distal hereditary motor type 2B |
1692 | HSPB1 |
1693 | Neuronopathy distal hereditary motor type 5 |
1694 | GARS1 |
1695 | Neuronopathy distal hereditary motor type 6 |
1696 | IGHMBP2 |
1697 | Neuronopathy distal hereditary motor type 7B |
1698 | DCTN1 |
1699 | Neuropathy sensor type 1E |
1700 | DNMT1 |
1701 | Neuropathy with liability to pressure palsies [HNPP] |
1702 | PMP22 |
1703 | Neuropathy with sensory ataxic, dysarthria, and ophthalmoparesis |
1704 | POLG |
1705 | Neuropathy, distal hereditary motor, type 5A |
1706 | BSCL2 |
1707 | Neuropathy, hereditary sensory and autonomic type 1C |
1708 | SPTLC2 |
1709 | Neuropathy, hereditary sensory and autonomic type 2 |
1710 | SCN9A |
1711 | Neuropathy, hereditary sensory and autonomic type 6 |
1712 | DST |
1713 | Neuropathy, hereditary sensory, type 1D |
1714 | ATL1 |
1715 | Neuropathy, hereditary sensory, type 1F |
1716 | ATL3 |
1717 | Neuropathy, hereditary sensory, with spastic paraplegia |
1718 | CCT5 |
1719 | Neutral lipid storage disease with myopathy |
1720 | PNPLA2 |
1721 | Niemann-Pick disease type C1 |
1722 | NPC1 |
1723 | Nonaka myopathy |
1724 | GNE |
1725 | Norrie disease |
1726 | NDP |
1727 | Occipital horn syndrome |
1728 | ATP7A |
1729 | Opitz G syndrome |
1730 | MID1 |
1731 | Oral-facial-digital syndrome type 1 |
1732 | OFD1 |
1733 | Pantothenate kinase-associated neurodegeneration |
1734 | PANK2 |
1735 | Paramyotonia congenita of von Eulenburg |
1736 | SCN4A |
1737 | Parietal foramina type 2 |
1738 | ALX4 |
1739 | PARK1 Parkinson |
1740 | SNCA |
1741 | PARK13 Parkinson |
1742 | HTRA2 |
1743 | PARK14 Parkinson |
1744 | PLA2G6 |
1745 | PARK15 Parkinson |
1746 | FBXO7 |
1747 | PARK17 Parkinson |
1748 | VPS35 |
1749 | PARK19 Parkinson, juvenile-onset |
1750 | DNAJC6 |
1751 | PARK2 Parkinson |
1752 | PRKN |
1753 | PARK20 Parkinson |
1754 | SYNJ1 |
1755 | PARK21 Parkinson |
1756 | DNAJC13 |
1757 | PARK4 Parkinson |
1758 | SNCA |
1759 | PARK5 Parkinson |
1760 | UCHL1 |
1761 | PARK6 Parkinson |
1762 | PINK1 |
1763 | PARK7 Parkinson |
1764 | PARK7 |
1765 | PARK8 Parkinson |
1766 | LRRK2 |
1767 | PARK9 Parkinson |
1768 | ATP13A2 |
1769 | Parkinson disease, late-onset, susceptibility to |
1770 | GBA |
1771 | Parkinson disease, susceptibility to, MT-TT related |
1772 | MT-TT |
1773 | Parkinsonism with spasticity, X-linked |
1774 | ATP6AP2 |
1775 | Parkinsonism-Dystonia, infantile |
1776 | SLC6A3 |
1777 | Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia |
1778 | SLC2A1 |
1779 | Paroxysmal nonkinesigenic dyskinesia |
1780 | PNKD |
1781 | Partington syndrome |
1782 | ARX |
1783 | Pelizaeus-Merzbacher disease |
1784 | PLP1 |
1785 | Pelizaeus-Merzbacher disease |
1786 | SLC16A2 |
1787 | Peripheral demyelinating neuropathy Waardenburg syndrome and Hirschsprung disease |
1788 | SOX10 |
1789 | Periventricular heterotopia with microcephaly |
1790 | ARFGEF2 |
1791 | Peroxisome biogenesis disorder 14B |
1792 | PEX11B |
1793 | Peroxisome biogenesis disorder type 10A |
1794 | PEX3 |
1795 | Peroxisome biogenesis disorder type 1B |
1796 | PEX1 |
1797 | Peroxisome biogenesis disorder type 2A |
1798 | PEX5 |
1799 | Peroxisome biogenesis disorder type 2B |
1800 | PEX5 |
1801 | Perrault syndrome |
1802 | HSD17B4 |
1803 | Perrault syndrome type 2 |
1804 | HARS2 |
1805 | Perrault syndrome type 4 |
1806 | LARS2 |
1807 | Perrault syndrome type 5 |
1808 | TWNK |
1809 | Phosphoglycerate kinase 1 deficiency |
1810 | PGK1 |
1811 | Pick disease |
1812 | PSEN1 |
1813 | Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy |
1814 | TREM2 |
1815 | Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy |
1816 | TYROBP |
1817 | Polyglucosan body myopathy type 1 with or without immunodeficiency |
1818 | RBCK1 |
1819 | Polymicrogyria bilateral occipital |
1820 | NR2E1 |
1821 | Pompe disease |
1822 | GAA |
1823 | Pontocerebellar hypoplasia type 1A |
1824 | VRK1 |
1825 | Pontocerebellar hypoplasia type 1B |
1826 | EXOSC3 |
1827 | Pontocerebellar hypoplasia type 2A |
1828 | TSEN54 |
1829 | Pontocerebellar hypoplasia type 2B |
1830 | TSEN2 |
1831 | Pontocerebellar hypoplasia type 2C |
1832 | TSEN34 |
1833 | Pontocerebellar hypoplasia type 2D |
1834 | SEPSECS |
1835 | Pontocerebellar hypoplasia type 2E |
1836 | VPS53 |
1837 | Pontocerebellar hypoplasia type 4 |
1838 | TSEN54 |
1839 | Pontocerebellar hypoplasia type 5 |
1840 | TSEN54 |
1841 | Pontocerebellar hypoplasia type 6 |
1842 | RARS2 |
1843 | Pontocerebellar hypoplasia type 8 |
1844 | CHMP1A |
1845 | Pontocerebellar hypoplasia, type 10 |
1846 | CLP1 |
1847 | Pontocerebellar hypoplasia, type 9 |
1848 | AMPD2 |
1849 | Porencephaly type 2 |
1850 | COL4A2 |
1851 | Potassium-aggravated myotonia |
1852 | SCN4A |
1853 | Prader-Willi syndrome |
1854 | chr. 15q11 |
1855 | Prader-Willi syndrome |
1856 | NDN |
1857 | Prader-Willi syndrome |
1858 | SNRPN |
1859 | Primary lateral sclerosis, juvenile |
1860 | ALS2 |
1861 | Progressive external ophthalmoplegia with mitochondrial deletions type 1, autosomal dominant |
1862 | POLG |
1863 | Progressive external ophthalmoplegia with mitochondrial deletions type 2, autosomal dominant |
1864 | SLC25A4 |
1865 | Progressive external ophthalmoplegia with mitochondrial deletions type 2, autosomal recessive |
1866 | RNASEH1 |
1867 | Progressive external ophthalmoplegia with mitochondrial deletions type 3, autosomal dominant |
1868 | TWNK |
1869 | Progressive external ophthalmoplegia with mitochondrial deletions type 4, autosomal dominant |
1870 | POLG2 |
1871 | Progressive external ophthalmoplegia with mitochondrial deletions type 5, autosomal dominant |
1872 | RRM2B |
1873 | Progressive myoclonus epilepsy type 1A |
1874 | PRICKLE1 |
1875 | Progressive myoclonus epilepsy type 3 |
1876 | KCTD7 |
1877 | Progressive myoclonus epilepsy type 6 |
1878 | GOSR2 |
1879 | Progressive myoclonus epilepsy type 8 |
1880 | CERS1 |
1881 | Psychomotor retardation |
1882 | TANC1 |
1883 | Ptosis, congenital |
1884 | ZFHX4 |
1885 | Pyridoxine-dependent epilepsy |
1886 | ALDH7A1 |
1887 | Pyruvate carboxylase deficiency |
1888 | PC |
1889 | Raynaud-Claes syndrome |
1890 | CLCN4 |
1891 | Renpenning syndrome |
1892 | PQBP1 |
1893 | Rett syndrome preserved speech variant |
1894 | MECP2 |
1895 | Rigid spine muscular dystrophy |
1896 | SELENON |
1897 | Rippling muscle disease |
1898 | CAV3 |
1899 | Rolandic epilepsy, mental retardation, and speech dyspraxia |
1900 | SRPX2 |
1901 | Roussy-Levy syndrome |
1902 | PMP22 |
1903 | Salih ataxia |
1904 | RUBCN |
1905 | Scapuloperoneal myopathy, MYH7 related |
1906 | MYH7 |
1907 | Schizophrenia, CALR related |
1908 | CALR |
1909 | Schizophrenia, CELSR2 related |
1910 | CELSR2 |
1911 | Schizophrenia, GRID2 related |
1912 | GRID2 |
1913 | Schizophrenia, NOTCH4 related |
1914 | NOTCH4 |
1915 | Schwartz-Jampel syndrome type 1 |
1916 | HSPG2 |
1917 | Segawa syndrome, autosomal recessive |
1918 | TH |
1919 | Seizures, benign familial infantile, type 2 |
1920 | PRRT2 |
1921 | Seizures, benign neonatal, type 1 |
1922 | KCNQ2 |
1923 | Seizures, benign neonatal, type 2 |
1924 | KCNQ3 |
1925 | SESAME syndrome |
1926 | KCNJ10 |
1927 | Sialuria, finish type |
1928 | SLC17A5 |
1929 | Simpson-Golabi-Behmel syndrome type 1 |
1930 | GPC3 |
1931 | Sjogren-Larsson syndrome |
1932 | ALDH3A2 |
1933 | Slowed nerve conduction velocity, autosomanal dominant |
1934 | ARHGEF10 |
1935 | Smith-Magenis syndrome |
1936 | RAI1 |
1937 | Smith-Magenis syndrome, ULK2 related |
1938 | ULK2 |
1939 | Spastic ataxia Charlevoix-Saguenay type |
1940 | SACS |
1941 | Spastic ataxia type 1, autosomal dominant |
1942 | VAMP1 |
1943 | Spastic ataxia type 2, autosomal recessive |
1944 | KIF1C |
1945 | Spastic ataxia type 3, autosomal recessive |
1946 | MARS2 |
1947 | Spastic ataxia type 4, autosomal recessive |
1948 | MTPAP |
1949 | Spastic ataxia type 5, autosomal recessive |
1950 | AFG3L2 |
1951 | Spastic paralysis, infantile onset ascending |
1952 | ALS2 |
1953 | Spastic paraplegia type 74, autosomal recessive |
1954 | IBA57 |
1955 | SPG1 |
1956 | L1CAM |
1957 | SPG10 |
1958 | KIF5A |
1959 | SPG11 |
1960 | SPG11 |
1961 | SPG12 |
1962 | RTN2 |
1963 | SPG13 |
1964 | HSPD1 |
1965 | SPG15 |
1966 | ZFYVE26 |
1967 | SPG17 |
1968 | BSCL2 |
1969 | SPG18 |
No. | Description |
---|---|
1 | 7-hydroxylation activity deficiency |
2 | CYP17A1 |
3 | 2,4-dienoyl-CoA reductase 1 |
4 | DECR1 |
5 | 2,4-dienoyl-CoA reductase deficiency |
6 | NADK2 |
7 | 2-aminoadipic 2-oxoadipic aciduria |
8 | DHTKD1 |
9 | 2-methylbutyrylglycinuria |
10 | ACADSB |
11 | 3-beta-hydroxysteroid dehydrogenase deficiency type 2 |
12 | HSD3B2 |
13 | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency |
14 | HMGCL |
15 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency |
16 | HMGCS2 |
17 | 3-hydroxyacyl-CoA dehydrogenase deficiency |
18 | HADH |
19 | 3-hydroxyisobutryl-CoA hydrolase deficiency |
20 | HIBCH |
21 | 3-methylcrontonyl-CoA carboxylase 1 deficiency |
22 | MCCC1 |
23 | 3-methylcrontonyl-CoA carboxylase 2 deficiency |
24 | MCCC2 |
25 | 3-methylglutaconic aciduria type 1 |
26 | AUH |
27 | 3-methylglutaconic aciduria type 3 |
28 | OPA3 |
29 | 3-methylglutaconic aciduria type 5 |
30 | DNAJC19 |
31 | 3-methylglutaconic aciduria type 7, with cataracts, neurologic involvement and neutropenia |
32 | CLPB |
33 | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome |
34 | SERAC1 |
35 | 6q24-related transient neonatal diabetes mellitus type 1 |
36 | UPD chr. 6 |
37 | Abetalipoproteinemia |
38 | MTTP |
39 | Acatalasemia |
40 | CAT |
41 | Acetycholinesterase deficiency |
42 | ACHE |
43 | Acetyl-CoA carboxylase deficiency |
44 | ACACA |
45 | Acute Alcohol sensitivity |
46 | ALDH2 |
47 | Acute hepatic porphyria |
48 | ALAD |
49 | Acyl-CoA medium-chain dehydrogenase deficiency |
50 | ACADM |
51 | Acyl-CoA multiple dehydrogenase deficiency |
52 | ETFA |
53 | Acyl-CoA multiple dehydrogenase deficiency |
54 | ETFB |
55 | Acyl-CoA short-chain dehydrogenase deficiency |
56 | ACADS |
57 | Acyl-CoA very long-chain dehydrogenase deficiency |
58 | ACADVL |
59 | Adenine phosphoribosyltransferase deficiency |
60 | APRT |
61 | Adenylosuccinase deficiency |
62 | ADSL |
63 | Adrenal hyperplasia due to 21-hydroxylase deficiency |
64 | CYP21A2 |
65 | Adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
66 | POR |
67 | Adrenal hyperplasia due to steroid 11-beta-hydroxylase deficiency |
68 | CYP11B1 |
69 | Adrenal hypoplasia |
70 | NR0B1 |
71 | AICA-ribosiduria due to ATIC deficiency |
72 | ATIC |
73 | Alkaptonuria |
74 | HGD |
75 | Alpha-2-macroglobulin deficiency |
76 | A2M |
77 | Alpha-ketoglutarate dehydrogenase deficiency |
78 | OGDH |
79 | Alpha-methylacyl CoA racemase deficiency |
80 | AMACR |
81 | Aminoacylase deficiency |
82 | ACY1 |
83 | AMP deaminase deficiency, erythrocytic |
84 | AMPD3 |
85 | Amyloidosis, familial visceral |
86 | APOA1 |
87 | Andersen disease |
88 | GBE1 |
89 | Anemia dyserythropoietic type 1A |
90 | CDAN1 |
91 | Anemia dyserythropoietic type 2 |
92 | SEC23B |
93 | Antitrypsin-alpha-1 deficiency |
94 | SERPINA1 |
95 | Aplastic anemia |
96 | PRF1 |
97 | Aplastic anemia, SBDS related |
98 | SBDS |
99 | Apolipoprotein A-II deficiency |
100 | APOA2 |
101 | Apolipoprotein C-II deficiency |
102 | APOC2 |
103 | Apparent mineralocorticoid excess |
104 | HSD11B2 |
105 | Arginase deficiency |
106 | ARG1 |
107 | Arginine-glycine amidinotransferase deficiency |
108 | GATM |
109 | Argininosuccinic aciduria |
110 | ASL |
111 | Aromatic L-amino acid decarboxylase deficiency (AADC) |
112 | DDC |
113 | Asparaginesynthetase deficiency |
114 | ASNS |
115 | Aspartylglucosaminuria |
116 | AGA |
117 | Beta-Galactosamide alpha-2,6-Sialyltransferase 2 deficiency |
118 | ST6GAL2 |
119 | Beta-ureidopropionase deficiency |
120 | UPB1 |
121 | Bile acid malabsorption, primary |
122 | SLC10A2 |
123 | Bile acid synthesis defect type 1, congenital |
124 | HSD3B7 |
125 | Bile acid synthesis defect type 2, congenital |
126 | AKR1D1 |
127 | Bile acid synthesis defect type 3, congenital |
128 | CYP7B1 |
129 | Bile acid synthesis defect type 4, congenital |
130 | AMACR |
131 | Bile acid synthesis defect type 5, congenital |
132 | ABCD3 |
133 | Biotinidase deficiency |
134 | BTD |
135 | Bloom syndrome |
136 | BLM |
137 | Branched-chain aminotransferase 1 deficiency |
138 | BCAT1 |
139 | Branched-chain aminotransferase 2 deficiency |
140 | BCAT2 |
141 | Branched-chain ketoacid dehydrogenase kinase deficiency |
142 | BCKDK |
143 | Bronchiectasis with or without elevated sweat chloride type 2 |
144 | SCNN1A |
145 | Butyrylcholinesterase deficiency |
146 | BCHE |
147 | Carbamoylphosphate synthetase I deficiency |
148 | CPS1 |
149 | Carnitine deficiency |
150 | SLC22A5 |
151 | Carnitine palmitoyltransferase 1A deficiency |
152 | CPT1A |
153 | Carnitine palmitoyltransferase 1B deficiency |
154 | CPT1B |
155 | Carnitine palmitoyltransferase 2 deficiency, infantile |
156 | CPT2 |
157 | Carnitine palmitoyltransferase 2 deficiency, lethal neonatal |
158 | CPT2 |
159 | Carnitine-acylcarnitine translocase deficiency |
160 | SLC25A20 |
161 | Catechol-o-methyltransferase deficiency |
162 | COMT |
163 | Ceroid lipofuscinosis neuronal type 1 |
164 | PPT1 |
165 | Ceroid lipofuscinosis neuronal type 10 |
166 | CTSD |
167 | Ceroid lipofuscinosis neuronal type 11 |
168 | GRN |
169 | Ceroid lipofuscinosis neuronal type 2 |
170 | TPP1 |
171 | Ceroid lipofuscinosis neuronal type 3 |
172 | CLN3 |
173 | Ceroid lipofuscinosis neuronal type 4 |
174 | DNAJC5 |
175 | Ceroid lipofuscinosis neuronal type 5 |
176 | CLN5 |
177 | Ceroid lipofuscinosis neuronal type 6 |
178 | CLN6 |
179 | Ceroid lipofuscinosis neuronal type 7 |
180 | MFSD8 |
181 | Ceroid lipofuscinosis neuronal type 8 |
182 | CLN8 |
183 | Chanarin-Dorfman syndrome |
184 | ABHD5 |
185 | Chloramphenicol resistance, MT-RNR2 related |
186 | MT-RNR2 |
187 | Cholestasis benign recurrent intrahepatic type 2 |
188 | ABCB11 |
189 | Cholestasis intrahepatic, of pregnancy, type 3 |
190 | ABCB4 |
191 | Cholestasis progressive intrahepatic type 1 |
192 | ATP8B1 |
193 | Cholestasis progressive intrahepatic type 2 |
194 | ABCB11 |
195 | Cholestasis progressive intrahepatic type 3 |
196 | ABCB4 |
197 | Cholestasis, benign recurrent intrahepatic |
198 | ATP8B1 |
199 | Cholestasis, intrahepatic, of pregnancy, type 1 |
200 | ATP8B1 |
201 | Cholesteryl ester storage disease |
202 | LIPA |
203 | Chylomicron retention disease |
204 | SAR1B |
205 | Citrin deficiency |
206 | SLC25A13 |
207 | Citrullinemia |
208 | ASS1 |
209 | Coenzyme Q10 deficiency type 6 |
210 | COQ6 |
211 | Coenzyme Q10 deficiency type 7 |
212 | COQ4 |
213 | Colchicine resistance |
214 | ABCB1 |
215 | Combined D-2- and L-2-hydroxyglutaric aciduria |
216 | SLC25A1 |
217 | Combined malonic and methylmalonic aciduria |
218 | ACSF3 |
219 | Combined oxidative phosphorylation deficiency type 1 |
220 | GFM1 |
221 | Combined oxidative phosphorylation deficiency type 10 |
222 | MTO1 |
223 | Combined oxidative phosphorylation deficiency type 11 |
224 | RMND1 |
225 | Combined oxidative phosphorylation deficiency type 12 |
226 | EARS2 |
227 | Combined oxidative phosphorylation deficiency type 13 |
228 | PNPT1 |
229 | Combined oxidative phosphorylation deficiency type 14 |
230 | FARS2 |
231 | Combined oxidative phosphorylation deficiency type 15 |
232 | MTFMT |
233 | Combined oxidative phosphorylation deficiency type 16 |
234 | MRPL44 |
235 | Combined oxidative phosphorylation deficiency type 17 |
236 | ELAC2 |
237 | Combined oxidative phosphorylation deficiency type 18 |
238 | SFXN4 |
239 | Combined oxidative phosphorylation deficiency type 19 |
240 | LYRM4 |
241 | Combined oxidative phosphorylation deficiency type 2 |
242 | MRPS16 |
243 | Combined oxidative phosphorylation deficiency type 20 |
244 | VARS2 |
245 | Combined oxidative phosphorylation deficiency type 21 |
246 | TARS2 |
247 | Combined oxidative phosphorylation deficiency type 22 |
248 | ATP5F1A |
249 | Combined oxidative phosphorylation deficiency type 23 |
250 | GTPBP3 |
251 | Combined oxidative phosphorylation deficiency type 24 |
252 | NARS2 |
253 | Combined oxidative phosphorylation deficiency type 25 |
254 | MARS2 |
255 | Combined oxidative phosphorylation deficiency type 26 |
256 | TRMT5 |
257 | Combined oxidative phosphorylation deficiency type 3 |
258 | TSFM |
259 | Combined oxidative phosphorylation deficiency type 4 |
260 | TUFM |
261 | Combined oxidative phosphorylation deficiency type 5 |
262 | MRPS22 |
263 | Combined oxidative phosphorylation deficiency type 6 |
264 | AIFM1 |
265 | Combined oxidative phosphorylation deficiency type 7 |
266 | C12ORF65 |
267 | Combined oxidative phosphorylation deficiency type 8 |
268 | AARS2 |
269 | Combined oxidative phosphorylation deficiency type 9 |
270 | MRPL3 |
271 | Congenital disorder of glycosylation, type Ip |
272 | ALG11 |
273 | Congenital disorder of glycosylation, type Iq |
274 | SRD5A3 |
275 | Congenital disorder of glycosylation, type Iw |
276 | STT3A |
277 | Coproporphyria |
278 | CPOX |
279 | Coronary artery disease, susceptibility to |
280 | LPA |
281 | Coumarin resistance |
282 | VKORC1 |
283 | Coumarin/Warfarin resistance due to CYP2C9 variants |
284 | CYP2C9 |
285 | CR1 deficiency |
286 | CR1 |
287 | Creatine deficiency syndrome X-linked |
288 | SLC6A8 |
289 | CYP2C19 related poor drug metabolism |
290 | CYP2C19 |
291 | Cystathioninuria |
292 | CTH |
293 | Cystic fibrosis |
294 | CFTR |
295 | Cystic fibrosis, SLC6A14 related |
296 | SLC6A14 |
297 | Cystinosis, nephropathic |
298 | CTNS |
299 | Cytochrome P450 deficiency |
300 | CYP1A2 |
301 | D-2-hydroxyglutaric aciduria type 1 |
302 | D2HGDH |
303 | D-2-hydroxyglutaric aciduria type 2 |
304 | IDH2 |
305 | D-bifunctional protein deficiency |
306 | HSD17B4 |
307 | D-glyceric aciduria |
308 | GLYCTK |
309 | Diabetes insipidus, nephrogenic, X-linked |
310 | AVPR2 |
311 | Diabetes insipidus, neurohypophyseal |
312 | AVP |
313 | Diabetes mellitus type 1 |
314 | INS |
315 | Diabetes mellitus, insulin-dependent type 20 |
316 | HNF1A |
317 | Diabetes mellitus, insulin-resistant with acanthosis nigricans |
318 | INSR |
319 | Diabetes mellitus, neonatal |
320 | GLIS3 |
321 | Diabetes mellitus, noninsulin-dependent |
322 | ABCC8 |
323 | Diabetes mellitus, noninsulin-dependent |
324 | AKT2 |
325 | Diabetes mellitus, noninsulin-dependent |
326 | KCNJ11 |
327 | Diabetes mellitus, permanent neonatal |
328 | ABCC8 |
329 | Diabetes mellitus, transient neonatal type 2 |
330 | ABCC8 |
331 | Diabetes, IGF2 related |
332 | IGF2 |
333 | Diarrhea type 1, secretory chloride, congenital |
334 | SLC26A3 |
335 | Diarrhea type 3, secretory sodium, congenital, syndromic |
336 | SPINT2 |
337 | Diarrhea type 4, malabsorptive, congenital |
338 | NEUROG3 |
339 | Dihydropyrimidine dehydrogenase deficiency |
340 | DPYD |
341 | Dihydropyrimidinuria |
342 | DPYS |
343 | Dimethylglycine dehydrogenase deficiency |
344 | DMGDH |
345 | Dyggve-Melchior-Clausen disease |
346 | DYM |
347 | Efavirenz, poor metabolism of |
348 | CYP2B6 |
349 | Enterokinase deficiency |
350 | TMPRSS15 |
351 | Erythrocyte lactate transporter defect |
352 | SLC16A1 |
353 | Fabry disease |
354 | GLA |
355 | Factor II deficiency |
356 | F2 |
357 | Factor V deficiency |
358 | F5 |
359 | Factor XIIIB deficiency |
360 | F13B |
361 | Fanconi anemia type A |
362 | FANCA |
363 | Fanconi anemia type B |
364 | FANCB |
365 | Fanconi anemia type C |
366 | FANCC |
367 | Fanconi anemia type D1 |
368 | BRCA2 |
369 | Fanconi anemia type D2 |
370 | FANCD2 |
371 | Fanconi anemia type E |
372 | FANCE |
373 | Fanconi anemia type F |
374 | FANCF |
375 | Fanconi anemia type G |
376 | FANCG |
377 | Fanconi anemia type I |
378 | FANCI |
379 | Fanconi anemia type J |
380 | BRIP1 |
381 | Fanconi anemia type L |
382 | FANCL |
383 | Fanconi anemia type M |
384 | FANCM |
385 | Fanconi anemia type N |
386 | PALB2 |
387 | Fanconi anemia type P |
388 | SLX4 |
389 | Fanconi anemia, XRCCR2 related |
390 | XRCC2 |
391 | Fanconi-Bickel syndrome |
392 | SLC2A2 |
393 | Farber disease |
394 | ASAH1 |
395 | Favism, susceptibility to |
396 | G6PD |
397 | Fish eye disease |
398 | LCAT |
399 | Fructose intolerance |
400 | ALDOB |
401 | Fructose uptake deficiency, SLC2A5 related |
402 | SLC2A5 |
403 | Fructose-1,6-bisphosphatase deficiency |
404 | FBP1 |
405 | Fructosuria essential |
406 | KHK |
407 | Fucosidosis |
408 | FUCA1 |
409 | Fumarase deficiency |
410 | FH |
411 | GABA-transaminase deficiency |
412 | ABAT |
413 | Galactokinase deficiency |
414 | GALK1 |
415 | Galactose epimerase deficiency |
416 | GALE |
417 | Galactosemia |
418 | GALT |
419 | Galactosialidosis |
420 | CTSA |
421 | Gallbladder disease type 1 |
422 | ABCB4 |
423 | Gaucher disease type 1 |
424 | GBA |
425 | Gaucher disease type 2 |
426 | GBA |
427 | Gaucher disease type 3 |
428 | GBA |
429 | Gaucher disease type 3C |
430 | GBA |
431 | Gaucher disease, atypical |
432 | PSAP |
433 | Gaucher disease, perinatal lethal |
434 | GBA |
435 | Glucocorticoid deficiency type 1 |
436 | MC2R |
437 | Glucocorticoid deficiency type 2 |
438 | MRAP |
439 | Glucocorticoid deficiency type 4, with or without mineralocorticoid deficiency |
440 | NNT |
441 | Glucose/Galactose malabsorption |
442 | SLC5A1 |
443 | Glutamate formiminotransferase deficiency |
444 | FTCD |
445 | Glutamine deficiency, congenital |
446 | GLUL |
447 | Glutaric acidemia type 1 |
448 | GCDH |
449 | Glutaric acidemia type 2C |
450 | ETFDH |
451 | Glutaric aciduria type 3 |
452 | SUGCT |
453 | Glutathione S-transferase theta-1 defficiency |
454 | GSTT1 |
455 | Glutathione synthetase deficiency |
456 | GSS |
457 | Glycerol kinase deficiency |
458 | GK |
459 | Glycine encephalopathy with normal serum glycine |
460 | SLC6A9 |
461 | Glycogen storage disease of heart (lethal) |
462 | PRKAG2 |
463 | Glycogen storage disease type 0 |
464 | GYS2 |
465 | Glycogen storage disease type 0 muscle |
466 | GYS1 |
467 | Glycogen storage disease type 10 |
468 | PGAM2 |
469 | Glycogen storage disease type 11 |
470 | LDHA |
471 | Glycogen storage disease type 12 |
472 | ALDOA |
473 | Glycogen storage disease type 13 |
474 | ENO3 |
475 | Glycogen storage disease type 14 |
476 | PGM1 |
477 | Glycogen storage disease type 15 |
478 | GYG1 |
479 | Glycogen storage disease type 1A |
480 | G6PC |
481 | Glycogen storage disease type 2 |
482 | GAA |
483 | Glycogen storage disease type 3 |
484 | AGL |
485 | Glycogen storage disease type 4 |
486 | GBE1 |
487 | Glycogen storage disease type 5 |
488 | PYGM |
489 | Glycogen storage disease type 6B |
490 | PYGL |
491 | Glycogen storage disease type 7 |
492 | PFKM |
493 | Glycogen storage disease type 9A |
494 | PHKA2 |
495 | Glycogen storage disease type 9B |
496 | PHKB |
497 | Glycogen storage disease type 9C |
498 | PHKG2 |
499 | Glycosylation disorder type 1A |
500 | PMM2 |
501 | Glycosylation disorder type 1B |
502 | MPI |
503 | Glycosylation disorder type 1C |
504 | ALG6 |
505 | Glycosylation disorder type 1D |
506 | ALG3 |
507 | Glycosylation disorder type 1E |
508 | DPM1 |
509 | Glycosylation disorder type 1F |
510 | MPDU1 |
511 | Glycosylation disorder type 1G |
512 | ALG12 |
513 | Glycosylation disorder type 1H |
514 | ALG8 |
515 | Glycosylation disorder type 1I |
516 | ALG2 |
517 | Glycosylation disorder type 1J |
518 | DPAGT1 |
519 | Glycosylation disorder type 1K |
520 | ALG1 |
521 | Glycosylation disorder type 1L |
522 | ALG9 |
523 | Glycosylation disorder type 1M |
524 | DOLK |
525 | Glycosylation disorder type 1N |
526 | RFT1 |
527 | Glycosylation disorder type 1O |
528 | DPM3 |
529 | Glycosylation disorder type 1S |
530 | ALG13 |
531 | Glycosylation disorder type 1U |
532 | DPM2 |
533 | Glycosylation disorder type 2A |
534 | MGAT2 |
535 | Glycosylation disorder type 2B |
536 | MOGS |
537 | Glycosylation disorder type 2C |
538 | SLC35C1 |
539 | Glycosylation disorder type 2D |
540 | B4GALT1 |
541 | Glycosylation disorder type 2E |
542 | COG7 |
543 | Glycosylation disorder type 2F |
544 | SLC35A1 |
545 | Glycosylation disorder type 2G |
546 | COG1 |
547 | Glycosylation disorder type 2H |
548 | COG8 |
549 | Glycosylation disorder type 2I |
550 | COG5 |
551 | Glycosylation disorder type 2J |
552 | COG4 |
553 | Glycosylation disorder type 2K |
554 | TMEM165 |
555 | Glycosylation disorder type 2M |
556 | SLC35A2 |
557 | Glycosylation disorder type 3 |
558 | COG6 |
559 | Glycosylation disorder type IR |
560 | DDOST |
561 | Glycosylation disorder x-linked |
562 | SSR4 |
563 | GM1-gangliosidosis type 1 |
564 | GLB1 |
565 | GM1-gangliosidosis type 2 |
566 | GLB1 |
567 | GM2-gangliosidosis type 2 |
568 | HEXB |
569 | Guanidinoacetate methyltransferase deficiency |
570 | GAMT |
571 | Hartnup disorder |
572 | SLC6A19 |
573 | Hawkinsinuria |
574 | HPD |
575 | HDL deficiency, type 2 |
576 | ABCA1 |
577 | Hemochromatosis classical |
578 | HFE |
579 | Hemochromatosis type 2A |
580 | HJV |
581 | Hemochromatosis type 2B |
582 | HAMP |
583 | Hemochromatosis type 3 |
584 | TFR2 |
585 | Hemochromatosis type 4 |
586 | SLC40A1 |
587 | Hemolytic anemia due to G6PD deficiency |
588 | G6PD |
589 | Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency |
590 | GPI |
591 | Hemophilia A |
592 | F8 |
593 | High density lipoprotein cholesterol level QTL 10 |
594 | CETP |
595 | Holocarboxylase synthetase deficiency |
596 | HLCS |
597 | Hurler syndrome |
598 | IDUA |
599 | Hurler-Scheie syndrome |
600 | IDUA |
601 | Hydrops, lactic acidosis, and sideroblastic anemia |
602 | LARS2 |
603 | Hyperalphalipoproteinemia |
604 | CETP |
605 | Hyperammonemia due to carbonic anhydrase VA deficiency |
606 | CA5A |
607 | Hypercalcemia infantile type |
608 | CYP24A1 |
609 | Hyperchlorhidrosis, isolated |
610 | CA12 |
611 | Hypercholanemia |
612 | BAAT |
613 | Hypercholanemia |
614 | TJP2 |
615 | Hypercholesterolemia autosomal dominant type 3 |
616 | PCSK9 |
617 | Hypercholesterolemia autosomal recessive |
618 | LDLRAP1 |
619 | Hypercholesterolemia due to LDL-receptor-disorder autosomal dominant |
620 | LDLR |
621 | Hypercholesterolemia type B autosomanl dominant |
622 | APOB |
623 | Hypercholesterolemia, familial, due to LDLR defect, modifier of |
624 | EPHX2 |
625 | Hypercholesterolemia, familial, modifier of |
626 | APOA2 |
627 | Hypercholesterolemia, susceptibility to |
628 | ITIH4 |
629 | Hypercholesterolemia, susceptibility to |
630 | PPP1R17 |
631 | Hyperchylomicronemia type 5 |
632 | APOA5 |
633 | Hyperinsulinaemia, association with, G6PC2 related |
634 | G6PC2 |
635 | Hyperinsulinemic hypoglycemia type 1 |
636 | ABCC8 |
637 | Hyperinsulinemic hypoglycemia type 2 |
638 | KCNJ11 |
639 | Hyperinsulinemic hypoglycemia type 3 |
640 | GCK |
641 | Hyperinsulinemic hypoglycemia type 6 |
642 | GLUD1 |
643 | Hyperinsulinemic hypoglycemia type 7 |
644 | SLC16A1 |
645 | Hyperinsulinism, UCP2 related |
646 | UCP2 |
647 | Hyperlipidemia, familial combined, susceptibility to |
648 | USF1 |
649 | Hyperlipoproteinemia type 1 |
650 | LPL |
651 | Hyperlysinemia type 1 |
652 | AASS |
653 | Hypermanganesemia with dystonia, polycythemia and cirrhosis |
654 | SLC30A10 |
655 | Hypermethioninemia due to adenosine kinase deficiency |
656 | ADK |
657 | Hyperornithinemia- Hyperammonemia - Homocitrullinuria syndrome |
658 | SLC25A15 |
659 | Hyperoxaluria type 1 |
660 | AGXT |
661 | Hyperoxaluria type 2 |
662 | GRHPR |
663 | Hyperoxaluria type 3 |
664 | HOGA1 |
665 | Hyperoxaluria, SLC26A6 related |
666 | SLC26A6 |
667 | Hyperphenylalaninemia, BH4 deficient, type C |
668 | QDPR |
669 | Hyperphenylalaninemia, BH4 deficient, type D |
670 | PCBD1 |
671 | Hyperphenylalaninemia, BH4-deficient, type A |
672 | PTS |
673 | Hyperprolinemia type 1 |
674 | PRODH |
675 | Hyperprolinemia type 2 |
676 | ALDH4A1 |
677 | Hypertriglyceridemia, susceptibility to |
678 | LIPI |
679 | Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis |
680 | SARS2 |
681 | Hypoaldosteronism congenital due to CMO I deficiency |
682 | CYP11B2 |
683 | Hypoaldosteronism, congenital, due to CMO II deficiency |
684 | CYP11B2 |
685 | Hypoalphalipoproteinemia |
686 | APOA1 |
687 | Hypobetalipoproteinemia type 1 |
688 | APOB |
689 | Hypocalcemia, autosomal dominant 2 |
690 | GNA11 |
691 | Hypocalciuric hypercalcemia, familial type 3 |
692 | AP2S1 |
693 | Hypoglycemia of infancy, leucine-sensitive |
694 | ABCC8 |
695 | Hypoinsulinemic hypoglycemia with hemihypertrophy |
696 | AKT2 |
697 | Hypomagnesemia type 1 |
698 | TRPM6 |
699 | Hypomagnesemia type 2 |
700 | FXYD2 |
701 | Hypomagnesemia type 3 |
702 | CLDN16 |
703 | Hypomagnesemia type 4 |
704 | EGF |
705 | Hypomagnesemia type 5 |
706 | CLDN19 |
707 | Hypomagnesemia type 6 |
708 | CNNM2 |
709 | Hypophosphatasia, adult |
710 | ALPL |
711 | Hypophosphatasia, childhood |
712 | ALPL |
713 | Hypophosphatasia, infantile |
714 | ALPL |
715 | Hypophosphatemic rickets with hypercalciuria |
716 | SLC34A3 |
717 | Hypophosphatemic rickets, autosomal dominant |
718 | FGF23 |
719 | Hypouricemia, renal type 1 |
720 | SLC22A12 |
721 | Hypouricemia, renal type 2 |
722 | SLC2A9 |
723 | Insulin-like growth factor resistance |
724 | IGF1R |
725 | Isobutyryl-CoA dehydrogenase deficiency |
726 | ACAD8 |
727 | Isovaleric acidemia |
728 | IVD |
729 | Krabbe disease |
730 | GALC |
731 | Krabbe disease, atypical |
732 | PSAP |
733 | L-2-hydroxyglutaric aciduria |
734 | L2HGDH |
735 | Lactase deficiency, congenital |
736 | LCT |
737 | Lactate dehydrogenase-B deficiency |
738 | LDHB |
739 | Lacticacidemia due to PDX1 deficiency |
740 | PDHX |
741 | Lactose intolerance, adult type |
742 | MCM6 |
743 | LCAD deficiency |
744 | ACADL |
745 | LCAT DEFICIENCY |
746 | LCAT |
747 | Leukocyte adhesion deficiency |
748 | ITGB1 |
749 | Leukocyte adhesion deficiency |
750 | ITGB2 |
751 | Lipodystrophy generalized type 1 |
752 | AGPAT2 |
753 | Lipodystrophy generalized type 2 |
754 | BSCL2 |
755 | Lipodystrophy generalized type 4 |
756 | CAVIN1 |
757 | Lipodystrophy type 2, familial partial |
758 | LMNA |
759 | Lipodystrophy, familial partial, type 3 |
760 | PPARG |
761 | Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
762 | HADHA |
763 | LPA deficiency, congenital |
764 | LPA |
765 | Lung alpha-beta hydrolase deficiency type 1 |
766 | ABHD1 |
767 | Lysosomal acid phosphatase deficiency |
768 | ACP2 |
769 | Malonyl-CoA decarboxylase deficiency |
770 | MLYCD |
771 | Mannose-binding protein deficiency |
772 | MBL2 |
773 | Mannosidosis, beta A, lysosomal-like |
774 | MANBAL |
775 | Mannosidosis-alpha |
776 | MAN2B1 |
777 | Mannosidosis-beta |
778 | MANBA |
779 | Maple syrup urine disease type 1a |
780 | BCKDHA |
781 | Maple syrup urine disease type 1b |
782 | BCKDHB |
783 | Maple syrup urine disease type 2 |
784 | DBT |
785 | Maple syrup urine disease type 3 |
786 | DLD |
787 | Maple syrup urine disease, mild variant |
788 | PPM1K |
789 | Maturity-onset diabetes of the young type 1 |
790 | HNF4A |
791 | Maturity-onset diabetes of the young type 10 |
792 | INS |
793 | Maturity-onset diabetes of the young type 11 |
794 | BLK |
795 | Maturity-onset diabetes of the young type 2 |
796 | GCK |
797 | Maturity-onset diabetes of the young type 3 |
798 | HNF1A |
799 | Maturity-onset diabetes of the young type 4 |
800 | PDX1 |
801 | Maturity-onset diabetes of the young type 5 |
802 | HNF1B |
803 | Maturity-onset diabetes of the young type 6 |
804 | NEUROD1 |
805 | Maturity-onset diabetes of the young type 7 |
806 | KLF11 |
807 | Maturity-onset diabetes of the young type 8 |
808 | CEL |
809 | Maturity-onset diabetes of the young type 9 |
810 | PAX4 |
811 | Maturity-onset diabetes of the young, NKX2-2 related |
812 | NKX2-2 |
813 | Maturity-onset diabetes of the young, RFX6 related |
814 | RFX6 |
815 | Maturity-onset diabetes of the young, ZFP57 related |
816 | ZFP57 |
817 | Mediterranean fever |
818 | MEFV |
819 | MELAS syndrome, MT-TL1 related |
820 | MT-TL1 |
821 | Metachromatic Leukodystrophy |
822 | ARSA |
823 | Methylacetoacetic aciduria |
824 | ACAT1 |
825 | Methylcobalamin deficiency CblG type |
826 | MTR |
827 | Methylmalonate semialdehyde dehydrogenase deficiency |
828 | ALDH6A1 |
829 | Methylmalonic aciduria CblA type |
830 | MMAA |
831 | Methylmalonic aciduria CblB type |
832 | MMAB |
833 | Methylmalonic aciduria CblC type |
834 | MMACHC |
835 | Methylmalonic aciduria CblD type |
836 | MMADHC |
837 | Methylmalonic aciduria CblF type |
838 | LMBRD1 |
839 | Methylmalonic aciduria CblJ type |
840 | ABCD4 |
841 | Methylmalonic aciduria CblR type |
842 | CD320 |
843 | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency |
844 | MMUT |
845 | Methylmalonyl-CoA epimerase deficiency |
846 | MCEE |
847 | Mevalonic aciduria |
848 | MVK |
849 | Microvascular complications of diabetes type 1 |
850 | VEGFA |
851 | Microvascular complications of diabetes type 6, susceptibility to |
852 | SOD2 |
853 | Mirage syndrome |
854 | SAMD9 |
855 | Mitchell-Riley syndrome |
856 | RFX6 |
857 | Mitochondrial complex III deficiency, nuclear type 7 |
858 | UQCC2 |
859 | Mitochondrial phosphate carrier deficiency |
860 | SLC25A3 |
861 | Mitochondrial pyruvate carrier deficiency |
862 | MPC1 |
863 | Molybdenum cofactor deficiency type A |
864 | MOCS1 |
865 | Molybdenum cofactor deficiency type B |
866 | MOCS2 |
867 | Molybdenum cofactor deficiency type C |
868 | GPHN |
869 | Monocarboxylate transporter 1 deficiency |
870 | SLC16A1 |
871 | Mucolipidosis type 2 alpha/beta |
872 | GNPTAB |
873 | Mucolipidosis type 3 |
874 | GNPTAB |
875 | Mucolipidosis type 3 gamma |
876 | GNPTG |
877 | Mucolipidosis type 4 |
878 | MCOLN1 |
879 | Mucopolysaccharidosis type 1H |
880 | IDUA |
881 | Mucopolysaccharidosis type 2 |
882 | IDS |
883 | Mucopolysaccharidosis type 3A |
884 | SGSH |
885 | Mucopolysaccharidosis type 3B |
886 | NAGLU |
887 | Mucopolysaccharidosis type 3C |
888 | HGSNAT |
889 | Mucopolysaccharidosis type 3D |
890 | GNS |
891 | Mucopolysaccharidosis type 4A |
892 | GALNS |
893 | Mucopolysaccharidosis type 4B |
894 | GLB1 |
895 | Mucopolysaccharidosis type 6 |
896 | ARSB |
897 | Mucopolysaccharidosis type 7 |
898 | GUSB |
899 | Mucopolysaccharidosis type 9 |
900 | HYAL1 |
901 | Muscle glycogenosis |
902 | PHKA1 |
903 | Myopathy due to myoadenylate deaminase deficiency |
904 | AMPD1 |
905 | N-acetylglutamate synthase deficiency |
906 | NAGS |
907 | Neuraminidase deficiency |
908 | NEU1 |
909 | Niemann-Pick disease type A/B |
910 | SMPD1 |
911 | Niemann-Pick disease type C1 |
912 | NPC1 |
913 | Niemann-Pick disease type C2 |
914 | NPC2 |
915 | Odontohypophosphatasia |
916 | ALPL |
917 | Ornithine transcarbamoylase deficiency |
918 | OTC |
919 | Orotic aciduria |
920 | UMPS |
921 | Pancreatic agenesis type 2 |
922 | PTF1A |
923 | Pancreatic and cerebellar agenesis |
924 | PTF1A |
925 | Pentosuria |
926 | DCXR |
927 | Periodic fever autosomal dominant |
928 | TNFRSF1A |
929 | Phenylketonuria |
930 | PAH |
931 | Phenylketonuria modifier, SLC7A5 related |
932 | SLC7A5 |
933 | Phosphoenolpyruvate carboxykinase deficiency, cytosolic |
934 | PCK1 |
935 | Phosphoenolpyruvate carboxykinase deficiency, mitochondrial |
936 | PCK2 |
937 | Phosphoglycerate dehydrogenase deficiency |
938 | PHGDH |
939 | Phosphoribosylpyrophosphate synthetase superactivity |
940 | PRPS1 |
941 | Phosphoserine aminotransferase deficiency |
942 | PSAT1 |
943 | Phosphoserine phosphatase deficiency |
944 | PSPH |
945 | Pituitary stalk interruption syndrome, GPR161 related |
946 | GPR161 |
947 | Pompe disease |
948 | GAA |
949 | Porphyria acute intermittent |
950 | HMBS |
951 | Porphyria congenital erythropoietic |
952 | UROS |
953 | Porphyria variegata |
954 | PPOX |
955 | Prolidase deficiency |
956 | PEPD |
957 | Propionic acidemia |
958 | PCCA |
959 | Propionic acidemia |
960 | PCCB |
961 | Prosaposin deficiency |
962 | PSAP |
963 | Protoporphyria, erythropoietic, X-linked |
964 | ALAS2 |
965 | Pseudohermaphroditism with gynecomastia |
966 | HSD17B3 |
967 | Pyridoxamine 5'-phosphate oxidase deficiency |
968 | PNPO |
969 | Pyruvate carboxylase deficiency |
970 | PC |
971 | Pyruvate dehydrogenase E1-alpha deficiency |
972 | PDHA1 |
973 | Pyruvate dehydrogenase E1-beta deficiency |
974 | PDHB |
975 | Pyruvate dehydrogenase E2 deficiency |
976 | DLAT |
977 | Pyruvate dehydrogenase lipoic acid synthetase deficiency |
978 | LIAS |
979 | Pyruvate dehydrogenase phosphatase deficiency |
980 | PDP1 |
981 | Pyruvate kinase deficiency with hemolytic anemia |
982 | PKLR |
983 | Refsum disease |
984 | PEX7 |
985 | Refsum disease |
986 | PHYH |
987 | Riboflavin deficiency |
988 | SLC52A1 |
989 | Ribose 5-phosphate isomerase deficiency |
990 | RPIA |
991 | Rickets, vitamin D 25-hydroxylation-deficient, type 1B |
992 | CYP2R1 |
993 | Rickets, vitamin D dependent, type 1 |
994 | CYP27B1 |
995 | Saccharopinuria |
996 | AASS |
997 | Sandhoff disease |
998 | HEXB |
999 | Sarcosinemia |
1000 | SARDH |
1001 | Scheie syndrome |
1002 | IDUA |
1003 | Schindler disease |
1004 | NAGA |
1005 | Serine hydrolase deficiency, SERHL2 related |
1006 | SERHL2 |
1007 | Succinic semialdehyde dehydrogenase deficiency |
1008 | ALDH5A1 |
1009 | Succinyl CoA:3-oxoacid CoA transferase deficiency |
1010 | OXCT1 |
1011 | Sucrase-isomaltase deficiency |
1012 | SI |
1013 | Sulfatase deficiency |
1014 | SUMF1 |
1015 | Sulfite oxidase deficiency |
1016 | SUOX |
1017 | Surfactant metabolism dysfunction |
1018 | SFTPD |
1019 | Surfactant metabolism dysfunction type 1 |
1020 | SFTPB |
1021 | Surfactant metabolism dysfunction type 2 |
1022 | SFTPC |
1023 | Surfactant metabolism dysfunction type 3 |
1024 | ABCA3 |
1025 | Surfactant metabolism dysfunction type 4 |
1026 | CSF2RA |
1027 | Surfactant metabolism dysfunction type 5 |
1028 | CSF2RB |
1029 | Tangier disease |
1030 | ABCA1 |
1031 | Tay-Sachs disease |
1032 | HEXA |
1033 | Tay-Sachs disease AB variant |
1034 | GM2A |
1035 | Thiamine metabolism dysfunction syndrome type 5 |
1036 | TPK1 |
1037 | TJP1 deficiency |
1038 | TJP1 |
1039 | TPMT deficiency |
1040 | TPMT |
1041 | Transaldolase deficiency |
1042 | TALDO1 |
1043 | Transcobalamin II deficiency |
1044 | TCN2 |
1045 | Trifunctional protein deficiency |
1046 | HADHA |
1047 | Trimethylaminuria |
1048 | FMO3 |
1049 | Triosephosphate isomerase deficiency |
1050 | TPI1 |
1051 | Tumoral calcinosis, hyperphosphatemic, familial, type 1 |
1052 | GALNT3 |
1053 | Tyrosine kinase 2 deficiency |
1054 | TYK2 |
1055 | Tyrosinemia type 1 |
1056 | FAH |
1057 | Tyrosinemia type 1B |
1058 | GSTZ1 |
1059 | Tyrosinemia type 2 |
1060 | TAT |
1061 | Tyrosinemia type 3 |
1062 | HPD |
1063 | Urbach-Wiethe disease |
1064 | ECM1 |
1065 | Von-Gierke disease |
1066 | G6PC |
1067 | Wilson disease |
1068 | ATP7B |
1069 | Wolman disease |
1070 | LIPA |
1071 | Xanthinuria type 1 |
1072 | XDH |
1073 | Xanthinuria type 2 |
1074 | MOCOS |
No. | Description |
---|---|
1 | Angioedema, hereditary |
2 | SERPING1 |
3 | Antithrombin III deficiency |
4 | SERPINC1 |
5 | Aortic aneurysm, familial thoracic type 3 |
6 | TGFBR2 |
7 | Aortic aneurysm, familial thoracic type 4 |
8 | MYH11 |
9 | Aortic aneurysm, familial thoracic type 5 |
10 | TGFBR1 |
11 | Aortic aneurysm, familial thoracic type 6 |
12 | ACTA2 |
13 | Aortic aneurysm, familial thoracic type 7 |
14 | MYLK |
15 | Aortic aneurysm, familial thoracic type 8 |
16 | PRKG1 |
17 | Aortic aneurysm, familial thoracic, MAT2A related |
18 | MAT2A |
19 | Aortic valve disease type 1 |
20 | NOTCH1 |
21 | Aortic valve disease type 2 |
22 | SMAD6 |
23 | Arterial calcification type 1, generalized, infantile |
24 | ENPP1 |
25 | Arterial calcification type 2, generalized, infantile |
26 | ABCC6 |
27 | Arterial Tortuosity Syndrome |
28 | SLC2A10 |
29 | Atherosclerosis, SOAT1 related |
30 | SOAT1 |
31 | Bernard Soulier syndrome type A1 |
32 | GP1BA |
33 | Bernard Soulier syndrome type A2 |
34 | GP1BA |
35 | Bernard Soulier syndrome type B |
36 | GP1BB |
37 | Bernard Soulier syndrome type C |
38 | GP9 |
39 | CADASIL |
40 | NOTCH3 |
41 | Capillary malformation-arteriovenous malformation |
42 | RASA1 |
43 | CARASIL |
44 | HTRA1 |
45 | Carotid intimal medial thickness type 1 |
46 | PPARG |
47 | Cerebral cavernous malformations type 1 |
48 | KRIT1 |
49 | Cerebral cavernous malformations type 2 |
50 | CCM2 |
51 | Cerebral cavernous malformations type 3 |
52 | PDCD10 |
53 | Coarctation of the aorta |
54 | MCTP2 |
55 | Coronary artery disease in familial hypercholesterolemia, protection against |
56 | ABCA1 |
57 | Fabry disease |
58 | GLA |
59 | Factor II deficiency |
60 | F2 |
61 | Factor VII deficiency |
62 | F7 |
63 | Glycoprotein Ia C807T polymorphism |
64 | ITGA2 |
65 | Hemorrhagic destruction of the brain, subependymal calcification, and cataracts |
66 | JAM3 |
67 | Homocystinuria |
68 | MTHFR |
69 | Homocystinuria due to cystathionine beta-synthase deficiency |
70 | CBS |
71 | Homocystinuria-megaloblastic anemia, cbl E type |
72 | MTRR |
73 | Hypertension early onset |
74 | NR3C2 |
75 | Hypertension, ADD2 related |
76 | ADD2 |
77 | Hypertension, salt-sensitive essential, susceptibility to |
78 | CYP3A5 |
79 | Hypertension, susceptibility to |
80 | NOS2 |
81 | Loeys-Dietz syndrome type 4 |
82 | TGFB2 |
83 | Moyamoya disease type 2, susceptibility to |
84 | RNF213 |
85 | Moyamoya type 6 with achalasia |
86 | GUCY1A3 |
87 | Myoglobinuria acute recurrent |
88 | LPIN1 |
89 | Myopathy with lactic acidosis hereditary |
90 | ISCU |
91 | Orthostatic intolerance |
92 | SLC6A2 |
93 | Parkes Weber syndrome |
94 | RASA1 |
95 | Plasminogen activator inhibitor type 1 |
96 | SERPINE1 |
97 | Polyarteritis nodosa, childhood-onset |
98 | ADA2 |
99 | Protein C Deficiency, AD |
100 | PROC |
101 | Protein S Deficiency, autosomal dominant |
102 | PROS1 |
103 | Pseudohypoaldosteronism type 2D |
104 | KLHL3 |
105 | Pseudohypoaldosteronism type 2E |
106 | CUL3 |
107 | Pulmonary hypertension, primary type |
108 | BMPR2 |
109 | Pulmonary venoocclusive disease type 1 |
110 | BMPR2 |
111 | Sneddon syndrome |
112 | ADA2 |
113 | Stormorken syndrome |
114 | STIM1 |
115 | Supravalvar aortic stenosis |
116 | ELN |
117 | Thrombophilia due to thrombin defect |
118 | F2 |
119 | Transposition of the great arteries, dextro-looped 1 |
120 | MED13L |
121 | Vascular system defects due to CALCRL deficiency |
122 | CALCRL |
123 | Vascular system defects due to GNA13 deficiency |
124 | GNA13 |
No. | Description |
---|---|
1 | Achondrogenesis type 2 |
2 | COL2A1 |
3 | Acrodysostosis type 1, with or without hormone resistance |
4 | PRKAR1A |
5 | Acromelic frontonasal dysostosis |
6 | ZSWIM6 |
7 | Acromesomelic dysplasia, Maroteaux type |
8 | NPR2 |
9 | Acromicric dysplasia |
10 | FBN1 |
11 | Adams-Oliver syndrome type 6 |
12 | DLL4 |
13 | ADULT syndrome, split hand-foot malformation |
14 | TP63 |
15 | Alacrima, achalasia and mental retardation syndrome |
16 | GMPPA |
17 | Alagille syndrome type 1 |
18 | JAG1 |
19 | Alagille syndrome type 2 |
20 | NOTCH2 |
21 | Alazami syndrome |
22 | LARP7 |
23 | Alpha-thalassemia/mental retardation syndrome |
24 | ATRX |
25 | Ankyloblepharon-ectodermal defects-cleft lip/palate |
26 | TP63 |
27 | Anterior segment mesenchymal dysgenesis |
28 | PITX3 |
29 | Antley-Bixler syndrome |
30 | FGFR2 |
31 | Apert syndrome |
32 | FGFR2 |
33 | Athabaskan brainstem dysgenesis syndrome |
34 | HOXA1 |
35 | Atrial septal defect type 2 |
36 | GATA4 |
37 | Atrial septal defect with atrioventricular conduction defects |
38 | NKX2-5 |
39 | Atrioventricular septal defect, partial with heterotaxy syndrome |
40 | CRELD1 |
41 | Auriculocondylar syndrome type 1 |
42 | GNAI3 |
43 | Auriculocondylar syndrome type 2 |
44 | PLCB4 |
45 | Axenfeld-Rieger syndrome type 1 |
46 | PITX2 |
47 | Axenfeld-Rieger syndrome type 3 |
48 | FOXC1 |
49 | Bainbridge-Ropers syndrome |
50 | ASXL3 |
51 | Band-like calcification with simplified gyration and polymicrogyria |
52 | OCLN |
53 | Baraitser-Winter syndrome type 1 |
54 | ACTB |
55 | Baraitser-Winter syndrome type 2 |
56 | ACTG1 |
57 | Basal cell nevus syndrome |
58 | PTCH1 |
59 | Basal cell nevus syndrome |
60 | SUFU |
61 | Basal ganglia calcification type 1, ideopathic |
62 | SLC20A2 |
63 | Basal ganglia calcification type 4 |
64 | PDGFRB |
65 | Basal ganglia calcification type 5, idiopathic |
66 | PDGFB |
67 | Basal ganglia calcification type 6, idiopathic |
68 | XPR1 |
69 | Beta-ureidopropionase deficiency |
70 | UPB1 |
71 | Bifid nose |
72 | FREM1 |
73 | Birt-Hogg-Dube syndrome |
74 | FLCN |
75 | Bjornstad syndrome |
76 | BCS1L |
77 | Blau syndrome |
78 | NOD2 |
79 | Bohring-Opitz syndrome |
80 | ASXL1 |
81 | Bone marrow failure syndrome type 2 |
82 | ERCC6L2 |
83 | Brachydactyly type A1C |
84 | GDF5 |
85 | Brachydactyly type A2 |
86 | BMP2 |
87 | Brachydactyly type A2 |
88 | BMPR1B |
89 | Brachydactyly type B1 |
90 | ROR2 |
91 | Brachydactyly type E1 |
92 | HOXD13 |
93 | Brachydactyly-mental retardation syndrome |
94 | HDAC4 |
95 | Brachydactyly-syndactyly syndrome |
96 | HOXD13 |
97 | Branchiooculofacial syndrome |
98 | TFAP2A |
99 | C syndrome |
100 | CD96 |
101 | Campomelic dysplasia |
102 | SOX9 |
103 | Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
104 | PRG4 |
105 | Camurati-Engelmann disease |
106 | TGFB1 |
107 | Cantu syndrome |
108 | ABCC9 |
109 | Carpenter syndrome |
110 | RAB23 |
111 | Carpenter syndrome type 2 |
112 | MEGF8 |
113 | Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia |
114 | IARS2 |
115 | Caudal regression syndrome |
116 | VANGL1 |
117 | Central hypoventilation syndrome with or without Hirschsprung disease |
118 | PHOX2B |
119 | Central hypoventilation syndrome, congenital |
120 | ASCL1 |
121 | Central hypoventilation syndrome, congenital |
122 | BDNF |
123 | Central hypoventilation syndrome, congenital |
124 | ECE1 |
125 | Central hypoventilation syndrome, congenital |
126 | EDN3 |
127 | Central hypoventilation syndrome, congenital |
128 | GDNF |
129 | Central hypoventilation syndrome, congenital |
130 | GFRA1 |
131 | Central hypoventilation syndrome, congenital |
132 | MECP2 |
133 | Central hypoventilation syndrome, congenital |
134 | PHOX2A |
135 | Central hypoventilation syndrome, congenital |
136 | RET |
137 | Central hypoventilation syndrome, congenital |
138 | ZEB2 |
139 | Cerebral dysgenesis, neuropathy, ichthyosis, palmoplantar keratoderma syndrome |
140 | SNAP29 |
141 | Cerebrooculofacioskeletal syndrome type 1 |
142 | ERCC6 |
143 | Cerebrooculofacioskeletal syndrome type 4 |
144 | ERCC1 |
145 | Char syndrome |
146 | TFAP2B |
147 | CHARGE syndrome |
148 | CHD7 |
149 | CHIME syndrome |
150 | PIGL |
151 | Chondrodysplasia with joint dislocations, GPAPP type |
152 | IMPAD1 |
153 | Chondrodysplasia, Blomstrand type |
154 | PTH1R |
155 | Choroideremia |
156 | CHM |
157 | Chrondrodysplasia, acromesomelic, with genital anomalies |
158 | BMPR1B |
159 | Chudley-McCullough syndrome |
160 | GPSM2 |
161 | Cleft palate, cardiac defects, and mental retardation |
162 | MEIS2 |
163 | Club foot |
164 | PITX1 |
165 | Cockayne syndrome type A |
166 | ERCC8 |
167 | Cockayne syndrome type B |
168 | ERCC6 |
169 | CODAS syndrome |
170 | LONP1 |
171 | Coffin-Siris syndrome, SMARCE1 related |
172 | SMARCE1 |
173 | Cold-induced sweating syndrome |
174 | CRLF1 |
175 | Cold-induced sweating syndrome type 2 |
176 | CLCF1 |
177 | Congenital heart defects and ectodermal dysplasia |
178 | PRKD1 |
179 | Congenital heart disease and transposition of the great arteries |
180 | FOXH1 |
181 | Congenital short-bowel syndrome |
182 | CLMP |
183 | Corpus callosum, agenesis of, with abnormal genitalia |
184 | ARX |
185 | Cortical malformations, occipital |
186 | LAMC3 |
187 | Costello syndrome |
188 | HRAS |
189 | Cousin syndrome |
190 | TBX15 |
191 | Craniodiaphyseal dysplasia, autosomal dominant |
192 | SOST |
193 | Cranioectodermal dysplasia type 1 |
194 | IFT122 |
195 | Cranioectodermal dysplasia type 2 |
196 | WDR35 |
197 | Cranioectodermal dysplasia type 3 |
198 | IFT43 |
199 | Cranioectodermal dysplasia type 4 |
200 | WDR19 |
201 | Craniofacial and neuro-developmental abnormalities |
202 | DISP1 |
203 | Craniofacial and neuro-developmental abnormalities, JAG2 related |
204 | JAG2 |
205 | Craniofacial anomalies and anterior segment dysgenesis syndrome |
206 | VSX1 |
207 | Craniofrontonasal syndrome |
208 | EFNB1 |
209 | Craniometaphyseal dysplasia |
210 | ANKH |
211 | Craniosynostosis and dental anomalies |
212 | IL11RA |
213 | Craniosynostosis type 1 |
214 | TWIST1 |
215 | Craniosynostosis type 2 |
216 | MSX2 |
217 | Craniosynostosis type 3 |
218 | TCF12 |
219 | Craniosynostosis type 4 |
220 | ERF |
221 | Craniosynostosis type 6 |
222 | ZIC1 |
223 | Craniosynostosis, FGFR1 related |
224 | FGFR1 |
225 | Craniosynostosis, nonspecific |
226 | FGFR2 |
227 | Crouzon syndrome |
228 | FGFR2 |
229 | Currarino syndrome |
230 | MNX1 |
231 | Czech dysplasia |
232 | COL2A1 |
233 | D-bifunctional protein deficiency |
234 | HSD17B4 |
235 | Dandy-Walker malformation and occipital cephaloceles, LAMC1 related |
236 | LAMC1 |
237 | De Sanctis-Cacchione syndrome |
238 | ERCC6 |
239 | Desanto-Shinawi syndrome |
240 | WAC |
241 | Desbuquois dysplasia type 1 |
242 | CANT1 |
243 | Desbuquois dysplasia type 2 |
244 | XYLT1 |
245 | Desmosterolosis |
246 | DHCR24 |
247 | Diamond Blackfan anemia type 15 with mandibulofacial dysostosis |
248 | RPS28 |
249 | Diamond-Blackfan anemia type 14 with mandibulofacial dysostosis |
250 | TSR2 |
251 | DiGeorge syndrome |
252 | TBX1 |
253 | Donnai-Barrow syndrome |
254 | LRP2 |
255 | DOOR syndrome |
256 | TBC1D24 |
257 | Duane Retraction syndrome |
258 | SALL4 |
259 | Dysmorphism, HMG20B related |
260 | HMG20B |
261 | Ectodactyly, ectodermal dysplasia, and cleft lip/palate syndrome type 3 |
262 | TP63 |
263 | Ellis-van Creveld syndrome |
264 | EVC |
265 | Ellis-van Creveld syndrome |
266 | EVC2 |
267 | Epiphyseal dysplasia, multiple, with myopia and deafness |
268 | COL2A1 |
269 | Faciogenital dysplasia |
270 | FGD1 |
271 | Fanconi anemia, complementation group Q |
272 | ERCC4 |
273 | Feingold syndrome |
274 | MYCN |
275 | Fetal akinesia deformation sequence |
276 | DOK7 |
277 | Fetal akinesia deformation sequence |
278 | RAPSN |
279 | Fibrochondrogenesis type 1 |
280 | COL11A1 |
281 | Fibular aplasia or hypoplasia, femoral bowing and poly-, syn-, and oligodactyly |
282 | WNT7A |
283 | FILS syndrome |
284 | POLE |
285 | Fraser syndrome |
286 | FRAS1 |
287 | Fraser syndrome |
288 | FREM2 |
289 | Fraser syndrome |
290 | GRIP1 |
291 | Frontonasal dysplasia type 1 |
292 | ALX3 |
293 | Frontonasal dysplasia type 2 |
294 | ALX4 |
295 | Fumarase deficiency |
296 | FH |
297 | Galloway-Mowat syndrome |
298 | WDR73 |
299 | Geleophysic dysplasia type 2 |
300 | FBN1 |
301 | Genitopatellar syndrome |
302 | KAT6B |
303 | Glass syndrome |
304 | SATB2 |
305 | Goldberg-Shprintzen megacolon syndrome |
306 | KIF1BP |
307 | GRACILE syndrome |
308 | BCS1L |
309 | Greenberg skeletal dysplasia |
310 | LBR |
311 | Greig cephalopolysyndactyly syndrome |
312 | GLI3 |
313 | Growth hormone insensitivity, partial |
314 | GHR |
315 | Growth retardation with deafness and mental retardation due to IGF1 deficiency |
316 | IGF1 |
317 | Growth retardation, developmental delay, facial dysmorphism |
318 | FTO |
319 | Guttmacher syndrome |
320 | HOXA13 |
321 | Hamamy syndrome |
322 | IRX5 |
323 | Hand-foot-uterus syndrome |
324 | HOXA13 |
325 | Hartsfield syndrome |
326 | FGFR1 |
327 | Heart-hand syndrome, Slovenian type |
328 | LMNA |
329 | Helsmoortel-van der Aa syndrome |
330 | ADNP |
331 | Hennekam lymphangiectasia-lymphedema syndrome type 2 |
332 | FAT4 |
333 | Heterotaxy, visceral type 1 |
334 | ZIC3 |
335 | Heterotaxy, visceral type 2 |
336 | CFC1 |
337 | Heterotaxy, visceral type 4 |
338 | ACVR2B |
339 | Heterotaxy, visceral type 5 |
340 | NODAL |
341 | Heterotaxy, visceral type 6 |
342 | CFAP53 |
343 | Heterotaxy, visceral type 7 |
344 | MMP21 |
345 | Heterotaxy, visceral type 8, autosomal |
346 | PKD1L1 |
347 | Heterotaxy, visceral, BCL9L related |
348 | BCL9L |
349 | Hirschsprung disease |
350 | ECE1 |
351 | Hirschsprung disease |
352 | EDN3 |
353 | Hirschsprung disease |
354 | EDNRB |
355 | Hirschsprung disease |
356 | KIF1BP |
357 | Hirschsprung disease |
358 | NRG1 |
359 | Hirschsprung disease |
360 | NRTN |
361 | Hirschsprung disease |
362 | RET |
363 | Hirschsprung disease |
364 | ZEB2 |
365 | Hirschsprung disease, type 3, susceptibility to |
366 | GDNF |
367 | Holoprosencephaly type 11 |
368 | CDON |
369 | Holoprosencephaly type 2 |
370 | SIX3 |
371 | Holoprosencephaly type 3 |
372 | SHH |
373 | Holoprosencephaly type 4 |
374 | TGIF1 |
375 | Holoprosencephaly type 5 |
376 | ZIC2 |
377 | Holoprosencephaly-type 9 |
378 | GLI2 |
379 | Holt-Oram syndrome |
380 | TBX5 |
381 | Hutchinson-Gilford progeria |
382 | LMNA |
383 | Hydranencephaly, Fowler type |
384 | FLVCR2 |
385 | Hydrolethalus syndrome |
386 | HYLS1 |
387 | Hypermethioninemia due to adenosine kinase deficiency |
388 | ADK |
389 | Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase |
390 | AHCY |
391 | Hyperphosphatasia with mental retardation syndrome type 1 |
392 | PIGV |
393 | Hyperphosphatasia with mental retardation syndrome type 2 |
394 | PIGO |
395 | Hyperphosphatasia with mental retardation syndrome type 3 |
396 | PGAP2 |
397 | Hyperphosphatasia with mental retardation syndrome type 4 |
398 | PGAP3 |
399 | Hyperphosphatasia with mental retardation syndrome type 5 |
400 | PIGW |
401 | Hypogonadism, alopecia, Diabetes mellitus, mental retardation and extrapyramidal syndrome |
402 | DCAF17 |
403 | Hypogonadotropic hypogonadism type 6 with or without anosmia |
404 | FGF8 |
405 | Hypospadias type 1, X-linked |
406 | AR |
407 | Hypospadias type 2, X-linked |
408 | MAMLD1 |
409 | IMAGE syndrome |
410 | CDKN1C |
411 | Immunodeficiency-centromeric instability-facial anomalies syndrome type 2 |
412 | ZBTB24 |
413 | Intestinal atresia, multiple |
414 | TTC7A |
415 | IVIC syndrome |
416 | SALL4 |
417 | Jackson-Weiss syndrome |
418 | FGFR1 |
419 | Jackson-Weiss syndrome |
420 | FGFR2 |
421 | Jawad syndrome |
422 | RBBP8 |
423 | Kabuki syndrome type 1 |
424 | KMT2D |
425 | Kabuki syndrome type 2 |
426 | KDM6A |
427 | Kagami-Ogata syndrome |
428 | paternal UPD chr. 14 |
429 | Kallmann syndrome type 2 |
430 | FGFR1 |
431 | Kallmann syndrome type 4 |
432 | PROK2 |
433 | Kallmann syndrome type 5 |
434 | CHD7 |
435 | KBG syndrome |
436 | ANKRD11 |
437 | Keutel syndrome |
438 | MGP |
439 | Kleefstra syndrome |
440 | EHMT1 |
441 | Klippel-Feil syndrome type 1, autosomal dominant |
442 | GDF6 |
443 | Klippel-Feil syndrome type 2, autosomal dominant |
444 | MEOX1 |
445 | Klippel-Feil syndrome type 3, autosomal dominant |
446 | GDF3 |
447 | Klippel-Feil syndrome type 4, autosomal dominant, with myopathy and facial dysmorphism |
448 | MYO18B |
449 | Kniest dysplasia |
450 | COL2A1 |
451 | Koolen syndrome |
452 | KANSL1 |
453 | LADD syndrome |
454 | FGF10 |
455 | LADD syndrome |
456 | FGFR2 |
457 | Langer-Giedion syndrome |
458 | EXT1 |
459 | Langer-Giedion syndrome |
460 | TRPS1 |
461 | Larsen syndrome |
462 | FLNB |
463 | Left-right axis malformations |
464 | LEFTY2 |
465 | Legionnaire disease, susceptibility to |
466 | TLR5 |
467 | Lenz-Majewski hyperostotic dwarfism |
468 | PTDSS1 |
469 | LEOPARD syndrome type 3 |
470 | BRAF |
471 | Lethal congenital contracture syndrome type 1 |
472 | GLE1 |
473 | Lethal congenital contracture syndrome type 4 |
474 | MYBPC1 |
475 | Limb-mammary syndrome |
476 | TP63 |
477 | Lissencephaly type 1 |
478 | PAFAH1B1 |
479 | Lissencephaly type 2 (Norman-Roberts type) |
480 | RELN |
481 | Lissencephaly type 3 |
482 | TUBA1A |
483 | Lissencephaly type 5 |
484 | LAMB1 |
485 | Lissencephaly, X-linked type 1 |
486 | DCX |
487 | Lissencephaly, X-linked type 2 |
488 | ARX |
489 | Lujan-Fryns syndrome |
490 | MED12 |
491 | Lymphedema-distichiasis syndrome |
492 | FOXC2 |
493 | Macrocephaly, alopecia, cutis laxa, and scoliosis |
494 | RIN2 |
495 | Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome |
496 | POLD1 |
497 | Mandibuloacral dysplasia |
498 | LMNA |
499 | Mandibulofacial dysostosis with microcephaly |
500 | EFTUD2 |
501 | Marden-Walker syndrome |
502 | PIEZO2 |
503 | Marfan lipodystrophy syndrome |
504 | FBN1 |
505 | Marfan syndrome |
506 | FBN1 |
507 | Martsolf syndrome |
508 | RAB3GAP2 |
509 | MASS syndrome |
510 | FBN1 |
511 | McLeod syndrome with or without chronic granulomatous disease |
512 | XK |
513 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome |
514 | PIK3R2 |
515 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 |
516 | AKT3 |
517 | Meier-Gorlin syndrome type 1 |
518 | ORC1 |
519 | Meier-Gorlin syndrome type 2 |
520 | ORC4 |
521 | Meier-Gorlin syndrome type 4 |
522 | CDT1 |
523 | Mental retardation and distinctive facial features with or without cardiac defects |
524 | MED13L |
525 | Mental retardation, autosomal dominant type 13 |
526 | DYNC1H1 |
527 | Mental retardation, truncal obesity, retinal dystrophy, and micropenis |
528 | INPP5E |
529 | Mental retardation, X-linked syndromic, Turner type |
530 | HUWE1 |
531 | Metaphyseal anadysplasia type 1 |
532 | MMP13 |
533 | Metaphyseal anadysplasia type 2 |
534 | MMP9 |
535 | Microcephalic osteodysplastic primordial dwarfism type 2 |
536 | PCNT |
537 | Microcephaly and chorioretinopathy with or without mental retardation |
538 | TUBGCP6 |
539 | Microcephaly with cortical malformations, autosomal recessive type 2 |
540 | WDR62 |
541 | Microcephaly with epilepsy and diabetes syndrome |
542 | IER3IP1 |
543 | Microcephaly with or without chorioretinopathy, Lymphedema, or Mental retardation, MCLMR |
544 | KIF11 |
545 | Microcephaly with symplified gyral pattern and insulin-dependant diabetes |
546 | GFM2 |
547 | Microcephaly, Amish type |
548 | SLC25A19 |
549 | Microcephaly, AP4M1 related |
550 | AP4M1 |
551 | Microcephaly, autosomal recessive type 1 |
552 | MCPH1 |
553 | Microcephaly, autosomal recessive type 11 |
554 | PHC1 |
555 | Microcephaly, autosomal recessive type 12 |
556 | CDK6 |
557 | Microcephaly, autosomal recessive type 13 |
558 | CENPE |
559 | Microcephaly, autosomal recessive type 3 |
560 | CDK5RAP2 |
561 | Microcephaly, autosomal recessive type 4 |
562 | KNL1 |
563 | Microcephaly, autosomal recessive type 5 |
564 | ASPM |
565 | Microcephaly, autosomal recessive type 6 |
566 | CENPJ |
567 | Microcephaly, autosomal recessive type 7 |
568 | STIL |
569 | Microcephaly, autosomal recessive type 8 |
570 | CEP135 |
571 | Microcephaly, autosomal recessive type 9 |
572 | CEP152 |
573 | Microcephaly, CEP63 related |
574 | CEP63 |
575 | Microcephaly, MRE11A related |
576 | MRE11 |
577 | Microcephaly, MSMO1 related |
578 | MSMO1 |
579 | Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy |
580 | QARS1 |
581 | Microcephaly, short stature, and polymicrogyria with seizures |
582 | RTTN |
583 | Microcephaly, TUBB2B related |
584 | TUBB2B |
585 | Miller Dieker lissencephaly syndrome |
586 | YWHAE |
587 | Mitochondrial complex III deficiency, nuclear type 7 |
588 | UQCC2 |
589 | Mitochondrial myopathy and sideroblastic anemia type 1 |
590 | PUS1 |
591 | Mosaic variegated aneuploidy syndrome type 2 |
592 | CEP57 |
593 | Mulibrey nanism |
594 | TRIM37 |
595 | Multiple congenital anomalies-hypotonia-seizures syndrome type 1 |
596 | PIGN |
597 | Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects |
598 | B3GAT3 |
599 | Myhre syndrome |
600 | SMAD4 |
601 | Native American myopathy |
602 | STAC3 |
603 | Neuroaxonal neurodegeneration, infantile, with facial dysmophism |
604 | NALCN |
605 | Neuroblastoma type 3, susceptibility to, familial |
606 | ALK |
607 | Nicolaides Baraitser syndrome |
608 | SMARCA2 |
609 | Nijmegen breakage syndrome |
610 | NBN |
611 | Noonan syndrom like |
612 | SHOC2 |
613 | Noonan syndrome type 1 |
614 | PTPN11 |
615 | Noonan syndrome type 10 |
616 | LZTR1 |
617 | Noonan syndrome type 3 |
618 | KRAS |
619 | Noonan syndrome type 4 |
620 | SOS1 |
621 | Noonan syndrome type 5 |
622 | RAF1 |
623 | Noonan syndrome type 6 |
624 | NRAS |
625 | Noonan syndrome type 7 |
626 | BRAF |
627 | Noonan syndrome type 8 |
628 | RIT1 |
629 | Noonan syndrome-like disorder with or without juvenile meylomonocytic leukemia |
630 | CBL |
631 | Oculodentodigital dysplasia |
632 | GJA1 |
633 | Ogden syndrome |
634 | NAA10 |
635 | Olmsted syndrome |
636 | TRPV3 |
637 | Opitz-Kaveggia syndrome |
638 | MED12 |
639 | Orofacial cleft type 10 |
640 | SUMO1 |
641 | Orofacial cleft type 11 |
642 | BMP4 |
643 | Orofacial cleft type 5 |
644 | MSX1 |
645 | Orofacial cleft type 6 |
646 | IRF6 |
647 | Orofacial cleft type 7 |
648 | NECTIN1 |
649 | Orofaciodigital syndrome type 14 |
650 | C2CD3 |
651 | Orofaciodigital syndrome type 4 |
652 | TCTN3 |
653 | Orofaciodigital syndrome type 5 |
654 | DDX59 |
655 | Orofaciodigital syndrome type 6 |
656 | CPLANE1 |
657 | Osteoglophonic dysplasia |
658 | FGFR1 |
659 | Otofaciocervical syndrome |
660 | EYA1 |
661 | Otospondylomegaepiphyseal dysplasia |
662 | COL11A2 |
663 | Otospondylomegaepiphyseal dysplasia |
664 | COL2A1 |
665 | Pallister-Hall syndrome |
666 | GLI3 |
667 | Papillorenal syndrome |
668 | PAX2 |
669 | Parietal foramina type 1 |
670 | MSX2 |
671 | Pelger-Huet anomaly |
672 | LBR |
673 | Pelvic organ prolapse, LAMC1 related |
674 | LAMC1 |
675 | Perlman Syndrome |
676 | DIS3L2 |
677 | Pfeiffer syndrome |
678 | FGFR1 |
679 | Pfeiffer syndrome |
680 | FGFR2 |
681 | Phelan-McDermid syndrome |
682 | chr. 22q13.3 |
683 | Pitt-Hopkins syndrome |
684 | NRXN1 |
685 | Pitt-Hopkins syndrome |
686 | TCF4 |
687 | Pituitary hormone deficiency type 1 |
688 | POU1F1 |
689 | Pituitary hormone deficiency type 2 |
690 | PROP1 |
691 | Platyspondylic skeletal dysplasia, Torrance type |
692 | COL2A1 |
693 | Polyhydramnios, megalencephaly, and symptomatic epilepsy |
694 | STRADA |
695 | Polymicrogyria asymmetric |
696 | TUBB2B |
697 | Polymicrogyria bilateral frontoparietal |
698 | ADGRG1 |
699 | Polymicrogyria bilateral occipital |
700 | NR2E1 |
701 | Polymicrogyria with optic nerve hypoplasia |
702 | TUBA8 |
703 | Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis |
704 | PI4KA |
705 | Popliteal pterygium syndrome type 1 |
706 | IRF6 |
707 | Popliteal pterygium syndrome, lethal type |
708 | RIPK4 |
709 | Porencephaly, familial |
710 | COL4A1 |
711 | Poretti-Boltshauser syndrome |
712 | LAMA1 |
713 | Postaxial acrofacial dysostosis |
714 | DHODH |
715 | Prolidase deficiency |
716 | PEPD |
717 | Prune belly syndrome |
718 | CHRM3 |
719 | Rapp-Hodgkin syndrome |
720 | TP63 |
721 | Retinal dystrophy, juvenile cataracts, and short stature syndrome |
722 | RDH11 |
723 | Rett syndrome |
724 | MECP2 |
725 | Rett syndrome, congenital variant |
726 | FOXG1 |
727 | Rhizomelic chondrodysplasia punctata type 2 |
728 | GNPAT |
729 | Rhizomelic chondrodysplasia punctata type 3 |
730 | AGPS |
731 | Rhizomelic chondrodysplasia punctata type 5 |
732 | PEX5 |
733 | Ritscher-Schinzel syndrome type 1 |
734 | WASHC5 |
735 | RNA processing related disorders |
736 | HNRNPU |
737 | Roberts syndrome |
738 | ESCO2 |
739 | Robinow syndrome, autosomal dominant type 1 |
740 | WNT5A |
741 | Robinow syndrome, autosomal dominant type 2 |
742 | DVL1 |
743 | Robinow syndrome, autosomal recessive |
744 | ROR2 |
745 | Robinow-Sorauf syndrome |
746 | TWIST1 |
747 | Rubinstein-Taybi syndrome |
748 | CREBBP |
749 | Rubinstein-Taybi syndrome |
750 | EP300 |
751 | Saethre-Chotzen syndrome |
752 | FGFR2 |
753 | Saethre-Chotzen syndrome |
754 | TWIST1 |
755 | SC Phocomelia syndrome |
756 | ESCO2 |
757 | Scaphocephaly, maxillary retrusion, and mental retardation |
758 | FGFR2 |
759 | Schaaf-Yang syndrome |
760 | MAGEL2 |
761 | Schinzel-Giedion midface retraction syndrome |
762 | SETBP1 |
763 | Schizencephaly |
764 | EMX2 |
765 | Schneckenbecken dysplasia |
766 | SLC35D1 |
767 | Sclerosteosis type 1 |
768 | SOST |
769 | Seckel syndrome |
770 | ATRIP |
771 | Seckel syndrome type 1 |
772 | ATR |
773 | Seckel syndrome type 2 |
774 | RBBP8 |
775 | Seckel syndrome type 4 |
776 | CENPJ |
777 | Seckel syndrome type 5 |
778 | CEP152 |
779 | Seckel syndrome type 6 |
780 | CEP63 |
781 | Seckel syndrome type 7 |
782 | NIN |
783 | SED congenita |
784 | COL2A1 |
785 | Seizures, scoliosis, and macrocephaly syndrome |
786 | EXT2 |
787 | Septooptic dysplasia |
788 | HESX1 |
789 | SERKAL syndrome |
790 | WNT4 |
791 | Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation |
792 | NHEJ1 |
793 | Short stature syndrome |
794 | SHOX |
795 | Short stature, microcephaly, and endocrine dysfunction |
796 | XRCC4 |
797 | Short stature, optic nerve atrophy, and Pelger-Huet anomaly |
798 | NBAS |
799 | SHORT syndrome |
800 | PIK3R1 |
801 | Short-rib thoracic dysplasia type 10 with or without polydactyly |
802 | IFT172 |
803 | Short-rib thoracic dysplasia type 11 with or without polydactyly |
804 | WDR34 |
805 | Short-rib thoracic dysplasia type 2 with or without polydactyly |
806 | IFT80 |
807 | Short-rib thoracic dysplasia type 3 with or without polydactyly |
808 | DYNC2H1 |
809 | Short-rib thoracic dysplasia type 4 with or without polydactyly |
810 | TTC21B |
811 | Short-rib thoracic dysplasia type 5 with or without polydactyly |
812 | WDR19 |
813 | Short-rib thoracic dysplasia type 6 with or without polydactyly |
814 | NEK1 |
815 | Short-rib thoracic dysplasia type 7 with or without polydactyly |
816 | WDR35 |
817 | Short-rib thoracic dysplasia type 8 with or without polydactyly |
818 | WDR60 |
819 | Shprintzen-Goldberg syndrome |
820 | SKI |
821 | Silver-Russell syndrome |
822 | chr. 11p15 |
823 | Silver-Russell syndrome |
824 | maternal UPD chr. 7 |
825 | Skeletal abnormalities, CBFB related |
826 | CBFB |
827 | Skeletal defects, genital hypoplasia, and mental retardation |
828 | ZBTB16 |
829 | SMED Strudwick type |
830 | COL2A1 |
831 | Smith-Lemli-Opitz syndrome |
832 | DHCR7 |
833 | Sotos syndrome type 1 |
834 | NSD1 |
835 | Sotos-like syndrome |
836 | NFIX |
837 | Speech-language disorder type 1 |
838 | FOXP2 |
839 | Spina bifida folate sensitive |
840 | MTRR |
841 | Split-hand/foot malformation type 1 with sensorineural hearing loss |
842 | DLX5 |
843 | Split-hand/foot malformation type 6 |
844 | WNT10B |
845 | Spondylo-megaepiphyseal-metaphyseal dysplasia |
846 | NKX3-2 |
847 | Spondylocostal dysostosis type 5 |
848 | TBX6 |
849 | Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures |
850 | B3GALT6 |
851 | Spondyloperipheral dysplasia |
852 | COL2A1 |
853 | Stiff skin syndrome |
854 | FBN1 |
855 | Stuve-Wiedemann syndrome |
856 | LIFR |
857 | Syndactyly type 1 |
858 | HOXD13 |
859 | Syndactyly type 5 |
860 | HOXD13 |
861 | Syndactyly, mesoaxial synostotic, with phalangeal reduction |
862 | BHLHA9 |
863 | TANC2 related brain disorders |
864 | TANC2 |
865 | Tarp syndrome |
866 | RBM10 |
867 | Temple syndrome |
868 | maternal UPD chr. 14 |
869 | Temple-Baraitser syndrome |
870 | KCNH1 |
871 | Temtamy preaxial brachydactyly syndrome |
872 | CHSY1 |
873 | Temtamy syndrome |
874 | C12orf57 |
875 | Tetraamelia, autosomal recessive |
876 | WNT3 |
877 | Three M syndrome type 1 |
878 | CUL7 |
879 | Three M syndrome type 2 |
880 | OBSL1 |
881 | Three M syndrome type 3 |
882 | CCDC8 |
883 | Toe syndactyly, telecanthus, and anogenital and renal malformations |
884 | FAM58A |
885 | Tooth agenesis, selective type 1 |
886 | MSX1 |
887 | Tooth agenesis, selective type 3 |
888 | PAX9 |
889 | Townes-Brocks syndrome |
890 | SALL1 |
891 | Transposition of great arteries, dextro-looped 3 |
892 | GDF1 |
893 | Transposition of the great arteries, dextro-looped 1 |
894 | MED13L |
895 | Treacher Collins syndrome type 1 |
896 | TCOF1 |
897 | Treacher Collins syndrome type 2 |
898 | POLR1D |
899 | Treacher Collins syndrome type 3 |
900 | POLR1C |
901 | Trigonocephaly type 1 |
902 | FGFR1 |
903 | Ulna and fibula, absence of, with severe limb deficiency |
904 | WNT7A |
905 | Ulnar-Mammary syndrome |
906 | TBX3 |
907 | Urofacial syndrome |
908 | LRIG2 |
909 | Urofacial syndrome type 1 |
910 | HPSE2 |
911 | Van den Ende-Gupta syndrome |
912 | SCARF2 |
913 | van der Woude syndrome type 1 |
914 | IRF6 |
915 | van der Woude syndrome type 2 |
916 | GRHL3 |
917 | Van Maldergem syndrome type 2 |
918 | FAT4 |
919 | Vater association |
920 | HOXD13 |
921 | Vici syndrome |
922 | EPG5 |
923 | Visceral myopathy |
924 | ACTG2 |
925 | Warburg micro syndrome type 1 |
926 | RAB3GAP1 |
927 | Warburg micro syndrome type 2 |
928 | RAB3GAP2 |
929 | Warsaw breakage syndrome |
930 | DDX11 |
931 | Weaver syndrome |
932 | EZH2 |
933 | Webb-Dattani syndrome |
934 | ARNT2 |
935 | Weill-Marchesani syndrome type 3 |
936 | LTBP2 |
937 | Weill-Marchesani syndrome, dominant type 2 |
938 | FBN1 |
939 | Werner syndrome |
940 | WRN |
941 | Wiedemann-Steiner syndrome |
942 | KMT2A |
943 | Williams-Beuren syndrome |
944 | chr. 7q11.23 |
945 | Witkop syndrome |
946 | MSX1 |
947 | XFE progeroid syndrome |
948 | ERCC4 |
949 | ZIC5 related brain disorders |
950 | ZIC5 |
No. | Description |
---|---|
1 | 3MC syndrome type 1 |
2 | MASP1 |
3 | 3MC syndrome type 2 |
4 | COLEC11 |
5 | Achondrogenesis type 1A |
6 | TRIP11 |
7 | Achondrogenesis type 1B |
8 | SLC26A2 |
9 | Achondrogenesis type 2 |
10 | COL2A1 |
11 | Achondroplasia |
12 | FGFR3 |
13 | Acne inversa familial type 3 |
14 | PSEN1 |
15 | Acrodermatitis enteropathica |
16 | SLC39A4 |
17 | Acrodysostosis 2 |
18 | PDE4D |
19 | Acrofacial dysostosis 1, Nager type |
20 | SF3B4 |
21 | Acrokeratosis verruciformis |
22 | ATP2A2 |
23 | Adams-Oliver syndrome type 1 |
24 | ARHGAP31 |
25 | Adams-Oliver syndrome type 2 |
26 | DOCK6 |
27 | Adams-Oliver syndrome type 3 |
28 | RBPJ |
29 | Adams-Oliver syndrome type 4 |
30 | EOGT |
31 | Adermatoglyphia |
32 | SMARCAD1 |
33 | Albinism, oculocutaneous nonsyndromic |
34 | SLC24A5 |
35 | Albinism, oculocutaneous type 1A |
36 | TYR |
37 | Albinism, oculocutaneous type 1B |
38 | TYR |
39 | Albinism, oculocutaneous type 2 |
40 | OCA2 |
41 | Albinism, oculocutaneous type 3 |
42 | TYRP1 |
43 | Albinism, oculocutaneous type 4 |
44 | SLC45A2 |
45 | Albinism, oculocutaneous type 5 |
46 | LRMDA |
47 | Alopecia universalis |
48 | HR |
49 | Amelogenesis imperfecta type 1A |
50 | LAMB3 |
51 | Amelogenesis imperfecta type 1B |
52 | ENAM |
53 | Amelogenesis imperfecta type 1C |
54 | ENAM |
55 | Amelogenesis imperfecta type 1E |
56 | AMELX |
57 | Amelogenesis imperfecta type 1F |
58 | AMBN |
59 | Amelogenesis imperfecta type 1G |
60 | FAM20A |
61 | Amelogenesis imperfecta type 1H |
62 | ITGB6 |
63 | Amelogenesis imperfecta type 2A1 |
64 | KLK4 |
65 | Amelogenesis imperfecta type 2A2 |
66 | MMP20 |
67 | Amelogenesis imperfecta type 2A3 |
68 | WDR72 |
69 | Amelogenesis imperfecta type 2A4 |
70 | C4orf26 |
71 | Amelogenesis imperfecta type 2A5 |
72 | SLC24A4 |
73 | Amelogenesis imperfecta type 3 |
74 | FAM83H |
75 | Amelogenesis imperfecta type 4 |
76 | DLX3 |
77 | Amelotin deficiency |
78 | AMTN |
79 | Amyloidosis, primary localized cutaneous, type 1 |
80 | OSMR |
81 | Amyloidosis, primary localized cutaneous, type 2 |
82 | IL31RA |
83 | Arthrogryposis, distal, type 1A |
84 | TPM2 |
85 | Arthrogryposis, distal, type 1B |
86 | MYBPC1 |
87 | Arthrogryposis, distal, type 2A |
88 | MYH3 |
89 | Arthrogryposis, distal, type 2B |
90 | MYH3 |
91 | Arthrogryposis, distal, type 2B |
92 | TNNI2 |
93 | Arthrogryposis, distal, type 2B |
94 | TNNT3 |
95 | Arthrogryposis, distal, type 3 |
96 | PIEZO2 |
97 | Arthrogryposis, distal, type 5 |
98 | PIEZO2 |
99 | Arthrogryposis, distal, type 5D |
100 | ECEL1 |
101 | Arthrogryposis, distal, type 7 |
102 | MYH8 |
103 | Arthrogryposis, mental retardation, and seizures |
104 | SLC35A3 |
105 | Arthrogryposis, renal dysfunction, and cholestasis type 1 |
106 | VPS33B |
107 | Arthrogryposis, renal dysfunction, and cholestasis type 2 |
108 | VIPAS39 |
109 | Arthropathy, progressive pseudorheumatoid, of childhood |
110 | WISP3 |
111 | Atelosteogenesis type 1 |
112 | FLNB |
113 | Atelosteogenesis type 3 |
114 | FLNB |
115 | Atrichia with papular lesions |
116 | HR |
117 | Atypical Mycobacterial infection |
118 | IFNGR2 |
119 | Atypical Mycobacterial infection |
120 | IKBKG |
121 | Atypical Mycobacterial infection |
122 | IL12RB1 |
123 | Atypical Mycobacterial infection |
124 | STAT1 |
125 | Atypical Mycobacterial infection, IL12RB2 related |
126 | IL12RB2 |
127 | Autoimmune lymphoproliferative syndrome type 1A |
128 | FAS |
129 | Autoimmune lymphoproliferative syndrome type 1B |
130 | FASLG |
131 | Autoimmune lymphoproliferative syndrome type 2A |
132 | CASP10 |
133 | Autoimmune lymphoproliferative syndrome type 2B |
134 | CASP8 |
135 | Autoimmune lymphoproliferative syndrome type 3 |
136 | PRKCD |
137 | Autoimmune polyendocrinopathy syndrome type 1 |
138 | AIRE |
139 | Autoinflammation, lipodystroph and dermatosis syndrome |
140 | PSMB8 |
141 | Avascular necrosis of the femoral head, primary |
142 | COL2A1 |
143 | B-cell expansion with NFKB and T-cell anergy |
144 | CARD11 |
145 | Bare lymphocyte syndrome, type 2 |
146 | RFXANK |
147 | Bare lymphocyte syndrome, type 2, complementation group A |
148 | CIITA |
149 | Beare-Stevenson cutis gyrata syndrome |
150 | FGFR2 |
151 | Bent bone dysplasia syndrome |
152 | FGFR2 |
153 | Bone mineral density QTL18, osteoporosis |
154 | PLS3 |
155 | Buschke-Ollendorff syndrome |
156 | LEMD3 |
157 | C1q deficiency |
158 | C1QA |
159 | C2 deficiency |
160 | C2 |
161 | C3 deficiency |
162 | C3 |
163 | C5 deficiency |
164 | C5 |
165 | C7 deficiency |
166 | C7 |
167 | Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia |
168 | IARS2 |
169 | Chediak-Higashi syndrome |
170 | LYST |
171 | Choanal atresia and lymphedema |
172 | PTPN14 |
173 | Chondrocalcinosis type 2 |
174 | ANKH |
175 | Chondrodysplasia punctata, X-linked dominant |
176 | EBP |
177 | Chondrodysplasia punctata, X-linked recessive |
178 | ARSE |
179 | Chondrosarcoma, familial |
180 | EXT1 |
181 | Cleidocranial dysplasia |
182 | RUNX2 |
183 | Cold autoinflammatory syndrome type 2 |
184 | NLRP12 |
185 | Cold autoinflammatory syndrome type 4, familial |
186 | NLRC4 |
187 | Cole disease |
188 | ENPP1 |
189 | Cole-Carpenter syndrome type 1 |
190 | P4HB |
191 | Combined cellular and humoral immune defects with granulomas |
192 | RAG2 |
193 | Combined immunodeficiency, B cell-negative, T cell-negative, NK cell positive |
194 | RAG2 |
195 | Combined immunodeficiency, X-linked, moderate |
196 | IL2RG |
197 | Contractural arachnodactyly, congenital |
198 | FBN2 |
199 | Cornelia de Lange syndrome type 1 |
200 | NIPBL |
201 | Cornelia de Lange syndrome type 2 |
202 | SMC1A |
203 | Cornelia de Lange syndrome type 3 |
204 | SMC3 |
205 | Cornelia de Lange syndrome type 4 |
206 | RAD21 |
207 | Cornelia de Lange syndrome type 5 |
208 | HDAC8 |
209 | Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome |
210 | TMCO1 |
211 | Craniofacial-skeletal-dermatologic dysplasia |
212 | FGFR2 |
213 | Crouzon syndrome with acanthosis nigricans |
214 | FGFR3 |
215 | Cutaneous telangiectasia and cancer syndrome, familial |
216 | ATR |
217 | Cutis laxa type 1A, autosomal recessive |
218 | FBLN5 |
219 | Cutis laxa type 1B, autosomal recessive |
220 | EFEMP2 |
221 | Cutis laxa type 2, autosomal dominant |
222 | FBLN5 |
223 | Cutis laxa type 2A, autosomal recessive |
224 | ATP6V0A2 |
225 | Cutis laxa type 2B, autosomal recessive |
226 | PYCR1 |
227 | Cutis laxa type 3A, autosomal recessive |
228 | ALDH18A1 |
229 | Cutis laxa type 3B, autosomal recessive |
230 | PYCR1 |
231 | Cutis laxa, autosomal dominant |
232 | ELN |
233 | Czech dysplasia |
234 | COL2A1 |
235 | Dentin dysplasia, type 2 |
236 | DSPP |
237 | Dentinogenesis imperfecta, Shields type 2 |
238 | DSPP |
239 | Dentinogenesis imperfecta, Shields type 3 |
240 | DSPP |
241 | Dermatitis, atopic type 2 |
242 | FLG |
243 | Dermatopathia pigmentosa reticularis |
244 | KRT14 |
245 | Diaphyseal medullary stenosis with malignant fibrous histiocytoma |
246 | MTAP |
247 | Diarrhea type 2 with microvillus atrophy |
248 | MYO5B |
249 | Diarrhea type 6 |
250 | GUCY2C |
251 | Dyschromatosis universalis hereditaria type 3 |
252 | ABCB6 |
253 | Dyskeratosis congenita, autosomal recessive type 1 |
254 | NOP10 |
255 | Dyskeratosis congenita, autosomal recessive type 2 |
256 | NHP2 |
257 | Dyskeratosis congenita, autosomal recessive type 4/ autosomal dominant type 2 |
258 | TERT |
259 | Dyskeratosis congenita, autosomal recessive type 5 |
260 | RTEL1 |
261 | Dyskeratosis congenita, autosomal recessive type 6 |
262 | PARN |
263 | Dyskeratosis congenita, autosomal recessive type 7 |
264 | ACD |
265 | Dyskeratosis congenita, X-linked |
266 | DKC1 |
267 | Dyssegmental dysplasia, Silverman-Handmaker type |
268 | HSPG2 |
269 | Ectodermal dysplasia type 4, hair/nail type |
270 | KRT85 |
271 | Ectodermal dysplasia, ectrodactyly, and macular dystrophy |
272 | CDH3 |
273 | Ectodermal dysplasia, hidrotic |
274 | GJB6 |
275 | Ectodermal dysplasia, hypohidrotic, autosomal recessive |
276 | EDAR |
277 | Ectodermal dysplasia, hypohidrotic, autosomal recessive |
278 | EDARADD |
279 | Ectodermal dysplasia, hypohidrotic, with immune deficiency |
280 | IKBKG |
281 | Ectodermal dysplasia, hypohidrotic, X-linked |
282 | EDA |
283 | Ectodermal dysplasia/skin fragility syndrome |
284 | PKP1 |
285 | Ehlers-Danlos syndrome type 1/2 |
286 | COL5A1 |
287 | Ehlers-Danlos syndrome type 1/2 |
288 | COL5A2 |
289 | Ehlers-Danlos syndrome type 3 |
290 | COL3A1 |
291 | Ehlers-Danlos syndrome type 3 |
292 | TNXB |
293 | Ehlers-Danlos syndrome type 4 |
294 | COL3A1 |
295 | Ehlers-Danlos syndrome type 4 |
296 | COL5A1 |
297 | Ehlers-Danlos syndrome type 6 |
298 | PLOD1 |
299 | Ehlers-Danlos syndrome type 7A |
300 | COL1A1 |
301 | Ehlers-Danlos syndrome type 7B |
302 | COL1A2 |
303 | Ehlers-Danlos syndrome type 7C |
304 | ADAMTS2 |
305 | Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss |
306 | FKBP14 |
307 | Ehlers-Danlos syndrome, musculocontractural type 1 |
308 | CHST14 |
309 | Ehlers-Danlos syndrome, musculocontractural type 2 |
310 | DSE |
311 | Ehlers-Danlos syndrome, progeroid type 1 |
312 | B4GALT7 |
313 | Ehlers-Danlos syndrome, progeroid type, type 2 |
314 | B3GALT6 |
315 | Emberger syndrome |
316 | GATA2 |
317 | Epidermolysis bullosa dystrophica |
318 | COL7A1 |
319 | Epidermolysis bullosa dystrophica, autosomal recessive, modifier of |
320 | MMP1 |
321 | Epidermolysis bullosa junctionalis with pyloric atresia |
322 | ITGA6 |
323 | Epidermolysis bullosa junctionalis with pyloric atresia |
324 | ITGB4 |
325 | Epidermolysis bullosa simplex |
326 | KRT5 |
327 | Epidermolysis bullosa simplex with pyloric atresia |
328 | PLEC |
329 | Epidermolysis bullosa simplex, autosomal recessive type 1 |
330 | KRT14 |
331 | Epidermolysis bullosa simplex, autosomal recessive type 2 |
332 | DST |
333 | Epidermolysis bullosa simplex, Dowling-Meara type |
334 | KRT14 |
335 | Epidermolysis bullosa simplex, Koebner type |
336 | KRT14 |
337 | Epidermolysis bullosa simplex, Ogna type |
338 | PLEC |
339 | Epidermolysis bullosa simplex, Weber-Cockayne type |
340 | KRT14 |
341 | Epidermolysis bullosa, generalized atrophic benign |
342 | LAMA3 |
343 | Epidermolysis bullosa, junctional |
344 | COL17A1 |
345 | Epidermolysis bullosa, junctional |
346 | LAMC2 |
347 | Epidermolysis bullosa, junctional, Herlitz type |
348 | LAMA3 |
349 | Epidermolysis bullosa, junctional, Herlitz type |
350 | LAMB3 |
351 | Epidermolysis bullosa, junctional, non-Herlitz type |
352 | LAMB3 |
353 | Epidermolysis bullosa, lethal acantholytic |
354 | DSP |
355 | Epidermolysis bullosa, nonspecific, autosomal recessive |
356 | EXPH5 |
357 | Epidermolytic hyperkeratosis |
358 | KRT1 |
359 | Epidermolytic hyperkeratosis |
360 | KRT10 |
361 | Epidermolytic palmoplantar keratoderma |
362 | KRT9 |
363 | Epiphyseal dysplasia, multiple, type 1 |
364 | COMP |
365 | Epiphyseal dysplasia, multiple, type 3 |
366 | COL9A3 |
367 | Epiphyseal dysplasia, multiple, type 5 |
368 | MATN3 |
369 | Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis and hyper IgE |
370 | DSG1 |
371 | Erythrokeratodermia variabilis et progressive |
372 | GJB3 |
373 | Erythrokeratodermia variabilis et progressive |
374 | GJB4 |
375 | Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis |
376 | COX4I2 |
377 | Exostoses, multiple, type 1 |
378 | EXT1 |
379 | Exostoses, multiple, type 2 |
380 | EXT2 |
381 | Fanconi anemia, complementation group Q |
382 | ERCC4 |
383 | Feingold syndrome type 2 |
384 | MIR17HG |
385 | Fibrochondrogenesis 2 |
386 | COL11A2 |
387 | Fibrochondrogenesis type 1 |
388 | COL11A1 |
389 | Fibrodysplasia ossificans progressiva |
390 | ACVR1 |
391 | Fibrosis of extraocular muscles, congenital type 2 |
392 | PHOX2A |
393 | Floating-Harbor syndrome |
394 | SRCAP |
395 | Focal dermal hypoplasia |
396 | PORCN |
397 | Frank-ter Haar syndrome |
398 | SH3PXD2B |
399 | Geleophysic dysplasia type 1 |
400 | ADAMTSL2 |
401 | Geroderma osteodysplasticum |
402 | GORAB |
403 | Ghosal hematodiaphyseal syndrome |
404 | TBXAS1 |
405 | Gnathodiaphyseal dysplasia |
406 | ANO5 |
407 | Gracile bone dysplasia |
408 | FAM111A |
409 | Granulomatous disease, chronic, autosomal recessive, cytochrome b- positive, type 1 |
410 | NCF1 |
411 | Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative |
412 | CYBA |
413 | Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2 |
414 | NCF2 |
415 | Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3 |
416 | NCF4 |
417 | Granulomatous disease, chronic, X-linked |
418 | CYBB |
419 | Greenberg skeletal dysplasia |
420 | LBR |
421 | Griscelli syndrome type 1 |
422 | MYO5A |
423 | Griscelli syndrome type 3 |
424 | MLPH |
425 | Haim-Munk syndrome |
426 | CTSC |
427 | Heimler syndrome type 1 |
428 | PEX1 |
429 | Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy |
430 | CD59 |
431 | Hemophagocytic lymphohistiocytosis type 2 |
432 | PRF1 |
433 | Hemophagocytic lymphohistiocytosis type 3 |
434 | UNC13D |
435 | Hemophagocytic lymphohistiocytosis type 4 |
436 | STX11 |
437 | Hemophagocytic lymphohistiocytosis type 5 |
438 | STXBP2 |
439 | Hennekam lymphangiectasia-lymphedema syndrome type 1 |
440 | CCBE1 |
441 | Hepatic venoocclusive disease with immunodeficiency |
442 | SP110 |
443 | Herpes simplex encephalitis type 2, susceptibility to |
444 | TLR3 |
445 | Histiocytosis-lymphadenopathy plus syndrome |
446 | SLC29A3 |
447 | Hyaline fibromatosis syndrome |
448 | ANTXR2 |
449 | Hyper-IgE recurrent infection syndrome |
450 | STAT3 |
451 | Hyper-IgE recurrent infection syndrome, autosomal recessive |
452 | DOCK8 |
453 | Hypertrophic osteoarthropathy type 1 |
454 | HPGD |
455 | Hypertrophic osteoarthropathy type 2 |
456 | SLCO2A1 |
457 | Hypochondroplasia |
458 | FGFR3 |
459 | Hypophosphatemic rickets with hypercalciuria |
460 | SLC34A3 |
461 | Hypophosphatemic rickets, autosomal dominant |
462 | FGF23 |
463 | Hypophosphatemic rickets, autosomal recessive type 1 |
464 | DMP1 |
465 | Hypophosphatemic rickets, autosomal recessive type 2 |
466 | ENPP1 |
467 | Hypophosphatemic rickets, X-linked |
468 | PHEX |
469 | Hypotrichosis and recurrent skin vesicles |
470 | DSC3 |
471 | Hypotrichosis type 1 |
472 | APCDD1 |
473 | Hypotrichosis type 11 |
474 | SNRPE |
475 | Hypotrichosis type 12 |
476 | RPL21 |
477 | Hypotrichosis type 13 |
478 | KRT71 |
479 | Hypotrichosis type 2 |
480 | CDSN |
481 | Hypotrichosis type 3 |
482 | KRT74 |
483 | Hypotrichosis type 4 |
484 | HR |
485 | Hypotrichosis type 6 |
486 | DSG4 |
487 | Hypotrichosis type 7 |
488 | LIPH |
489 | Hypotrichosis type 8 |
490 | LPAR6 |
491 | Hypotrichosis-lymphedema-telangiectasia syndrome |
492 | SOX18 |
493 | Ichthyosiform erythroderma, congenital, nonbullous type 1 |
494 | ALOXE3 |
495 | Ichthyosiform erythroderma, congenital, nonbullous type 1 |
496 | NIPAL4 |
497 | Ichthyosis congenital, autosomal recessive, PNPLA1 related |
498 | PNPLA1 |
499 | Ichthyosis congenital, Harlequin fetus type |
500 | ABCA12 |
501 | Ichthyosis follicularis, atricia, and photophobia syndrome |
502 | MBTPS2 |
503 | Ichthyosis prematurity syndrome |
504 | SLC27A4 |
505 | Ichthyosis vulgaris |
506 | FLG |
507 | Ichthyosis, bullous type |
508 | KRT2 |
509 | Ichthyosis, congenital, autosomal recessive type 1 |
510 | TGM1 |
511 | Ichthyosis, congenital, autosomal recessive, type 11 |
512 | ST14 |
513 | Ichthyosis, congenital, autosomal recessive, type 2 |
514 | ALOX12B |
515 | Ichthyosis, congenital, autosomal recessive, type 9 |
516 | CERS3 |
517 | Ichthyosis, lamellar type 2 |
518 | ABCA12 |
519 | Ichthyosis, lamellar type 3 |
520 | CYP4F22 |
521 | Ichthyosis, lamellar type 4 |
522 | LIPN |
523 | Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis |
524 | CLDN1 |
525 | Ichthyosis, spastic quadriplegia, and mental retardation |
526 | ELOVL4 |
527 | Ichthyosis, X-linked |
528 | STS |
529 | Immunodeficiency common variable type 1 |
530 | ICOS |
531 | Immunodeficiency common variable type 10 |
532 | NFKB2 |
533 | Immunodeficiency common variable type 2 |
534 | TNFRSF13B |
535 | Immunodeficiency common variable type 3 |
536 | CD19 |
537 | Immunodeficiency common variable type 4 |
538 | TNFRSF13C |
539 | Immunodeficiency common variable type 6 |
540 | CD81 |
541 | Immunodeficiency common variable type 8 |
542 | LRBA |
543 | Immunodeficiency due to defect in MAPBP-interacting protein |
544 | LAMTOR2 |
545 | Immunodeficiency due to purine nucleoside phosphorylase deficiency |
546 | PNP |
547 | Immunodeficiency type 10 |
548 | STIM1 |
549 | Immunodeficiency type 11 |
550 | CARD11 |
551 | Immunodeficiency type 12 |
552 | MALT1 |
553 | Immunodeficiency type 14 |
554 | PIK3CD |
555 | Immunodeficiency type 15 |
556 | IKBKB |
557 | Immunodeficiency type 18 |
558 | CD3E |
559 | Immunodeficiency type 19 |
560 | CD3D |
561 | Immunodeficiency type 2, with hyper-IgM |
562 | AICDA |
563 | Immunodeficiency type 21 |
564 | GATA2 |
565 | Immunodeficiency type 22 |
566 | LCK |
567 | Immunodeficiency type 24 |
568 | CTPS1 |
569 | Immunodeficiency type 25 |
570 | CD247 |
571 | Immunodeficiency type 3, with hyper-IgM |
572 | CD40 |
573 | Immunodeficiency type 32A, mycobacteriosis, autosomal dominant |
574 | IRF8 |
575 | Immunodeficiency type 32B, monocyte and dendritic cell deficiency, autosomal recessive |
576 | IRF8 |
577 | Immunodeficiency type 34 |
578 | CYBB |
579 | Immunodeficiency type 35 |
580 | TYK2 |
581 | Immunodeficiency type 36 |
582 | PIK3R1 |
583 | Immunodeficiency type 38 |
584 | ISG15 |
585 | Immunodeficiency type 42 |
586 | RORC |
587 | Immunodeficiency type 5, with hyper IgM |
588 | UNG |
589 | Immunodeficiency type 8 |
590 | CORO1A |
591 | Immunodeficiency, isolated |
592 | IKBKG |
593 | Immunodeficiency, primary, autosomal recessive, IL21R-related |
594 | IL21R |
595 | Immunodeficiency, X-linked with hyper-IgM |
596 | CD40LG |
597 | Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 |
598 | DNMT3B |
599 | Immunodeficiency-centromeric instability-facial anomalies syndrome type 2 |
600 | ZBTB24 |
601 | Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked |
602 | FOXP3 |
603 | Immunological disorder, PECAM1 related |
604 | PECAM1 |
605 | Immunological disorder, PICALM related |
606 | PICALM |
607 | Incontinentia pigmenti type 2 |
608 | IKBKG |
609 | Inflammatory bowel disease type 13 |
610 | ABCB1 |
611 | Inflammatory skin and bowel disease, neonatal, type 1 |
612 | ADAM17 |
613 | Interleukin 12A deficiency |
614 | IL12A |
615 | Interleukin 2 receptor deficiency |
616 | IL2RA |
617 | Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital |
618 | ITGA3 |
619 | Invasive pneumococcal disease, recurrent isolated type 1 |
620 | IRAK4 |
621 | Invasive pneumococcal disease, recurrent isolated type 2 |
622 | IKBKG |
623 | IRAK4 deficiency |
624 | IRAK4 |
625 | Keratoderma, palmoplantar, punctate type 1A |
626 | AAGAB |
627 | Keratosis follicularis spinulosa declavans, X-linked |
628 | MBTPS2 |
629 | Keratosis linearis with ichthyosis congenita and sclerosing keratoderma |
630 | POMP |
631 | Keratosis palmoplantaris striata type 1 |
632 | DSG1 |
633 | Keratosis palmoplantaris striata type 2 |
634 | DSP |
635 | Kindler syndrome |
636 | FBLIM1 |
637 | Kindler syndrome |
638 | FERMT1 |
639 | Laryngoonychocutaneous syndrome |
640 | LAMA3 |
641 | Legg-Calve-Perthes disease |
642 | COL2A1 |
643 | Legius syndrome |
644 | SPRED1 |
645 | Leukocyte adhesion deficiency type 3 |
646 | FERMT3 |
647 | LIG4 syndrome |
648 | LIG4 |
649 | Loeys-Dietz syndrome type 1A |
650 | TGFBR1 |
651 | Loeys-Dietz syndrome type 1B |
652 | TGFBR2 |
653 | Loeys-Dietz syndrome type 1C |
654 | SMAD3 |
655 | Loeys-Dietz syndrome type 2A |
656 | TGFBR1 |
657 | Loeys-Dietz syndrome type 2B |
658 | TGFBR2 |
659 | Lymphedema, hereditary, type 1A |
660 | FLT4 |
661 | Lymphedema, hereditary, type IC |
662 | GJC2 |
663 | Lymphoproliferative syndrome type 2 |
664 | CD27 |
665 | Majeed syndrome |
666 | LPIN2 |
667 | Major histocompatibility comples 1 deficiency |
668 | MR1 |
669 | Mal de Meleda |
670 | SLURP1 |
671 | Malaria, cerebral, susceptibility to |
672 | ICAM1 |
673 | Malaria, resistance to |
674 | FCGR2B |
675 | Mandibuloacral dysplasia with type B lipodystrophy |
676 | ZMPSTE24 |
677 | Marfan syndrome, TGFBR1 related |
678 | TGFBR1 |
679 | Marfan syndrome, TGFBR2 related |
680 | TGFBR2 |
681 | McKusick-Kaufman syndrome |
682 | MKKS |
683 | Meconium ileus |
684 | GUCY2C |
685 | MEDNIK syndrome |
686 | AP1S1 |
687 | MERRF syndrome, MT-TK related |
688 | MT-TK |
689 | MERRF syndrome, MT-TP related |
690 | MT-TP |
691 | Metaphyseal chondrodysplasia, Schmid type |
692 | COL10A1 |
693 | Metaphyseal chondromatosis with increased urinary excretion of D-2-hydroxyglutarate |
694 | IDH1 |
695 | Muckle-wells syndrome |
696 | NLRP3 |
697 | Multicentric carpotarsal osteolysis syndrome |
698 | MAFB |
699 | Multicentric osteolysis, nodulosis, and arthropathy |
700 | MMP2 |
701 | Multiple pterygium syndrome lethal type |
702 | CHRNA1 |
703 | Multiple pterygium syndrome lethal type |
704 | CHRND |
705 | Mycobacterial infection, atypical, familial disseminated |
706 | IFNGR1 |
707 | Naegeli-Franceschetti-Jadassohn syndrome |
708 | KRT14 |
709 | Nail-Patella syndrome |
710 | LMX1B |
711 | Nephrolithiasis/osteoporosis, hypophosphatemic, type 2 |
712 | SLC9A3R1 |
713 | Netherton syndrome |
714 | SPINK5 |
715 | Neurofibromatosis type 1 |
716 | NF1 |
717 | Neurofibromatosis type 1 -like syndrome |
718 | SPRED1 |
719 | Neurofibromatosis type 2 |
720 | NF2 |
721 | Neutropenia, nonimmune chronic idiopathic, of adults |
722 | GFI1 |
723 | Neutropenia, severe congenital type 2, autosomal dominant |
724 | GFI1 |
725 | Neutropenia, severe congenital type 4, autosomal recessive |
726 | G6PC3 |
727 | Neutropenia, severe congenital type 5, autosomal recessive |
728 | VPS45 |
729 | Neutropenia, severe congenital type 6, autosomal recessive |
730 | JAGN1 |
731 | Neutrophil immunodeficiency syndrome |
732 | RAC2 |
733 | Odontoonychodermal dysplasia |
734 | WNT10A |
735 | Olmsted syndrome |
736 | TRPV3 |
737 | Omenn syndrome |
738 | DCLRE1C |
739 | Omenn syndrome |
740 | RAG2 |
741 | Omodysplasia type 1 |
742 | GPC6 |
743 | Opsismodysplasia |
744 | INPPL1 |
745 | Osseous heteroplasia, progressive |
746 | GNAS |
747 | Osteoarthritis with mild chondrodysplasia |
748 | COL2A1 |
749 | Osteogenesis and dental anomalies, CSF1 related |
750 | CSF1 |
751 | Osteogenesis disorders, CREB3L1 related |
752 | CREB3L1 |
753 | Osteogenesis imperfecta |
754 | COL1A1 |
755 | Osteogenesis imperfecta |
756 | COL1A2 |
757 | Osteogenesis imperfecta type 10 |
758 | SERPINH1 |
759 | Osteogenesis imperfecta type 11 |
760 | FKBP10 |
761 | Osteogenesis imperfecta type 12 |
762 | SP7 |
763 | Osteogenesis imperfecta type 13 |
764 | BMP1 |
765 | Osteogenesis imperfecta type 14 |
766 | TMEM38B |
767 | Osteogenesis imperfecta type 15 |
768 | WNT1 |
769 | Osteogenesis imperfecta type 5 |
770 | IFITM5 |
771 | Osteogenesis imperfecta type 6 |
772 | SERPINF1 |
773 | Osteogenesis imperfecta type 7 |
774 | CRTAP |
775 | Osteogenesis imperfecta type 8 |
776 | P3H1 |
777 | Osteogenesis imperfecta type 9 |
778 | PPIB |
779 | Osteogenesis imperfecta with congenital joint contractures |
780 | PLOD2 |
781 | Osteolysis, familial expansile |
782 | TNFRSF11A |
783 | Osteomyelitis, sterile multifocal, with periostitis and pustulosis |
784 | IL1RN |
785 | Osteopathia striata with cranial sclerosis |
786 | AMER1 |
787 | Osteopetrosis of infancy, malignant |
788 | SNX10 |
789 | Osteopetrosis, autosomal dominant type 1 |
790 | CLCN7 |
791 | Osteopetrosis, autosomal recessive type 1 |
792 | TCIRG1 |
793 | Osteopetrosis, autosomal recessive type 2 |
794 | TNFSF11 |
795 | Osteopetrosis, autosomal recessive type 3 |
796 | CA2 |
797 | Osteopetrosis, autosomal recessive type 4 |
798 | CLCN7 |
799 | Osteopetrosis, autosomal recessive type 5 |
800 | OSTM1 |
801 | Osteopetrosis, autosomal recessive type 6 |
802 | PLEKHM1 |
803 | Osteopetrosis, autosomal recessive type 7 |
804 | TNFRSF11A |
805 | Osteoporosis pseudoglioma syndrome |
806 | LRP5 |
807 | Pachyonychia congenita type 1 |
808 | KRT16 |
809 | Pachyonychia congenita type 2 |
810 | KRT17 |
811 | Pachyonychia congenita type 3 |
812 | KRT6A |
813 | Pachyonychia congenita type 4 |
814 | KRT6B |
815 | Paget disease of bone |
816 | SQSTM1 |
817 | Paget disease, juvenile |
818 | TNFRSF11B |
819 | Palmoplantar keratoderma, nonepidermolytic, focal |
820 | KRT16 |
821 | Papillon-Lefevre syndrome |
822 | CTSC |
823 | Peeling skin syndrome type 1 |
824 | CDSN |
825 | Peeling skin syndrome type 2 |
826 | TGM5 |
827 | Peeling skin syndrome type 3 |
828 | CHST8 |
829 | Peeling skin syndrome type 4 |
830 | CSTA |
831 | Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads |
832 | CAST |
833 | Piebaldism |
834 | KIT |
835 | Piebaldism |
836 | SNAI2 |
837 | Pityriasis rubra pilaris |
838 | CARD14 |
839 | Poikiloderma with neutropenia |
840 | USB1 |
841 | Porokeratosis type 3, disseminated superficial actinic |
842 | MVK |
843 | Porphyria cutanea tarda |
844 | UROD |
845 | Protoporphyria, erythropoietic type 1 |
846 | FECH |
847 | Pseudoachondroplasia |
848 | COMP |
849 | Pseudoxanthoma elasticum |
850 | ABCC6 |
851 | Pseudoxanthoma elasticum, forme fruste |
852 | ABCC6 |
853 | Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency |
854 | GGCX |
855 | Psoriasis susceptibility type 11 |
856 | IL12B |
857 | Psoriasis type 2 |
858 | CARD14 |
859 | Psoriasis, generalized pustular |
860 | IL36RN |
861 | Pterygium syndrome |
862 | CHRNG |
863 | Pulmonary fibrosis and/or bone marrow failure, telomere-related, type 1 |
864 | TERT |
865 | Pulmonary fibrosis and/or bone marrow failure, telomere-related, type 4 |
866 | PARN |
867 | Pycnodysostosis |
868 | CTSK |
869 | Pyogenic bacterial infections, recurrent, due to MYD88 deficiency |
870 | MYD88 |
871 | Pyogenic sterile arthritis, pyoderma gangrenosum, and acne |
872 | PSTPIP1 |
873 | Radioulnar synostosis, FGFRL1 related |
874 | FGFRL1 |
875 | Raine syndrome |
876 | FAM20C |
877 | Restrictive dermopathy, lethal |
878 | LMNA |
879 | Restrictive dermopathy, lethal |
880 | ZMPSTE24 |
881 | Reticular dysgenesis |
882 | AK2 |
883 | Reticulate acropigmentation of Kitamura |
884 | ADAM10 |
885 | Rheumatoid arthritis, susceptibility to |
886 | AFF3 |
887 | Rheumatoid arthritis, TNFAIP3 related |
888 | TNFAIP3 |
889 | Rickets, vitamin D 25-hydroxylation-deficient, type 1B |
890 | CYP2R1 |
891 | Rickets, vitamin D dependent, type 1 |
892 | CYP27B1 |
893 | Rickets, vitamin D-resistant, type 2A |
894 | VDR |
895 | Sarcoidosis, early-onset |
896 | NOD2 |
897 | Selective T-cell defect |
898 | ZAP70 |
899 | Severe combined immunodeficiency due to ADA deficiency |
900 | ADA |
901 | Severe combined immunodeficiency due to IL2 deficiency |
902 | IL2 |
903 | Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation |
904 | NHEJ1 |
905 | Severe combined immunodeficiency, Athabascan type |
906 | DCLRE1C |
907 | Severe combined immunodeficiency, B cell-negative |
908 | RAG1 |
909 | Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive |
910 | PTPRC |
911 | Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type |
912 | IL7R |
913 | Skin fragility-woolly hair syndrome |
914 | DSP |
915 | Skin hair eye pigmentation type 6 |
916 | SLC24A4 |
917 | Smith-McCort dysplasia |
918 | DYM |
919 | Spondylocarpotarsal synostosis syndrome |
920 | FLNB |
921 | Spondylocheirodysplasia, Ehlers-Danlos syndrome-like |
922 | SLC39A13 |
923 | Spondylocostal dysostosis, autosomal recessive type 1 |
924 | DLL3 |
925 | Spondylocostal dysostosis, autosomal recessive type 2 |
926 | MESP2 |
927 | Spondylocostal dysostosis, autosomal recessive type 3 |
928 | LFNG |
929 | Spondyloenchondrodysplasia with immune dysregulation |
930 | ACP5 |
931 | Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures |
932 | B3GALT6 |
933 | Spondyloepimetaphyseal dysplasia, MATN3 related |
934 | MATN3 |
935 | Spondyloepiphyseal dysplasia with congenital joint dislocations |
936 | CHST3 |
937 | Spondylometaepiphyseal dysplasia, short limb-hand type |
938 | DDR2 |
939 | Steatocystoma multiplex |
940 | KRT17 |
941 | Stiff skin syndrome |
942 | FBN1 |
943 | Systemic lupus erythematosus |
944 | DNASE1 |
945 | Systemic lupus erythematosus type 16 |
946 | DNASE1L3 |
947 | Systemic lupus erythematosus, susceptibility to |
948 | ITGAM |
949 | T-cell immunodeficiency, congenital alopecia, and nail dystrophy |
950 | FOXN1 |
951 | Telangiectasia hereditary hemorrhagic type 5 |
952 | GDF2 |
953 | Telangiectasia, hereditary hemorrhagic, of Rendu, Osler and Weber type 1 |
954 | ENG |
955 | Telangiectasia, hereditary hemorrhagic, type 2 |
956 | ACVRL1 |
957 | Terminal osseous dysplasis |
958 | FLNA |
959 | Thrombospondin Type 1 domain-containing protein 1 |
960 | THSD1 |
961 | Trichodontoosseous syndrome |
962 | DLX3 |
963 | Trichohepatoenteric syndrome type 1 |
964 | TTC37 |
965 | Trichohepatoenteric syndrome type 2 |
966 | SKIV2L |
967 | Trichorhinophalangeal syndrome type 1 |
968 | TRPS1 |
969 | Trichothiodystrophy |
970 | ERCC2 |
971 | Trichothiodystrophy |
972 | ERCC3 |
973 | Trichothiodystrophy |
974 | GTF2H5 |
975 | Trichothiodystrophy, nonphotosensitive type 1 |
976 | MPLKIP |
977 | Tuftelin deficiency |
978 | TUFT1 |
979 | Tylosis with esophageal cancer |
980 | RHBDF2 |
981 | UV-sensitive syndrome type 1 |
982 | ERCC6 |
983 | UV-sensitive syndrome type 3 |
984 | UVSSA |
985 | Van Buchem disease |
986 | SOST |
987 | Vasculopathy, infantile-onset, TMEM173/STING related |
988 | TMEM173 |
989 | Vitiligo-associated multiple autoimmune disease |
990 | NLRP1 |
991 | Vohwinkel syndrome with ichthyosis |
992 | LORICRIN |
993 | Waardenburg syndrome type 1 |
994 | PAX3 |
995 | Waardenburg syndrome type 2E |
996 | SOX10 |
997 | Waardenburg syndrome type 4C |
998 | SOX10 |
999 | WHIM syndrome |
1000 | CXCR4 |
1001 | Winchester Syndrome |
1002 | MMP14 |
1003 | Wolcott-Rallison syndrome |
1004 | EIF2AK3 |
1005 | Wrinkly skin syndrome |
1006 | ATP6V0A2 |
1007 | Xeroderma pigmentosum, group A |
1008 | XPA |
1009 | Xeroderma pigmentosum, group C |
1010 | XPC |
1011 | Xeroderma pigmentosum, group D |
1012 | ERCC2 |
1013 | Xeroderma pigmentosum, group E, DDB-negative subtype |
1014 | DDB2 |
1015 | Xeroderma pigmentosum, group F |
1016 | ERCC4 |
1017 | Xeroderma pigmentosum, group G |
1018 | ERCC5 |
1019 | Xeroderma pigmentosum, variant type |
1020 | POLH |
1021 | XFE progeroid syndrome |
1022 | ERCC4 |
No. | Description |
---|---|
1 | Accelerated tumor formation, susceptibility to |
2 | MDM2 |
3 | Adenosine triphosphate, elevated, of erythrocytes |
4 | PKLR |
5 | Afibrinogenemia, congenital |
6 | FGA |
7 | Afibrinogenemia, congenital |
8 | FGB |
9 | Afibrinogenemia, congenital |
10 | FGG |
11 | Agammaglobulinemia and isolated hormone deficiency |
12 | BTK |
13 | Agammaglobulinemia type 1, X-linked |
14 | BTK |
15 | Agammaglobulinemia type 2, autosomal recessive |
16 | IGLL1 |
17 | Agammaglobulinemia type 3, autosomal recessive |
18 | CD79A |
19 | Agammaglobulinemia type 4, autosomal recessive |
20 | BLNK |
21 | Agammaglobulinemia type 5, autosomal recessive |
22 | LRRC8A |
23 | Agammaglobulinemia type 6, autosomal recessive |
24 | CD79B |
25 | Agammaglobulinemia type 7, autosomal recessive |
26 | PIK3R1 |
27 | Alpha-thalassemia/mental retardation syndrome |
28 | ATRX |
29 | Anemia, neonatal hemolytic, fatal and near-fatal |
30 | SPTB |
31 | Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive |
32 | GLRX5 |
33 | Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive |
34 | SLC25A38 |
35 | Anemia, sideroblastic, type 4 |
36 | HSPA9 |
37 | Anemia, sideroblastic, with ataxia |
38 | ABCB7 |
39 | Anemia, sideroblastic, X-linked |
40 | ALAS2 |
41 | Anemia, X-linked |
42 | GATA1 |
43 | Anhaptoglobinemia |
44 | HP |
45 | Bare lymphocyte syndrome, type 2, complementation group C |
46 | RFX5 |
47 | Bleeding disorder, platelet-type 15 |
48 | ACTN1 |
49 | Bleeding disorder, platelet-type 17 |
50 | GFI1B |
51 | Bleeding disorder, platelet-type 8 |
52 | P2RY12 |
53 | Bone marrow failure syndrome type 1 |
54 | SRP72 |
55 | Bone marrow failure syndrome type 2 |
56 | ERCC6L2 |
57 | Cyanosis, transient neonatal |
58 | HBG2 |
59 | Dehydrated hereditary stomatocytosis |
60 | PIEZO1 |
61 | Delta-beta thalassemia |
62 | HBB |
63 | Diamond Blackfan anemia type 15 with mandibulofacial dysostosis |
64 | RPS28 |
65 | Diamond-Blackfan anemia type 1 |
66 | RPS19 |
67 | Diamond-Blackfan anemia type 10 |
68 | RPS26 |
69 | Diamond-Blackfan anemia type 11 |
70 | RPL26 |
71 | Diamond-Blackfan anemia type 12 |
72 | RPL15 |
73 | Diamond-Blackfan anemia type 13 |
74 | RPS29 |
75 | Diamond-Blackfan anemia type 14 with mandibulofacial dysostosis |
76 | TSR2 |
77 | Diamond-blackfan anemia type 3 |
78 | RPS24 |
79 | Diamond-Blackfan anemia type 4 |
80 | RPS17 |
81 | Diamond-Blackfan anemia type 5 |
82 | RPL35A |
83 | Diamond-Blackfan anemia type 6 |
84 | RPL5 |
85 | Diamond-Blackfan anemia type 7 |
86 | RPL11 |
87 | Diamond-Blackfan anemia type 8 |
88 | RPS7 |
89 | Diamond-Blackfan anemia type 9 |
90 | RPS10 |
91 | Dyserythropoietic anemia |
92 | COX4I2 |
93 | Dyserythropoietic anemia, congenital, type 1B |
94 | C15orf41 |
95 | Dyserythropoietic anemia, congenital, type 3 |
96 | KIF23 |
97 | Dyserythropoietic anemia, congenital, type 4 |
98 | KLF1 |
99 | Dysprothrombinemia |
100 | F2 |
101 | Erythrocytosis, familial type 1 |
102 | EPOR |
103 | Erythrocytosis, familial type 3 |
104 | EGLN1 |
105 | Erythrocytosis, familial type 4 |
106 | EPAS1 |
107 | Factor X deficiency |
108 | F10 |
109 | Favism, susceptibility to |
110 | G6PD |
111 | Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative |
112 | CYBA |
113 | Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2 |
114 | NCF2 |
115 | Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3 |
116 | NCF4 |
117 | Granulomatous disease, chronic, X-linked |
118 | CYBB |
119 | Hemolytic anemia due to G6PD deficiency |
120 | G6PD |
121 | Hemolytic anemia due to triosephosphate isomerase deficiency |
122 | TPI1 |
123 | Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy |
124 | CD59 |
125 | Hemolytic anemia, Kell-system related |
126 | KEL |
127 | Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency |
128 | GPI |
129 | Hemophilia B |
130 | F9 |
131 | Hereditary persistence of fetal hemoglobin |
132 | HBG2 |
133 | Hydrops, lactic acidosis, and sideroblastic anemia |
134 | LARS2 |
135 | Intrinsic factor deficiency |
136 | CBLIF |
137 | Iron-refractory iron deficiency anemia |
138 | TMPRSS6 |
139 | Leukemia, acute myeloid form, susceptible due to TERT germline mutation |
140 | TERT |
141 | Leukocyte adhesion deficiency type 3 |
142 | FERMT3 |
143 | Lutheran inhibitor blood group |
144 | KLF1 |
145 | Lymphoproliferative syndrome type 1 |
146 | ITK |
147 | Lymphoproliferative syndrome, autoimmune, type 5 |
148 | CTLA4 |
149 | Lymphoproliferative syndrome, X-linked type 1 |
150 | SH2D1A |
151 | Lymphoproliferative syndrome, X-linked type 2 |
152 | XIAP |
153 | Megaloblastic anemia type 1 |
154 | AMN |
155 | Megaloblastic anemia type 1, Finnish type |
156 | CUBN |
157 | Methemoglobinemia type 1 |
158 | CYB5R3 |
159 | Myeloproliferative disorder, chronic, with eosinophilia |
160 | PDGFRB |
161 | Neutropenia, severe congenital type 1 |
162 | ELANE |
163 | Neutropenia, severe congenital type 3 |
164 | HAX1 |
165 | Neutropenia, severe congenital type 5, autosomal recessive |
166 | VPS45 |
167 | Neutrophilia, hereditary |
168 | CSF3R |
169 | Platelet aggregation disorder |
170 | PEAR1 |
171 | Platelet dense granule secretion defect, excessive bleeding |
172 | FLI1 |
173 | Platelet disorder with associated myeloid malignancy |
174 | RUNX1 |
175 | Platelet glycoprotein IV deficiency |
176 | CD36 |
177 | Protoporphyria, erythropoietic, X-linked |
178 | ALAS2 |
179 | Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency |
180 | GGCX |
181 | Schimke immunoosseous dysplasia |
182 | SMARCAL1 |
183 | SCID autosomal recessive T negative B positive type |
184 | JAK3 |
185 | Sea-blue histiocyte disease |
186 | APOE |
187 | Shwachman-Diamond syndrome |
188 | SBDS |
189 | Sickle cell anemia |
190 | HBB |
191 | Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay |
192 | TRNT1 |
193 | Spherocytosis type 1 |
194 | ANK1 |
195 | Spherocytosis type 2 |
196 | SPTB |
197 | Spherocytosis type 3 |
198 | SPTA1 |
199 | Spherocytosis type 5 |
200 | EPB42 |
201 | Stormorken syndrome |
202 | STIM1 |
203 | Thalassemia, alpha |
204 | HBA1 |
205 | Thalassemia, alpha |
206 | HBA2 |
207 | Thalassemia, delta |
208 | HBD |
209 | Thiamine-responsive megaloblastic anemia syndrome |
210 | SLC19A2 |
211 | Thrombocytopenia congenital amegakaryocytic |
212 | MPL |
213 | Thrombocytopenia type 2 |
214 | ANKRD26 |
215 | Thrombocytopenia type 2 |
216 | MASTL |
217 | Thrombocytopenia type 4 |
218 | CYCS |
219 | Thrombocytopenia type 5 |
220 | ETV6 |
221 | Thrombocytopenia with beta thalassemia X-linked |
222 | GATA1 |
223 | Thrombocytopenia, neonatal alloimmune |
224 | ITGA2B |
225 | Thrombocytopenia, neonatal alloimmune |
226 | ITGB3 |
227 | Thrombocytopenia, X-linked |
228 | GATA1 |
229 | Thrombocytopenia, X-linked, intermittent |
230 | WAS |
231 | Thrombocytosis, familial, JAK2 related |
232 | JAK2 |
233 | Thrombophilia due to thrombin defect |
234 | F2 |
235 | Thrombophilia, X-linked, due to factor IX defect |
236 | F9 |
237 | Thrombotic thrombocytopenic purpura |
238 | ADAMTS13 |
239 | Thromboxane synthase deficiency |
240 | TBXAS1 |
241 | Vitamin K-dependent clotting factors combined deficiency type 1 |
242 | GGCX |
243 | von Willebrand disease |
244 | VWF |
245 | von Willebrand disease platelet type |
246 | GP1BA |
247 | 17-beta hydroxysteroid dehydrogenase X deficiency |
248 | HSD17B10 |
249 | Achalasia addisonianism alacrimia syndrome |
250 | AAAS |
251 | Acromegaly, predisposition to, due to germline GPR101 mutation |
252 | GPR101 |
253 | Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete |
254 | CYP11A1 |
255 | Adrenocorticotropic hormone deficiency |
256 | TBX19 |
257 | Alport syndrome, autosomal recessive |
258 | COL4A3 |
259 | Alport syndrome, autosomal recessive |
260 | COL4A4 |
261 | Alport syndrome, X-Linked |
262 | COL4A5 |
263 | Androgen insensitivity |
264 | AR |
265 | Androgen insensitivity, partial, with or without breast cancer |
266 | AR |
267 | Androgen-binding protein deficiency |
268 | SHBG |
269 | Arthrogryposis, renal dysfunction, and cholestasis type 2 |
270 | VIPAS39 |
271 | Bardet-Biedl syndrome type 1 |
272 | BBS1 |
273 | Bardet-Biedl syndrome type 10 |
274 | BBS10 |
275 | Bardet-Biedl syndrome type 11 |
276 | TRIM32 |
277 | Bardet-Biedl syndrome type 12 |
278 | BBS12 |
279 | Bardet-Biedl syndrome type 13 |
280 | MKS1 |
281 | Bardet-Biedl syndrome type 14 |
282 | CEP290 |
283 | Bardet-Biedl syndrome type 15 |
284 | WDPCP |
285 | Bardet-Biedl syndrome type 2 |
286 | BBS2 |
287 | Bardet-Biedl syndrome type 3 |
288 | ARL6 |
289 | Bardet-Biedl syndrome type 4 |
290 | BBS4 |
291 | Bardet-Biedl syndrome type 5 |
292 | BBS5 |
293 | Bardet-Biedl syndrome type 6 |
294 | MKKS |
295 | Bardet-Biedl syndrome type 7 |
296 | BBS7 |
297 | Bardet-Biedl syndrome type 8 |
298 | TTC8 |
299 | Bardet-Biedl syndrome type 9 |
300 | BBS9 |
301 | Bardet-Biedl syndrome, LZTFL1 related |
302 | LZTFL1 |
303 | Bardet-Biedl syndrome, modifier of, CCDC28B related |
304 | CCDC28B |
305 | Bartter syndrome |
306 | SLC12A2 |
307 | Bartter syndrome |
308 | SLC12A3 |
309 | Bartter syndrome |
310 | SLC12A5 |
311 | Bartter syndrome |
312 | SLC12A7 |
313 | Bartter syndrome type 1 |
314 | SLC12A1 |
315 | Bartter syndrome type 2 |
316 | KCNJ1 |
317 | Bartter syndrome type 3 |
318 | CLCNKB |
319 | Bartter syndrome type 4a |
320 | BSND |
321 | Bartter syndrome type 4b |
322 | CLCNKA |
323 | Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia |
324 | IARS2 |
325 | Cholestasis, infantile, NR1H4 related |
326 | NR1H4 |
327 | Crigler-Najjar syndrome, type 1 |
328 | UGT1A1 |
329 | Crigler-Najjar syndrome, type 2 |
330 | UGT1A1 |
331 | Cryptorchidism |
332 | RXFP2 |
333 | Cystinosis, nephropathic |
334 | CTNS |
335 | Cystinuria |
336 | PREPL |
337 | Cystinuria |
338 | SLC3A1 |
339 | Cystinuria |
340 | SLC7A9 |
341 | Dent disease |
342 | CLCN5 |
343 | Diabetes insipidus, nephrogenic, autosomal |
344 | AQP2 |
345 | Dubin-Johnson syndrome |
346 | ABCC2 |
347 | Endocrine-cerebroosteodysplasia |
348 | ICK |
349 | Epstein syndrome |
350 | MYH9 |
351 | Estrogen resistance |
352 | ESR1 |
353 | Factor XI deficiency |
354 | F11 |
355 | Factor XII deficiency |
356 | F12 |
357 | Factor XIIIA deficiency |
358 | F13A1 |
359 | Fanconi renotubular syndrome type 2 |
360 | SLC34A1 |
361 | Fanconi-Bickel syndrome |
362 | SLC2A2 |
363 | Focal segmental glomerulosclerosis and dilated cardiomyopath, MT-TY related |
364 | MT-TY |
365 | Focal segmental glomerulosclerosis type 1 |
366 | ACTN4 |
367 | Focal segmental glomerulosclerosis type 2 |
368 | TRPC6 |
369 | Focal segmental glomerulosclerosis type 3 |
370 | CD2AP |
371 | Focal segmental glomerulosclerosis type 4, susceptibility to |
372 | APOL1 |
373 | Focal segmental glomerulosclerosis type 5 |
374 | INF2 |
375 | Focal segmental glomerulosclerosis type 6 |
376 | MYO1E |
377 | Focal segmental glomerulosclerosis type 7 |
378 | PAX2 |
379 | Focal segmental glomerulosclerosis type 8 |
380 | ANLN |
381 | Focal segmental glomerulosclerosis type 9 |
382 | CRB2 |
383 | Focal segmental glomerulosclerosis, LAMA5 related |
384 | LAMA5 |
385 | FSH releasing protein deficiency |
386 | INHBA |
387 | Gilbert syndrome |
388 | UGT1A1 |
389 | Gitelman syndrome |
390 | SLC12A3 |
391 | Glomerulocystic kidney disease with hyperuricemia and isosthenuria |
392 | UMOD |
393 | Glucocorticoid deficiency type 4, with or without mineralocorticoid deficiency |
394 | NNT |
395 | Glucocorticoid resistance, generalized |
396 | NR3C1 |
397 | Glycine encephalopathy |
398 | AMT |
399 | Glycine encephalopathy |
400 | GLDC |
401 | Glycine N-methyltransferase deficiency |
402 | GNMT |
403 | Goitre, multinodular |
404 | KEAP1 |
405 | Growth hormone deficiency |
406 | GH1 |
407 | Growth hormone deficiency |
408 | GHRHR |
409 | Growth hormone insensitivity with immunodeficiency |
410 | STAT5B |
411 | Hemolytic uremic syndrome |
412 | CFB |
413 | Hemolytic uremic syndrome |
414 | CFH |
415 | Hemolytic uremic syndrome |
416 | CFHR1 |
417 | Hemolytic uremic syndrome |
418 | CFHR2 |
419 | Hemolytic uremic syndrome |
420 | CFHR3 |
421 | Hemolytic uremic syndrome |
422 | CFHR4 |
423 | Hemolytic uremic syndrome |
424 | CFHR5 |
425 | Hemolytic uremic syndrome |
426 | CFI |
427 | Hemolytic uremic syndrome |
428 | THBD |
429 | Hemolytic uremic syndrome, atypical type 2, susceptibility to |
430 | CD46 |
431 | Hepatic failure, early onset, and neurologic disorder |
432 | SCO1 |
433 | Hepatic venoocclusive disease with immunodeficiency |
434 | SP110 |
435 | Hyperaldosteronism type 3 |
436 | KCNJ5 |
437 | Hyperbilirubinemia, familial transient neonatal |
438 | UGT1A1 |
439 | Hyperbilirubinemia, Rotor type |
440 | SLCO1B1 |
441 | Hyperbilirubinemia, Rotor type |
442 | SLCO1B3 |
443 | Hyperparathyroidism type 1, familial |
444 | CDC73 |
445 | Hyperparathyroidism type 2, familial |
446 | CDC73 |
447 | Hyperparathyroidism, neonatal severe |
448 | CASR |
449 | Hypertriglyceridemia, transient infantile |
450 | GPD1 |
451 | Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis |
452 | SARS2 |
453 | Hyperuricemic nephropathy, familial juvenile type 1 |
454 | UMOD |
455 | Hypocalcemia, autosomal dominant, with Bartter syndrome |
456 | CASR |
457 | Hypocalciuric hypercalcemia, type 1 |
458 | CASR |
459 | Hypogonadotropic hypogonadism |
460 | KISS1R |
461 | Hypogonadotropic hypogonadism |
462 | LHB |
463 | Hypogonadotropic hypogonadism |
464 | NSMF |
465 | Hypogonadotropic hypogonadism type 10 with or without anosmia |
466 | TAC3 |
467 | Hypogonadotropic hypogonadism type 11 with or without anosmia |
468 | TACR3 |
469 | Hypogonadotropic hypogonadism type 12 with or without anosmia |
470 | GNRH1 |
471 | Hypogonadotropic hypogonadism type 15 with or without anosmia |
472 | HS6ST1 |
473 | Hypogonadotropic hypogonadism type 3 with or without anosmia |
474 | PROKR2 |
475 | Hypogonadotropic hypogonadism type 7 with or without anosmia |
476 | GNRHR |
477 | Hypoparathyroidism |
478 | PTH |
479 | Hypoparathyroidism, familial isolated |
480 | GCM2 |
481 | Hypoparathyroidism, sensorineural deafness, and renal dysplasia |
482 | GATA3 |
483 | Hypoparathyroidism-retardation-dysmorphism syndrome |
484 | TBCE |
485 | Hypophosphatemic rickets |
486 | CLCN5 |
487 | Hypothyroidism congenital nongoitrous type 1 |
488 | TSHR |
489 | Hypothyroidism congenital nongoitrous type 2, familial |
490 | PAX8 |
491 | Hypothyroidism congenital nongoitrous type 4 |
492 | TSHB |
493 | Hypothyroidism congenital nongoitrous type 6 |
494 | THRA |
495 | Hypothyroidism, isolated, TRHR related |
496 | TRHR |
497 | Hypotonia-cystinuria syndrome |
498 | PREPL |
499 | Hypouricemia, renal type 1 |
500 | SLC22A12 |
501 | Hypouricemia, renal type 2 |
502 | SLC2A9 |
503 | Immunodeficiency with natural killer cell deficiency |
504 | MCM4 |
505 | Immunodeficiency, common variable type 7 |
506 | CR2 |
507 | Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia |
508 | MAGT1 |
509 | Infantile liver failure syndrome type 2 |
510 | NBAS |
511 | Interstitial nephritis karyomegalic |
512 | FAN1 |
513 | Intrahepatic cholestasis of pregnancy, NR1H4 related |
514 | NR1H4 |
515 | Johanson Blizzard syndrome |
516 | UBR1 |
517 | Kallmann syndrome type 1 |
518 | ANOS1 |
519 | Kallmann syndrome type 2 |
520 | FGFR1 |
521 | Kallmann syndrome type 4 |
522 | PROK2 |
523 | Kallmann syndrome, SEMA3A related |
524 | SEMA3A |
525 | Laron syndrome |
526 | GHR |
527 | Liddle syndrome |
528 | SCNN1B |
529 | Liddle syndrome |
530 | SCNN1G |
531 | Lipoid congenital adrenal hyperplasia |
532 | STAR |
533 | Lipoprotein glomerulopathy |
534 | APOE |
535 | Liver failure transient infantile |
536 | TRMU |
537 | Lowe oculocerebrorenal syndrome |
538 | OCRL |
539 | LYSINURIC PROTEIN INTOLERANCE |
540 | SLC7A7 |
541 | McKusick-Kaufman syndrome |
542 | MKKS |
543 | Meckel syndrome type 1 |
544 | MKS1 |
545 | Meckel syndrome type 10 |
546 | B9D2 |
547 | Meckel syndrome type 3 |
548 | TMEM67 |
549 | Meckel syndrome type 4 |
550 | CEP290 |
551 | Meckel syndrome type 8 |
552 | TCTN2 |
553 | Meckel syndrome type 9 |
554 | B9D1 |
555 | Medullary cystic kidney disease type 2 |
556 | UMOD |
557 | Menkes disease |
558 | ATP7A |
559 | Mirage syndrome |
560 | SAMD9 |
561 | Multiple endocrine neoplasia type 1 |
562 | MEN1 |
563 | Nephrogenic syndrome of inapproriate antidiuresis |
564 | AVPR2 |
565 | Nephrolithiasis type 1 |
566 | CLCN5 |
567 | Nephrolithiasis/osteoporosis, hypophosphatemic, type 1 |
568 | SLC34A1 |
569 | Nephrolithiasis/osteoporosis, hypophosphatemic, type 2 |
570 | SLC9A3R1 |
571 | Nephronophthisis type 1 |
572 | NPHP1 |
573 | Nephronophthisis type 12 |
574 | TTC21B |
575 | Nephronophthisis type 13 |
576 | WDR19 |
577 | Nephronophthisis type 14 |
578 | ZNF423 |
579 | Nephronophthisis type 15 |
580 | CEP164 |
581 | Nephronophthisis type 16 |
582 | ANKS6 |
583 | Nephronophthisis type 19 |
584 | DCDC2 |
585 | Nephronophthisis type 2 |
586 | INVS |
587 | Nephronophthisis type 3 |
588 | NPHP3 |
589 | Nephronophthisis type 4 |
590 | NPHP4 |
591 | Nephronophthisis type 7 |
592 | GLIS2 |
593 | Nephronophthisis type 9 |
594 | NEK8 |
595 | Nephronophthisis-like nephropathy type 1 |
596 | XPNPEP3 |
597 | Nephrosis, Finnish type |
598 | NPHS1 |
599 | Nephrotic syndrome |
600 | NPHS2 |
601 | Nephrotic syndrome type 2 |
602 | NPHS1 |
603 | Nephrotic syndrome type 3 |
604 | PLCE1 |
605 | Nephrotic syndrome type 5 |
606 | LAMB2 |
607 | Nephrotic syndrome type 7 |
608 | DGKE |
609 | Nephrotic syndrome type 8 |
610 | ARHGDIA |
611 | Nephrotic syndrome type 9 |
612 | COQ8B |
613 | Obesity |
614 | MC4R |
615 | Obesity due to leptin deficiency |
616 | LEP |
617 | Obesity with adrenal insufficiency and red hair |
618 | POMC |
619 | Obesity with impaired prohormone processing |
620 | PCSK1 |
621 | Obesity, early-onset, susceptibility to |
622 | POMC |
623 | Obesity, severe |
624 | PPARG |
625 | Obesity, susceptibility to, SLC6A14 related |
626 | SLC6A14 |
627 | Ovalocytosis |
628 | SLC4A1 |
629 | Pancreatitis |
630 | CTRC |
631 | Pancreatitis |
632 | PRSS1 |
633 | Pancreatitis |
634 | SPINK1 |
635 | Pancreatitis, chronic, early onset |
636 | CPA1 |
637 | Pancreatitis, chronic, protection against |
638 | PRSS2 |
639 | Panhypopituitarism, X-linked |
640 | SOX3 |
641 | Parathyroid adenoma with cystic changes, familial |
642 | CDC73 |
643 | Pendred syndrome |
644 | SLC26A4 |
645 | Pigmented nodular adrenocortical disease type 1, primary |
646 | PRKAR1A |
647 | Pituitary hormone deficiency, combined type 3 |
648 | LHX3 |
649 | Pituitary hormone deficiency, combined type 4 |
650 | LHX4 |
651 | Polycystic kidney and hepatic disease |
652 | PKHD1 |
653 | Polycystic kidney disease type 1, autosomal dominant |
654 | PKD1 |
655 | Polycystic kidney disease type 1, autosomal recessive |
656 | PKHD1 |
657 | Polycystic kidney disease type 2, autosomal dominant |
658 | PKD2 |
659 | Polycystic liver disease |
660 | PRKCSH |
661 | Polycystic ovary syndrome type 1 |
662 | SULT2A1 |
663 | Polycystic ovary syndrome type 1 |
664 | SULT2B1 |
665 | Precocious puberty, male |
666 | LHCGR |
667 | Premature ovarian failure type 1 |
668 | FMR1 |
669 | Primary aldosteronism, seizures, and neurologic abnormalities |
670 | CACNA1D |
671 | Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis |
672 | CLCN5 |
673 | Pseudohypoaldosteronism, type 1, autosomal dominant |
674 | NR3C2 |
675 | Pseudohypoaldosteronism, type 1, autosomal recessive |
676 | SCNN1A |
677 | Pseudohypoaldosteronism, type 1, autosomal recessive |
678 | SCNN1B |
679 | Pseudohypoaldosteronism, type 1, autosomal recessive |
680 | SCNN1G |
681 | Pseudohypoaldosteronism, type 2B |
682 | WNK4 |
683 | Pseudohypoparathyroidism type 1A |
684 | GNAS |
685 | Pseudohypoparathyroidism type 1B |
686 | GNAS |
687 | Pseudohypoparathyroidism type 1C |
688 | GNAS |
689 | Pseudopseudohypoparathyroidism |
690 | GNAS |
691 | Renal cystic dysplasia, cystic, susceptibility to |
692 | BICC1 |
693 | Renal dysfunction due to SLC26A1 deficiency |
694 | SLC26A1 |
695 | Renal glucosuria |
696 | SLC5A2 |
697 | Renal tubular acidosis with deafness |
698 | ATP6V1B1 |
699 | Renal tubular acidosis, distal, autosomal recessive |
700 | ATP6V0A4 |
701 | Renal tubular acidosis, proximal, with ocular abnormalities |
702 | SLC4A4 |
703 | Renal tubular acidosis, SLC4A5 related |
704 | SLC4A5 |
705 | Renal tubular dysgenesis |
706 | ACE |
707 | Renal tubular dysgenesis |
708 | AGT |
709 | Renal tubular dysgenesis |
710 | AGTR1 |
711 | Renal tubular dysgenesis |
712 | REN |
713 | Senior-Loken syndrome type 6 |
714 | CEP290 |
715 | Senior-Loken syndrome type 7 |
716 | SDCCAG8 |
717 | Senior-Loken syndrome type 8 |
718 | WDR19 |
719 | SERKAL syndrome |
720 | WNT4 |
721 | Thromocytopenia-Absent-Radius-Syndrome |
722 | RBM8A |
723 | Thyroid dyshormonogenesis type 1 |
724 | SLC5A5 |
725 | Thyroid dyshormonogenesis type 2A |
726 | TPO |
727 | Thyroid dyshormonogenesis type 3 |
728 | TG |
729 | Thyroid dyshormonogenesis type 4 |
730 | IYD |
731 | Thyroid dyshormonogenesis type 5 |
732 | DUOXA2 |
733 | Thyroid dyshormonogenesis type 6 |
734 | DUOX1 |
735 | Thyroid dyshormonogenesis type 6 |
736 | DUOX2 |
737 | Thyroid hormone metabolism abnormal |
738 | SECISBP2 |
739 | Thyroid hormone resistance |
740 | THRB |
741 | Trifunctional protein deficiency |
742 | HADHB |
743 | Ventriculomegaly with cystic kidney disease |
744 | CRB2 |
745 | Vesicoureteral reflux type 2 |
746 | ROBO2 |
747 | Vesicoureteral reflux type 3 |
748 | SOX17 |
749 | Wilms tumor type 1, familial |
750 | WT1 |
751 | Wilson-Turner syndrome |
752 | LAS1L |
753 | Wolcott-Rallison syndrome |
754 | EIF2AK3 |
No. | Description |
---|---|
1 | Achondrogenesis type 1b (SLC26A2 gene) |
2 | Achondroplasia (FGFR3 gene- G1138A and G1138C) Targeted mutation analysis |
3 | Acromicric dysplasia (FBN1 gene) |
4 | Anauxetic dysplasia (RMRP gene) |
5 | Atelosteogenesis type 2 (SLC26A2 gene) |
6 | Bent bone dysplasia syndrome (FGFR2 gene) |
7 | Brachydactyly, type B1 (ROR2 gene) |
8 | Caffey disease (COL1A1 gene) |
9 | Crouzon syndrome with acanthosis nigricans (FGFR3 gene) |
10 | De la Chapelle dysplasia (SLC26A2 gene) |
11 | Diastrophic dysplasia (SLC26A2 gene) |
12 | Epiphyseal dysplasia, Type 4 (SLC26A2 gene) |
13 | Gracile bone dysplasia (FAM111A gene) |
14 | Hypochondroplasia (FGFR3 gene) ( |
15 | Arthropathy, progressive, spondyloepiphyseal dysplasia tarda (WISP3 gene) |
16 | Tarsal-carpal coalition syndrome (NOG gene) |
17 | Kenny-Caffey syndrome-1 (TBCE gene) |
18 | Cleidocranial dysostosis (RUNX2 gene) ( |
19 | Klippel Feil syndrome- Type 3 - Autosomal Dominant (GDF3 gene) |
20 | Larsen syndrome (FLNB gene) |
21 | Metaphyseal dysplasia without hypotrichosis (RMRP gene) |
22 | Muenke syndrome (FGFR3 gene) |
23 | Nail-patella syndrome (LMX1B gene) |
24 | Osteogenesis imperfecta, type 7 (CRTAP genes) |
25 | Osteopetrosis, autosomal recessive 1 (TCIRG1 gene) |
26 | Pycnodysostosis (CTSK gene) |
27 | Robinow syndrome (ROR2 gene) |
28 | Cartilage-hair hypoplasia (RMRP gene) |
29 | Shprintzen-Goldberg Craniosynostosis Syndrome (FBN1 gene) |
30 | Spondylocostal Dysostosis (DLL3 gene) |
31 | Spondylometaepiphyseal dysplasia, short limb-hand type (DDR2 geni) |
32 | Thanatophoric dysplasia type 1 and type 2 (FGFR3 gene) |
No. | Description |
---|---|
1 | Alpha-thalassemia (HBA1, HBA2 ve HBZ genes) (Deletion analysis- MLPA) |
2 | Beta-thalassemia (HBB gene) |
3 | BOMBAY PHENOTYPE - PARA-BOMBAY PHENOTYPE (FUT1 gene) |
4 | Del (20q) (FISH) |
5 | A.11q22.3 (ATM Deletion) (FISH) |
6 | B.11q23 Deletion (FISH) |
7 | C.13q14.3 Deletion (RB1) (FISH) |
8 | D.19p13 (E2A) (Breakapart) (FISH) |
9 | E.20q12 (20q) Deletion (FISH) |
10 | F.5q31 Deletion (EGR1) (FISH) |
11 | G.7q31 Deletion (FISH) |
12 | H.8 Trisomy/ Monosomy (FISH) |
13 | I.AML - MDS Panel (Del (5q) - t(15;17) (q22;q21) (PML/ RARA) - TP53 - t(8;21) (q22;q22) (ETO/ AML1) - Trisomy 8 - t(11;?) (q23;?) (MLL/ ?) - -7/ Del (7q) (Monosomy 7/ Delesyon 7q) - inv(16) (p13;q22) (CBFB/ MYH11) - Del (20q)) (FISH) (PANEL) |
14 | J.cMYC/ IGH, IGL and IGK Translocation (Burkit Lymphoma) t(8;14) , t(8;22) and t(2;8) (FISH) |
15 | K.FIP1L1/CHIC2/PDGFRA Deletion/Fusion (FISH) |
16 | L.JAK2 V600E Mutation (Sequence analysis) |
17 | M.CLL Panel (t(11;14) (q13;q32) and 14q32 Deletion (IgH/ CCND1) - Trisomy 12 - 13q14.3 Deletion (RB1) - p53 Gene (TP53) (17p13.1) - 6q23 Deletion - 11q22.3 Deletion (ATM)) (FISH) (PANEL) |
18 | N.Leukemia, acute myeloid (NPM1 gen) |
19 | O.Monosomy 4 (FISH) |
20 | P.Monosomy 5 (FISH) |
21 | Q.Monosomy 7/ deletion 7q (-7/del7q) (FISH) |
22 | R.Multipl Myeloma Panel CKS1B/CDKN2C (P18) (1q21/ 1p32.3) Amplification/Deletion, IGH (14q32) breakapart, t(11;14) (q13;q32) (IgH/ CCND1), t(11:14) (IGH/ MYEOV), P53 Gene (TP53) (17p13.1), t(4;14) (IgH/ FGRF3), t(14;16) (IGH/MAF), 9, 11 and 15 aneuploidy, 1 |
23 | S.P16 (FISH) |
24 | T.P53 Gene (TP53) (17p13.1) (FISH) |
25 | U.t (11;?) (q23;?) (MLL / ?) (MLL TRANSLOCATIONS) (FISH) |
26 | V.t(14:16) (IGH/MAF) (FISH) |
27 | W.t (3;3) (q21;q26) and inv (3) (q21q26) (EVI1) (FISH) |
28 | X.t (4;11) (q21;q23) (MLL / AF4) (REAL-TIME PCR) |
29 | Y.t(4;14) (IgH/ FGRF3) (FISH) |
30 | Z.t (8;14) (q14;q32) (?-IGH) (FISH) |
31 | Z1. Trisomy 10 (FISH) |
32 | Z2. Trisomy 12 (FISH) |
33 | Z3. Von Willebrand disease, type 1,2A, 2B, 2M, 2N, 3 (VWF gene) |
34 | Z4. Warfarin sensitivity (F9 gene) Xq13.2 (XIST) (FISH) |
35 | Z5. ALL Paneli (t(11;?) (q23;?) (MLL/ ?) - t(12;21) (p13;q22) (TEL/ AML1) - E2A (TCF3) Break Apart - MYC rearrangements - IgH rearrangements - t(9;22) (q34;q11.2) - 4, 10, 17. abnormalities - aneuploidies - p16) (FISH) |
36 | Diamond-Blackfan anemia 1 (RPS19 gene) |
37 | Thrombophilia, X-linked, due to factor 9 defect (F9 gene) |
38 | Hemophilia A (F8 gene) |
39 | Hemophilia B (F9 gene) |
40 | Thrombosis, hyperhomocysteinemic (CBS gene) |
41 | Human Platelet Antigen (HPA1, HPA2, HPA3, HPA4, HPA5 and HPA15 genes, a and b alleles) |
42 | inv (16) (p13;q22) (CBFB / MYH11)/ t (16;16) (p13;q22) (CBFB / MYH11) (REAL-TIME PCR) |
43 | Chimerism (FISH) (Same gender) |
44 | Sickle cell anemia (HBB gene) (GLU6VAL) |
45 | t (11;14) (q13;q32) (IgH / CCND1) (FISH) |
46 | t (12;21) (p13;q22) (TEL / AML1) (FISH) |
47 | t (14;18) (q32;q21) (IgH / BCL2) (FISH) |
48 | t (15;17) (q22;q21) (PML / RARA) (FISH) |
49 | t (8;21) (q22;q22) (ETO / AML1) (FISH) |
50 | t (9;22) (q34;q11.2) (BCR/ABL) (Philadelphia chromosome) (FISH) |
51 | Thrombocytopenia, congenital amegakaryocytic (MPL gene) |
52 | Thrombocytopenia, X-linked (WAS gene) |
No. | Description |
---|---|
1 | Amniotic fluid- Chromosome analysis |
2 | Bloom syndrome (Kromozom analizi ve SCE-Sister Chromatid Exchange) |
3 | Skin biopsy- Chromosome analysis |
4 | DEB test (Fanconi anemia) |
5 | Abortion- Chromosome analysis |
6 | Fetal blood sample - Chromosome analysis |
7 | Fragile-X chromosome analysis |
8 | Gonad biopsy- Chromosome analysis |
9 | High resolution (HRB) chromosome analysis |
10 | ICF (Immundeficiency- Centromeric instability- Facial anomalies) |
11 | SCE-Sister Chromatid Exchange |
12 | Peripheral blood- Chromosome analysis |
13 | Solid Tissue biopsy- Chromosome analysis |
14 | Xseroderma pigmentosum |
No. | Description |
---|---|
1 | Acrodermatitis Enteropathica (SLC39A4 gene) |
2 | Alagille syndrome (JAG1 gene) |
3 | Cholestasis, benign recurrent intrahepatic (ATP8B1, ABCB11 genes) |
4 | CriglerNajjar syndrome type 1 and type 2 (UGT1A1 gene) |
5 | DubinJohnson syndrome (ABCC2 gene) |
6 | Cholestasis, familial intrahepatic, of pregnancy (ABCB4 gene) |
7 | Gilbert's syndrome (UGT1A1 gene) |
8 | Cholestasis, progressive familial intrahepatic 1 (PFIC1) (ATP8B1 gene) |
9 | Diarrhea 1, secretory chloride, congenital (SLC26A3 gene) |
10 | Pancreatitis, chronic (CTRC gene) |
No. | Description |
---|---|
1 | Growth hormone insensitivity with immunodeficiency (STAT5B gene) |
2 | Immunodeficiency due to defect in CD3-zeta (CD247 gene) |
3 | Neutrophilia, hereditary (CSF3R gene) |
4 | Hyper-IgE recurrent infection syndrome (STAT3 gene) |
5 | IPEX syndrome (Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked) |
6 | IRAK4 deficiency (IRAK4 gene) |
7 | Immunodeficiency 23 (PGM3 gene) |
8 | Immunodeficiency, common variable, 2 (TNFRSF13B gene) |
9 | Invasive pneumococcal disease, recurrent isolated, 1 (IRAK4 gene) |
10 | Combined cellular and humoral immune defects with granulomas (RAG1 gene) |
11 | Complement C1q deficiency (C1QA, C1QB, C1QC genes) |
12 | Kostmann disease (HAX1 gene) |
13 | LIG4 sendromu (LIG4 gene) |
14 | Nijmegen breakage syndrome (NBN Gene-c.657_661del5/ c.657_661del5657del5 mutations |
15 | Neutrophil immunodeficiency syndrome (RAC2 gene) |
16 | Omenn syndrome (RAG1 gene) |
17 | Autoimmune Diseases (Autoimmune Hypothyroidism, type1 diabetes mellitus, etc) (CTLA4 gene) |
18 | Macroglobulinemia, Waldenstrom, somatic (MYD88 gene) |
19 | Reticular dysgenesis (AK2 gene) |
20 | Neutropenia, cyclic (ELANE gene) |
21 | Wiskott-Aldrich syndrome (WAS gene) |
22 | Immunodeficiency, X-linked, with hyper-IgM (CD40LG gene) |
NO. | TEST NAME | SAMPLE TYPE |
---|---|---|
1 | 17-Hydroxypregnenolone | 24 Hrs Urine |
2 | 17-OHP [17-Hydroxyprogesterone] | Serum |
3 | 5-HIAA [5-Hydroxyindole Acetic Acid] | 24 Hrs Urine |
4 | ACE [Angiotensin Converting Enzyme] Level | Serum |
5 | ACHR [Acetylcholine Receptor] Antibodies, Quantitative | Serum |
6 | ACTH [Adrenocorticotropic Hormone] | Serum |
7 | Activated Protein C Resistance, PCR | Plasma [Sodium Citrate] |
8 | Activated Protein C Resistance, PCR | Whole Blood [EDTA] |
9 | Adenovirus | |
10 | ADH [Anti-diuretic Hormone] [Vasopressin] | Plasma [EDTA] & Serum |
11 | AFB Smear | Body fluid |
12 | AFB Smear | Sputum |
13 | AFP [Alpha Fetoprotein] | Serum |
14 | Albumin | Serum |
15 | Aldolase | Serum |
16 | Aldosterone level | 24 Hrs Urine |
17 | Aldosterone level [Supine] | Serum |
18 | Aldosterone level [Up right] | Serum |
19 | Aldosterone/Renin Ratio (Supine) [ARR] | |
20 | Aldosterone/Renin Ratio (Up right) [ARR] | |
21 | Alkaline Phosphatase Iso-enzymes | Serum |
22 | Allergy, Food Panel [30 Allergens] | Serum |
23 | Allergy, Paediatric Panel [30 Allergens] | Serum |
24 | Allergy, Respiratory Panel [30 Allergens] | Serum |
25 | ALP [Alkaline Phosphatase] | Serum |
26 | Alpha Thalassemia Trait | Whole Blood [EDTA] |
27 | ALT [Alanine Aminotransferase] [GPT] | Serum |
28 | AMA [Anti Mitochondrial Antibody] | Serum |
29 | AMH [Anti Mullerian Hormone] | Serum |
30 | Amylase | 24 Hrs Urine |
31 | Amylase | Spot Urine |
32 | Amylase | Body Fluid |
33 | Amylase | Serum |
34 | ANA [Anti-Nuclear Antibody] | Serum |
35 | ANA Latex | Serum |
36 | ANA- Profile (All Profiles) | Serum |
37 | ANA- Profile: | Serum |
AIH [Autoimmune Hepatitis] [LKM1 Abs, LC1 Abs, SLA Abs, F-actin Abs] | ||
38 | ANA- Profile: | Serum |
Autoimmune Gastritis [IF (intrinsic factor), PCA (Parietal Cell Antibodies)] | ||
39 | ANA- Profile: | Serum |
Celiac Disease [Anti-gliadin Abs, Anti-tTG Abs] | ||
40 | ANA- Profile: | Serum |
Goodpasture syndrome [GBM (Glomerular Basement Membrane)] | ||
41 | ANA- Profile: | Serum |
Milk intolerance [ß-Lactoglobulin Abs] | ||
42 | ANA- Profile: | Serum |
PBC [Primary Biliary Cirrhosis] [M2 Abs, M2/PDC-E2, M2/BCO ADC-E2, M2/OGDC-E2, gp210, sp100] | ||
43 | ANA- Profile: | Serum |
Polymyositis/Dermatomyositis and Scleroderma [Jo-1 Abs, PL-7 & PL-12 Abs, EJ, OJ, KS, HA, ZO, SRP Abs, MDA-5 Abs, Anti-TIF1-l Abs, Mi-2 Abs, HMGCR Abs, SAE Abs, NXP-2 Abs, PM-Scl Abs, Ku Abs, Scl-70 Abs, RNA polymerase III Abs, Th/To, Anti-Fibrillarin Abs, NOR-90] | ||
44 | ANA- Profile: | Serum |
Sharp Syndrome [RNP Abs, Sm/RNP Abs] | ||
45 | ANA- Profile: | Serum |
Sjogrens Syndrome [Anti-SSA, TRIM21, SSB Abs] | ||
46 | ANA- Profile: | Serum |
SLE [Systemic Lupus Erythromatosus] [ds-DNA Abs, Histone Protein, Nucleosome Abs, Sm Abs, Ribosome P protein (RPP) Abs, PCNA, Centromere Abs] | ||
47 | ANA- Profile: | Serum |
Vasculitis syndrome [Proteinase 3 (RP3), Myeloperoxidase MPO, C-ANCA, P-ANCA] | ||
48 | ANCA/PR3 [Antineutrophil Cytoplasmic Antibodies] | Serum |
49 | Androgen | Serum |
50 | Androstenedione | Serum |
51 | Anti- Chlamydia Antibodies, IgA | Serum |
52 | Anti- Chlamydia Antibodies, IgG | Serum |
53 | Anti- Chlamydia Antibodies, IgM | Serum |
54 | Anti-Cardiolipin Antibodies, IgG | Serum |
55 | Anti-Cardiolipin Antibodies, IgM | Serum |
56 | Anti-Endomysial Antibodies, IgA | Serum |
57 | Anti-Endomysial Antibodies, IgG | Serum |
58 | Anti-GAD [Glutamic Acid Decarboxylase Abs] [GADA] | Serum |
59 | Anti-HBc Ab [Hepatitis B Core Antibodies, IgM] | Serum |
60 | Anti-HBc Ab [Hepatitis B Core Antibodies, Total] | Serum |
61 | Anti-HBe Ab [Hepatitis B Envelope Antibodies] | Serum |
62 | Anti-HBs Ab [Hepatitis B Surface Antibody] titer | Serum |
63 | Anti-Insulin Antibodies | Serum |
64 | Anti-Intrinsic factor | Serum |
65 | Anti-La [Anti-SS-B Antibody] | Serum |
66 | Anti-Ro [Anti-SS-A Antibody] | Serum |
67 | Anti-Sm [Anti-Smith Antibodies] | Serum |
68 | Anti-Sperm Antibody | Serum |
69 | Anti-TG [Anti Thyroglobulin Antibodies] | Serum |
70 | Anti-Thrombin III | Plasma [Sodium Citrate] |
71 | Anti-TPO [Anti Thyroid Peroxidase Antibodies] | Serum< |